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RESUMO 
 
A resistência aos antimicrobianos (AMR) é atualmente um dos principais problemas 
de saúde pública a nível mundial. Sem que se vislumbrem medidas corretivas imediatas, 
a conjugação da emergência de bactérias multirresistentes com o enfraquecimento do 
interesse da indústria farmacêutica na descoberta de novos compostos antimicrobianos 
invoca o espetro de estarmos a progredir em direção a uma era pós-antimicrobiana, que 
nos deixará indefesos mesmo perante as infeções bacterianas mais vulgares. A 
emergência e a disseminação massiva dos determinantes de resistência é resultado de 
décadas de uso de antibióticos, no homem e nos animais, sem um conhecimento cabal 
do impacto ecológico destes compostos na flora bacteriana. A evolução da medicina 
veterinária e a sensibilização da população para a saúde e bem-estar animais 
conduziram a um incremento quer da longevidade dos animais de companhia, quer da 
frequência de patologias crónicas e imunodebilitantes, amplamente associadas a maior 
probabilidade de carecerem de tratamentos antimicrobianos que, por sua vez, 
promoveram a emergência de AMR nestes animais. Para defesa da saúde humana e 
animal, é importante recolher informação epidemiológica, relativa a cães e gatos, que 
auxilie a antibioterapia empírica e que, ao mesmo tempo, apoie o desenvolvimento de 
estratégias conservativas para o controlo dos riscos de transmissão de estirpes 
multirresistentes entre animais de companhia e os seus coabitantes humanos. 
Considerando as referidas preocupações, dois objetivos foram propostos para o 
presente estudo: i) a monitorização dos perfis de AMR de Escherichia coli e Enterococcus 
spp. isolados em fezes de cães e gatos atendidos na Clínica Veterinária da Universidade 
do Porto (UPVet), Portugal, e estudo dos respetivos fatores de risco; e ii) a avaliação da 
disseminação e partilha de bactérias ou de determinantes genéticos de resistência 
antimicrobiana através do ambiente doméstico, considerando coabitantes humanos, 
animais de companhia e superfícies e objetos frequentemente tocados por ambos. 
Para o trabalho de monitorização recolheram-se zaragatoas rectais em 81 cães e 
30 gatos que não haviam sido submetidos a qualquer tratamento antibioterapêutico nos 
quatro meses que antecederam a colheita. A seleção dos animais foi efetuada por um 
método sistemático aleatório, entre Setembro de 2009 e Maio de 2012. Os proprietários 
assinaram um termo de consentimento, preencheram um questionário e permitiram a 
amostragem dos animais, através de zaragatoa rectal, para posterior isolamento de E. 
coli e enterococos. A Comissão de Ética do Instituto de Ciências Biomédicas Abel 
Salazar da Universidade do Porto deu a sua aprovação prévia à realização do estudo.  
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Obtiveram-se 396 isolados de E. coli e 315 isolados de Enterococcus spp. Uma 
proporção considerável de isolados de E. coli revelou resistência à ampicilina (51,3%), à 
cefalotina (46,7%), à tetraciclina (45,2%) e à estreptomicina (43,4%). Os enterococos 
mostraram-se mais resistentes à tetraciclina (67,0%), à rifampicina (60,3%), ao 
aztreonam (58,4%), à quinupristina/dalfopristina (54,0%) e à eritromicina (53,0%). Não se 
encontraram resistências à nitrofurantoína nem ao imipenem. O “tratamento prévio com 
quinolonas” foi considerado o principal fator de risco para a presença de AMR em 12 
(ampicilina, cefalotina, ceftazidima, cefotaxima, ácido nalidíxico, ciprofloxacina, 
gentamicina, tetraciclina, estreptomicina, cloramfenicol, trimetoprim-sulfametoxazol e 
aztreonam) dos 15 antimicrobianos testados para E. coli e em 3 (cloranfenicol, 
ciprofloxacina e azitromicina) dos 9 antimicrobianos testados para enterococos. Os 
“hábitos de coprofagia” foram também positivamente associados a um maior risco de 
AMR para E. coli (ampicilina, amoxicilina-ácido clavulânico, cefamicina, ciprofloxacina, 
estreptomicina e trimetoprim-sulfametoxazol) e para os enterococos, relativamente à 
tetraciclina, rifampicina, gentamicina, cloranfenicol, ciprofloxacina, eritromicina e 
azitromicina.  
Em função dos perfis de resistência antimicrobiana encontrados e/ou historial 
antibioterapêutico dos animais, alguns proprietários foram abordados no sentido de 
colaborarem na segunda fase do estudo, para se proceder à recolha de amostras nos 
coabitantes humanos e animais, assim como em algumas superfícies e objetos de uso 
frequente no quotidiano doméstico. Realizaram-se três estudos para avaliação da 
potencial disseminação de enterococos em agregados domésticos, originários de dois 
cães e um gato amostrados para o estudo de prevalência; para os trabalhos com E. coli 
participaram três agregados selecionados a partir do universo de 81 cães amostrados. Os 
resultados obtidos evidenciaram a disseminação de E. coli e Enterococcus faecalis 
multirresistentes entre animais de companhia (cães e gatos) e respetivos proprietários. 
As mesmas estirpes foram também encontradas disseminadas em diversos objetos e 
superfícies do ambiente doméstico.  
Os resultados do presente estudo deveriam alertar a classe médico-veterinária 
para o problema da emergência da AMR nos animais de companhia, para os fatores de 
risco que a regulam, assim como para a possibilidade de disseminação intra- e inter-
espécies. 
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ABSTRACT 
 
Antimicrobial resistance (AMR) is currently a major threat to public health around the 
world. In the absence of urgent corrective and protective actions, the worrying conjuncture 
of bacteria developing resistance against all known classes of antibiotics at a time that 
pharmaceutical industry was weakening investment in discovering new ones, mankind is 
heading towards a post-antibiotic era, in which many common bacterial infections will no 
longer have a cure. The increasing emergence and spread of AMR is the result of 
decades of usage of antibiotics in humans and animals with a misperception of the 
ecological impact of this usage on the bacterial flora. Advances in veterinary medicine and 
heightened sensibility of population towards the health and welfare of pets conducted to a 
rise in pets’ longevity with a substantial augment in chronic debilitating and 
immunocompromising conditions and higher probability for needing antimicrobial 
treatments, guiding to the emergence of AMR amongst these animals. Due to both animal 
and human health concerns, investigation efforts involving dogs and cats are needed to 
provide epidemiological information that could guide antimicrobial empiric therapy and 
help the development of conservative risk management strategies to mitigate the 
transmission of multidrug-resistant strains between them and their human cohabitants. 
Bearing in mind the above concerns, two main purposes were addressed for the 
present work: i) a survey study of AMR profiles of fecal Escherichia coli and Enterococcus 
spp. from dogs and cats attending the Small Animal Veterinary Clinic  of Porto University 
(UPVet) in Portugal, with an estimation of the respective risk factors; and ii) the 
assessment of within household spread and share of antimicrobial resistant determinants 
or bacteria, taking into consideration cohabitant humans and pets and common touched 
objects and surfaces. 
For the surveillance work, fecal samples were obtained from 81 dogs and 30 cats 
that were not submitted to any antimicrobial therapy within the preceding four months. A 
random systematic approach was adopted to select the animals for the survey study at 
the UPVet, from September 2009 to May 2012. The owners were asked to sign in a term 
of acceptance, to fill a questionnaire and to allow the collection of fecal samples from their 
pets using rectal swabs in order to perform E. coli and enterococci isolation. A previous 
approval was obtained from the Ethics Committee of the Abel Salazar Institute for the 
Biomedical Sciences, University of Porto.  
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Three hundred and ninety six E. coli and 315 enterococci isolates were obtained. A 
considerable proportion of E. coli isolates displayed resistance to ampicillin (51.3%), 
cephalothin (46.7%), tetracycline (45.2%) and streptomycin (43.4%). Enterococci were 
more resistant to tetracycline (67.0%), rifampicin (60.3%), aztreonam (58.4%), 
quinupristin/dalfopristin (54.0%) and erythromycin (53.0%). No resistances were found to 
nitrofurantoin and imipenem. It was found that “Previous quinolone treatment” was the 
main risk factor for the presence of AMR in 12 (ampicillin, cephalothin, ceftazidime, 
cefotaxime, nalidixic acid, ciprofloxacin, gentamicin, tetracycline, streptomycin, 
chloramphenicol, trimethoprim-sulfamethoxazol and aztreonam) out of the 15 
antimicrobials assessed for E. coli and in 3 (chloramphenicol, ciprofloxacin and 
azithromycin) out of the 9 of the antimicrobials assessed for enterococci. “Coprophagic 
habits” were also positively associated with an increased risk of AMR in E. coli (for 
ampicillin, amoxicillin-clavulanic acid, cephamycin, ciprofloxacin, streptomycin, and 
trimethoprim-sulfamethoxazol) and in enterococci (for tetracycline, rifampicin, gentamicin, 
chloramphenicol, ciprofloxacin, erythromycin and azithromycin). 
Considering the resistance profiles found into some enteric bacteria and/or the 
previous clinical records of the animals, some of the owners were asked to enter the 
second branch of the study, expanding the investigation to the humans and pets 
cohabitants as well as to some frequently touched household objects and surfaces. 
Domestic aggregates from two dogs and one cat agreed to collaborate in the enterococci 
spread investigation whereas three dog owners’ endorsed the E. coli dissemination study. 
Results showed that multidrug-resistant E. coli and Enterococcus faecalis can happen 
between pets (dogs and cats) and owners. Those strains were also disseminated 
throughout home and household objects and surfaces. 
Results from the present study should alert veterinarians for the AMR emergence 
problem in small animals, the risk factors that regulate it as well as of its ways of intra- and 
inter-species spread. 
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1.1. GENERAL INTRODUCTION  
 
 
1.1.1. The phenomenon of antimicrobial resistance 
 
Antibiotics are one of the most important therapeutic discoveries in medical history. 
When antibiotics were first introduced in the 1940s, they were called “wonder drugs”, the 
“miracle” of modern medicine (WHO, 2011). Major diseases that killed millions of people 
could then be treated. Its widespread use for over 70 years, however, “educated” bacteria 
to become resistant and, apparently, the global resistance phenomenon has caught 
everyone unprepared (Prescott, 2014). According to the World Health Organization 
(WHO, 2012a), the world is heading towards a post-antibiotic era, in which many common 
infections will no longer be cured with antibiotics because bacteria are becoming largely 
resistant to them (Andersson and Hughes, 2010; EAAD, 2013). The increasing global 
resistance rates in many bacterial species, responsible for both community- and hospital-
related infections (Enterobacteriaceae, staphylococci and enterococci,), as well as the 
emergence and rapid dissemination of new mechanisms of resistance (e.g. extended-
spectrum beta-lactamases (ESBL) and carbapenemases), are two staggering phenomena 
(Carlet et al., 2012). Infections by resistant bacteria are currently quite common, and 
some pathogens are resistant to multiple types or classes of antibiotics (CDC, 2013). 
Portugal is not immune to this problem, with alarming detection rates of ESBL producing 
and fluoroquinolone-resistant E. coli isolates in both nosocomial and community infections 
(Machado et al., 2006; Mendonça et al., 2007; Guimarães et al., 2009). Resistance 
dramatically reduces first-line and second-line antibiotic treatment options, forcing 
healthcare providers to use antibiotics that may be more toxic to the patient, more 
expensive and frequently less effective, thus increasing the risk of complications, delayed 
recuperation, long-term disability and even fatal outcomes (Andersson and Hughes, 2010; 
Carlet et al., 2012; CDC, 2013). Additionally, the increasing resistance to last-line 
antibiotics, such as carbapenems used to treat healthcare-associated infections, means 
that presently carbapenem-resistant infections are being treated with old and toxic drugs, 
which may be considered a drawback in antimicrobial therapy (EAAD, 2013). 
The implications of AMR emergence go beyond the resurgence of deadly 
infections; it will also threat many life-saving and life-prolonging interventions attending to 
the emergence of highly-resistant pathogens in hospital settings (Bassetti and Righi, 
2013; EAAD, 2013). 
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To address these issues, it is imperative that novel classes of antibiotics 
demonstrating activity against bacterial strains resistant to the existing ones are 
introduced into the clinical practice (Georgopapadakou, 2013). Nonetheless, only a small 
number are currently in development and most belong to the existing classes: 
lipoglycopeptides, cephalosporins, amino-glycosides, ketolides, oxazolidinones and 
antifolates (Projan and Bradford, 2007). Worryingly, antibiotics under development target 
almost exclusively Gram-positive bacteria (O’Neill, 2008). There is thus an urgent need for 
compounds active against Gram-negative bacteria, particularly Enterobacteriaceae 
displaying resistance against currently available drugs (Bassetti and Righi, 2013).  
The threatening hospital-emerging “superbugs” are just the extreme expression of 
a much broader and disturbing phenomenon. The development of resistance is a natural 
biological process that will occur, sooner or later, for every drug. It is based on the genetic 
plasticity of bacteria and has emerged as the consequence of a “selective pressure” 
exerted by the antimicrobial usage in human and veterinary medicine, animal and fish 
production, agriculture and food technology (van de Sande-Bruinsma et al., 2008; da 
Costa et al., 2013). There is considerable evidence that antimicrobial use selects for 
resistance in commensals and zoonotic pathogens of both humans (Enne, 2010; da Costa 
et al., 2013; EAAD, 2013) and animals (McEwen and Fedorka-Cray, 2002; Berge et al., 
2006). 
The development of antibiotic resistance is usually associated with genetic 
changes, either mutations in elements relevant for the activity of the antibiotic, or the 
acquisition of resistance genes. The later may occur by transduction (mediated by 
bacteriophages), conjugation (which involves direct cell-to-cell contact and transfer of 
plasmids or transposons) or transformation, involving the uptake of free DNA that results 
from bacterial lysis (da Costa et al., 2013). Horizontal gene transfer (HGT) among bacteria 
is crucial for resistance spreading, particularly within mixed bacterial populations such as 
intestinal microbiota (McDermott et al., 2003; Smillie et al., 2011). Co-selection of 
resistance to more than one antibiotic, owing to genetic linkage of the resistance genes 
(that can be present in the same plasmid or transposon), is a common feature of 
resistance acquired by HGT. For that reason, the frequency of resistance to an antibiotic 
may augment, even if that antibiotic is no longer used (O’Brien, 2002; Summers, 2002; 
Andersson and Hughes, 2010). In some situations, resistance can be achieved without 
genetic alterations. These non-inherited resistances are associated to specific phenotypic 
processes such as growth in biofilms, a stationary growth phase or persistence, swarming 
motility, and surfactant or flagella synthesis (Kearns, 2010). 
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In summary, AMR emergence is a natural process that has been vastly 
accelerated and amplified by several human practices, behaviors and policy failures. 
Unreasonable and inappropriate use of antimicrobials is by far the major driver of drug 
resistance (Turnidge and Christiansen, 2005; Enne, 2010; da Costa et al., 2013; EAAD, 
2013). Thus, it is extremely important to simultaneously adopt numerous interventions or 
actions in order to restrain or stabilize resistance and gain time while new antibiotics can 
be developed (Prescott, 2014). Such interventions are based on public health strategies 
like immunization, infection control, protection of food supplies, antibiotic stewardship, and 
reduction of person-to-person spread through screening, treatment and education (CDC, 
2013). Among those, the ethics of Good Stewardship Practice (GSP) is being highlighted 
as an active and dynamic process of continuous improvement in antibiotic use that must 
be approached by all antibiotic users (Weese et al., 2013; Prescott, 2014). 
The presence of AMR in the commensal microbiota of animals can have a serious 
impact in human health because these bacteria are most likely to be transferred to 
humans through i) direct; or ii) indirect contact; iii) the food chain and iv) transference of 
genetic resistance determinants to zoonotic pathogens (McEwen and Fedorka-Cray, 
2002; Guardabassi et al., 2004; da Costa et al., 2013).  
According to Prescott (2014), the complex epidemiology of resistance is such that 
potentially ‘‘resistance anywhere is resistance everywhere’’. This concept is reflected in 
Figure 1. 
Figure 1. Schematic representation of the global dissemination of antimicrobial resistance 
(bacteria and resistance genes). Adapted from Prescott (2014).  
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The food chain is believed to be the most effective way for antimicrobial-resistant 
bacteria transmission from animals to humans. Relevant data were achieved for E. coli 
(Hammerum et al., 2010) as well as for Enterococcus spp. (Heuer et al., 2006). Resistant 
pathogenic or non-pathogenic bacteria are selected in the intestinal flora of animals, 
contaminate foods of animal origin and colonize or transfer resistance to other bacteria in 
the human gut (van den Bogaard et al., 2000). However, resistant bacteria or their genetic 
determinants, originated from direct or indirect contact with other sources (e.g. 
contaminated hands, foods, drinks or water) can also achieve and colonize human 
intestine through the alimentary pathway (Prescott, 2014). 
Direct contact is probably the most frequent form for antimicrobial resistant 
bacteria to pass from animals to humans. Farm workers have frequent contact with skin, 
feces and urine as well as secretions from oral, nasal or genital cavities of animals. Some 
reports support the possibility for E. coli (or its resistance genes) to be transmitted through 
direct contact between humans and farm animals such as cattle (Madec et al., 2012), pigs 
(van den Bogaard et al., 2000; Zhao et al., 2010), chicken and poultry (Zhao et al., 2010; 
Girlich et al., 2007; Huang et al., 2009); the same was reported for Enterococcus spp. 
(van den Bogaard et al., 2000). A similar situation happens with companion animals: 
direct interaction between pets and owners enables the contact with the animals’ skin, 
residues of urine and feces, and oral, auricular and nasal secretions. Several reports have 
documented the presence of fecal multidrug-resistant E. coli and Enterococcus spp. in 
dogs and cats (Nam et al., 2010; Wieler et al., 2011; Leonard et al., 2012; Hamilton et al., 
2013) and some of them reported that such multidrug-resistant E. coli strains were shared 
between humans and pets (Stenske et al., 2009; Harada et al., 2012) or between 
cohabitant pets (Leonard et al., 2012) whereas others have postulated that pets could be 
reservoirs of Enterococcus spp. associated with human infections (Damborg et al., 2009; 
Kwon et al., 2012; Tremblay et al., 2013).  
More recently, the environmental pathways were recognized as important routes 
for AMR spread between different biomes (van Elsas et al., 2011). In addition, antibiotics 
used in human and veterinary medicine may contaminate the environment via wastewater 
treatment plant effluents, hospital and processing plant effluents, application of agricultural 
wastes and biosolids to fields, and leakage from waste-storage containers and landfills 
(Williams et al., 2005; da Costa et al., 2008; Kümmerer, 2009; Chagas et al., 2011; Wang 
et al., 2012). Thus, the emergence of resistant pathogens could occur distantly from the 
original place where such drugs were used and a long time after the original selection 
pressure. The pool of antibiotic resistant microorganisms in the environment is thought to 
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be enormous and capable of sharing genes and resistance mechanisms (Martínez, 2012; 
Perry and Wright, 2013) between them. Every use of an antimicrobial drug has provided 
the selective pressure necessary to capture, accommodate and turn these complex 
structures functional, not affecting the bacterial fitness in diverse environments (van Elsas 
et al., 2011). Presently, this ecological framework is receiving much more attention, with 
research focused on the assessment of all pathways of indirect transmission, which may 
be very broad (e.g. water cycle) or narrow (e. g. hand contact surfaces in hospitals 
(Kramer et al., (2006)). Various studies have reported dissemination of multidrug-resistant 
microorganisms through veterinary clinical settings (Murphy et al., 2010; Hamilton et al., 
2012; Kukanich et al., 2012). 
 
 
1.1.2. The importance of Escherichia coli and enterococci  
 
Few microorganisms are as versatile as E. coli. Most strains are harmless and an 
important part of the normal intestinal microflora of humans and other mammals, being 
able to compete with the abundant facultative anaerobe intestinal microflora (Kaper et al., 
2004). However, there are several highly adapted E. coli clones that have acquired 
specific virulence attributes, which confers an increased ability to adapt to new niches and 
allow them to cause a broad spectrum of disease. These virulence traits, frequently 
encoded on genetic elements that can be shifted into different strains to create novel 
combinations of virulence factors, or on genetic elements that might once have been 
mobile, but have now evolved to become ‘locked’ into the genome. Only the most 
successful combinations of virulence factors have persisted to become specific 
pathotypes of E. coli that are capable of causing disease in healthy individuals (Kaper et 
al., 2004). Extra-intestinal pathogenic E. coli (ExPEC), despite being part of the intestinal 
microflora of a fraction of the healthy population,  they can reach and colonize niches 
outside of the gut, causing disease such as urinary tract infection (UTI), septicemia or 
meningitis in newborns, as well as UTI or systemic disease in many animals (Köhler and 
Dobrindt, 2011). Although the host fecal flora is usually the immediate source of ExPEC 
strains, external reservoirs from which hosts can acquire such strains, as well as the 
relevant mechanisms of transmission, are still poorly understood (Johnson et al., 2008). 
Similar to the acquisition of virulence attributes, the evolution of resistance reflects 
the genomic plasticity of E. coli, which results from the frequent acquisition and loss of 
genomic information as well as the high recombination rates within the flexible genome 
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(Brzuszkiewicz et al., 2009; Tenaillon et al., 2010). Such features make this bacterium an 
important “indicator” that could be used to track the evolution and dissemination of 
antibiotic resistance in different ecosystems (van den Bogaard and Stobberingh, 2000; 
Sáenz et al., 2004; Costa et al., 2008a; Murphy et al., 2009). 
Enterococci are also commensals of the intestinal microbiota of people and 
animals; however, they have emerged as one of the most prevalent nosocomial 
pathogens worldwide, mostly due to their metabolic versatility and intrinsic resistance to 
inhospitable conditions, which allow them to extensively colonize different environments. 
Although unable to form spores, enterococci are highly tolerant to desiccation and can 
persist for months on dried surfaces. Enterococci also tolerate extremes of pH, ionizing 
radiation, osmotic and oxidative stresses, high heavy metal concentrations, and antibiotics 
(Ramsey et al., 2014). Moreover, enterococci can also survive or grow over a wide range 
of temperatures for mesophilic bacteria, from 10 to 45°C. Finally, some strains of 
enterococci have emerged worldwide as multidrug-resistant and hospital-acquired 
pathogens (Damborg et al., 2009; Ghosh et al., 2011; Kwon et al., 2012; Tremblay et al., 
2013; Werner et al., 2013). The species of the highest clinical importance are 
Enterococcus faecalis and Enterococcus faecium. Generally, the resistance 
characteristics of these two species can be categorized as intrinsic resistance, acquired 
resistance, and tolerance (Kristich et al., 2014).  
Although the prevalence of human hospital-acquired enterococci infections is 
being assessed, little is known about the prevalence of enterococci infections acquired in 
veterinary hospitals and clinics. Gosh et al., (2011) found that dogs discharged from 
intensive care units on antimicrobial treatment, harboured a large community of multidrug-
resistant enterococci. These were probably originated from the endogenous flora of 
animals with compromised immunity or from the environmental bacteria (KuKanich et al., 
2012). 
In addition, E. coli and Enterococcus spp. are able to enter into various 
transmission cycles, such as: i) the in- and through-household intra- and inter-species 
transmission; ii) have the ability to exchange resistance genetic determinants with a broad 
diversity of microbial flora, and iii) survive in the environment (objects, surfaces, food) for 
enough time to have the opportunity to colonize a new host. In Portugal, multidrug-
resistant E. coli were recently identified in feces of seagulls (Poeta et al., 2008; Simões et 
al., 2010), wild boars (Poeta et al., 2009) and other wild animals (Costa et al., 2008b). 
Moreover, multidrug-resistant isolates of Enterococcus spp. and E. coli were recovered 
from 30 fecal samples of the wild Iberian lynx from South Spain (Gonçalves et al., 2013). 
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There are currently irrefutable evidences of distant AMR dissemination, such as the 
findings of antimicrobial-resistant strains in animals from inhospitable places worldwide, 
as in the Arctic birds (Sjölund et al., 2008) or in the Iguanas from Galapagos Islands 
(Thaller et al., 2010). 
Taking into account the previous considerations, E. coli and Enterococcus spp. are 
invaluable bacteria to assess the burden of antibiotic resistance within a certain 
population. Regular monitoring of the level of AMR in pathogens and normal flora has 
been recommended by the World Health Organization since 2001 at WHO Global 
Strategy for Containment of AMR (WHO 2012b). Some national and international 
surveillance programs on AMR have been established for people as well as for food-
producing animals (SENTRY, SCOPE, SWEDRES, SVARM, FAO, DANMAP and 
NARMS) although pet animals have been ordinarily excluded from such programs (Gosh 
et al., 2011).  
 
 
1.1.3. The role of companion animals 
 
A crucial importance has been attributed to the transmission of multidrug-resistant 
bacteria (or genetic material) between food-producing animals and humans, while little 
attention has been given to the contribution of companion animals to the scenario of AMR. 
It is expectable that dogs and cats, by sharing the same household, being exposed to the 
same substances and contacting with the same objects and surfaces as their owners, 
influence the AMR status of the domestic aggregate. Therefore, such pets play a role in 
the supply of bacteria to the household pool of microorganisms, hence contributing to the 
spread and even share of household antimicrobial resistant bacteria or genetic 
determinants. 
During the last decades, a change in the social role of companion animals has 
taken place, resulting in closer contacts between owners and their pets. The evolution of 
veterinary practice, the improved living conditions of the community and the increased 
sense of social responsibility for the welfare and health of pets have conducted to an 
extended pets’ longevity with a substantial augment of oncologic and geriatric patients, 
more prone to chronic, debilitating and immunocompromising diseases and in need for 
antimicrobial treatments (da Costa et al., 2013). 
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Portugal accompanied the global veterinary medicine evolution and has, at the 
present time, 4798 active veterinary practitioners and 1240 approved small animal 
veterinary attendance centers (CAMVs) (OMV, 2014). In the recent years, more and new 
veterinary approved antimicrobial formulations became available to the Portuguese 
professionals. Nowadays, Portugal has 168 approved antimicrobial medicament 
presentations for veterinary use (DGAV, 2014) with quinolones comprising almost half of 
them (47.0%), whereas amoxicillin and clavulanic acid constitute 24.4% and 
cephalosporins 11.3% (all first generation with one exception: cefovecin). According to 
DGAV data (2010), during the last years massive quantities of veterinary antimicrobials 
were consumed in Portugal, reaching a maximum in 2010 (179,874 kilograms) with a 
gradual decline since then (158,906 kilograms in 2012). Unfortunately, detailed data are 
unavailable, hampering the in depth analysis of the specific use of antimicrobials in the 
Portuguese veterinary field. Examples are the lack of information about which 
antimicrobials are the most administered to a particular species or to what extent are 
antibiotics used in human medicine also administered to companion animals.  
The general focus on agriculture and food-producing animals as a source of 
resistant bacteria and resistance genes for human pathogens may underestimate the role 
of companion animals as one of the contributors to resistance in human pathogens. 
However, the close contact between companion animals and humans builds up a unique 
and critical aspect related to antimicrobial resistance that creates opportunities for inter-
species transmission of multidrug-resistant bacteria (EMA, 2013). Furthermore, similar to 
human medicine, the high prevalence of pets’ infections by resistant microorganisms is 
limiting the veterinary therapeutic options. In fact, resistant strains to last-line antibiotics of 
exclusive human use, such as carbapenems, were already recovered from companion 
animals (Shaheen et al., 2013). Therefore, veterinarians play an important role in the 
global approach for combating AMR. The assessment of the real need for antimicrobial 
treatment; rational and appropriate choice of the drugs; knowledge of the resistance 
transmission pathways; sharing of surveillance data; and animal owners information on 
preventive measures during and after antimicrobial treatment are important stress points 
in the clinical activity of small animal practitioners that are essential in such context. 
In summary, antimicrobial resistance is a kind of snow ball that is rolling down the 
hill and embodying everyone that is nearby. 
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1.2. RATIONALE AND AIMS 
 
One of the current challenges in AMR is to assess the public health burden that 
companion animals’ resistant bacteria or resistance genes represent. This assessment is 
made difficult by the lack of data, as well as by the fact that transmission of antimicrobial 
resistance is a complex and largely unpredictable phenomenon involving different routes 
and mechanisms.  
Given the importance of antibiotics for human and animal health, this difficulty 
cannot be considered an insurmountable obstacle. Rather, it should be understood as an 
object of study for which every single contribution is important. 
 
Two purposes were planned for the present work: 
 
I – A survey study of the antimicrobial resistance profiles of fecal E. coli and 
Enterococcus spp. from domestic dogs and cats in Portugal and the estimation of risk 
factors for antimicrobial resistance development;  
 
II – The assessment of the spread and share of antimicrobial resistant 
determinants or bacteria within household, comprising human and pet cohabitants and 
common touched objects and surfaces.  
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Abstract 
Antimicrobial resistance (AMR) is a growing global public health problem for which 
the use of antimicrobials both in human and animal medical practice have an important 
contribution. The objectives of the present cross-sectional study were: 1) to determine the 
prevalence of resistance in Escherichia coli isolated from feces of pets from Porto region, 
in Portugal, against 19 antimicrobial agents and 2) to assess individual, clinical and 
environmental characteristics associated with each pet as risk markers for the AMR found 
in E. coli isolates.  
From September 2009 to May 2012, rectal swabs were collected from pets 
selected using a systematic random procedure from the ordinary population of animals 
attending the Veterinary Hospital of Porto University. A total of 78 dogs and 22 cats were 
sampled with the aim of isolating E. coli. Animal owners, who allowed the collection of 
fecal samples from their pets, answered a questionnaire to collect information about the 
markers that could influence the AMR of enteric E. coli. Chromocult tryptone bile X-
glucuronide agar was employed for E. coli isolation and disc diffusion method was used to 
determine antimicrobial susceptibility. The data were analyzed using a multilevel, 
univariable and multivariable generalized linear mixed model (GLMM). Several (49.7%) 
out of the 396 isolates obtained in this study were multidrug-resistant. Antimicrobial 
agents for which many E. coli isolates exhibited resistance were ampicillin (51.3%), 
cephalothin (46.7%), tetracycline (45.2%) and streptomycin (43.4%). Previous quinolone 
treatment was the main risk marker for the presence of AMR in 12 (ampicillin, cephalothin, 
ceftazidime, cefotaxime, nalidixic acid, ciprofloxacin, gentamicin, tetracycline, 
streptomycin, chloramphenicol, trimethoprim-sulfamethoxazol and aztreonam) out of the 
15 antimicrobials assessed. Coprophagic habits were also positively associated with an 
increased risk of AMR for 6 drugs: ampicillin, amoxicillin-clavulanic acid, cephamycin, 
ciprofloxacin, streptomycin, and trimethoprim-sulfamethoxazol.  
In summary, pets with record of one or more previous treatments with quinolones 
and exhibiting coprophagic habits were at increased risk of harboring multidrug-resistant 
E. coli strains in their feces when compared with pets having not such characteristics. 
AMR is a serious global problem and assessing the risk markers for the presence of drug-
resistant bacteria in pets, a very close source of resistance determinants to humans, is 
essential for the implementation of safe handling procedures for companion animals and 
prudent selection of antimicrobial substances in veterinary practice. 
Keywords: Antimicrobial resistance; pets; Escherichia coli; prevalence; risk markers.  
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1. Introduction 
Antimicrobial resistance (AMR) will probably be one of the main global public 
health problems of the next decade (Carlet et al., 2012). The phenomenon of AMR, which 
is based on the genetic plasticity of bacteria, has the selective pressure exerted by the 
antimicrobial usage in human and veterinary medicine, animal production, fish production, 
agriculture and food technology, the main driver force for its emergence (Kearns, 2010; 
EAAD, 2013; Martins da Costa et al., 2013). Resistant bacteria may be transmitted 
between interdependent hosts and spread into the environment, contributing to the 
worldwide increase of AMR (CDC, 2013). The progress in veterinary medicine and the 
number of domestic pets treated by specialized practitioners generated an increased 
usage of antimicrobial treatments (Martins da Costa et al., 2013). Additionally, pets live 
longer and are in closer contact with their owners, favoring the mutual transfer of microbial 
flora, directly by skin or bacteria-containing material contact (e.g. saliva and feces) and 
indirectly, via the household environment (Martins et al., 2013). When reaching the new 
host, resistant bacteria can colonize, infect, or remain in that particular environment for 
very short periods of time. In all cases, resistant bacteria can either spread their 
resistance genes to host-resident bacteria (commensals or pathogens) or accept 
resistance genes from such microorganisms (Jernberg et al., 2010). As a consequence, 
AMR in companion animals is simultaneously an important veterinary medical issue and a 
public health concern (Lloyd, 2007).  
The regular monitoring of AMR in pathogenic and normal flora has been 
recommended by the World Health Organization and the European Centre for Disease 
Prevention and Control. For this purpose, the European Antimicrobial Resistance 
Surveillance Network (EARS-Net), involving 53 countries, was created (EFSA and 
ECDPC, 2013). Similar programs have been proposed for veterinary medicine, leading to 
the development of field studies on food animals (Aarestrup, 2004; Taylor et al., 2008) 
and pets (Moyaert et al., 2006; Lloyd, 2007; Costa et al., 2008; Murphy et al., 2009; 
Leonard et al., 2012). However, to our knowledge, no studies have included clinical 
histories of both pets and their cohabitants neither household features in order to assess 
potential AMR risk markers. 
Escherichia coli is an important member of the normal intestinal microflora of 
humans and other mammals, but it can be also a highly versatile pathogen, causing 
diverse intestinal and extra intestinal diseases by means of virulence factors that affect a 
wide range of cellular processes (Kaper et al., 2004). Carriage of AMR has been 
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associated with several treatment failures in both human and veterinary patients (Toutain 
et al., 2010; Vigil et al., 2009).  
The present study intended to determine the proportion of antimicrobial resistance 
of E. coli isolated from feces of pets from Porto region, in Portugal, as well as to assess 
individual, clinical and environmental characteristics of pets as risk markers for the AMR 
found in the isolated strains. It is hypothesized that animals with relevant clinical 
background will harbor more resistance E. coli isolates. 
 
 
2. Materials and methods 
 
2.1. Enrollment and sampling  
A random systematic approach was used to select animals to the present cross-
sectional study, performed at the Veterinary Hospital of Porto University (UPVET). From 
September 2009 to May 2012, on Monday or Tuesday, one among the first five pets to 
arrive at the UPVET attending room was randomly selected to be included in the study. If 
the owners refused to collaborate in the study the next pet, by order of arrival, was 
included, without following any criteria. To be eligible to be enrolled in the study, the 
animal should not have received any antimicrobial therapy within the preceding 4 months. 
The owners were asked to sign a consent form, to fill a questionnaire and to allow the 
collection of fecal samples from their pets using rectal swabs. Approval to conduct the 
study was previously obtained from the Ethics Committee of the Abel Salazar Institute for 
the Biomedical Sciences, University of Porto. 
 
2.2. Questionnaire  
By a brief questionnaire, owners were asked to provide information about possible 
risk markers for multidrug-resistant (Magiorakos et al., 2012) E. coli colonization. The 
questionnaire was constructed following similar studies in animals (Akwar et al., 2007; 
Ahmed et al., 2012; Boothe, 2012) and humans (McDonald et al., 2001; Sotto et al., 2001; 
Lietzau et al., 2007; Kalter et al., 2010; Lastours et al., 2010). To evaluate the potential 
risk markers, questionnaires included individual and clinical characteristics, such as 1) 
species, 2) gender, 3) age, 4) daily access to the outside environment (indoor habitat 
refers to those animals which live predominantly at home or with very restricted access 
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outdoor), 5) diet  (“commercial” refers to the animals that were fed with strictly commercial 
dry or wet food), 6) coprophagic habits (ingestion of feces, both their own or from other 
animals), 7) previous systemic antimicrobial treatments with particular emphasis on 8) 
previous systemic quinolone treatments (assessed through the clinical file of the pet), 9) 
existence of cohabitant pets in the household, 10) previous antimicrobial treatments 
received by owners, 11) owners’ professional connection with healthcare units such as 
human or veterinary hospitals, clinics or health centers (such elements were classified as 
“Health Professionals”, 12) “reason for veterinary visit” (recorded by the veterinary 
surgeon following a complete physical examination). 
 
2.3. Escherichia coli isolation  
Fecal samples were obtained using saline wet swabs that were introduced with 
circular movements into the rectum of each animal. Swabs were immediately immersed 
on Buffered Peptone Water (BPW) (Oxoid, Basingstoke, Hampshire, England), 
transported to the laboratory and stored at room temperature for 1 h. Then, for E. coli 
isolation, an aliquot of 5 µl was streaked on Chromocult tryptone bile X-glucuronide (TBX) 
agar (Biokar Diagnostics, Allonne, Beauvais, France) and incubated at 37 °C for 24 h. 
Two to five confirmed pure colonies with typical appearance of E. coli were selected on 
the basis of colony size and morphology. The described procedure and the biochemical 
confirmation of isolates were adapted from standard protocols used in similar studies, 
aiming to achieve the most reliable and accurate E. coli detection (Costa et al., 2008; 
Simões et al., 2010; Martins et al., 2013).  
 
2.4. Antimicrobial susceptibility characterization 
Disk diffusion assay, following standard guidelines (CLSI, 2012), was performed to 
assess the antimicrobial susceptibility of each isolate. Antimicrobial drugs were selected in 
order to include those regularly used in both human and veterinary medicine and to 
provide diversity by representing different antimicrobial classes (Goossens et al., 2005; 
Elseviers et al., 2007; EFSA and ECDPC, 2013). A total of 19 antimicrobial agents (AM) 
(Oxoid, Basingstoke, Hampshire, England) were used: ampicillin (AMP, 10 µg), 
amoxicillin-clavulanic acid (AMC, 30 µg), cephalothin (CEF, 30 µg), cefoxitin (FOX, 30 
µg), ceftazidime (CAZ, 30 µg), cefotaxime (CTX, 30 µg), nalidixic acid (NAL, 30 µg), 
ciprofloxacin (CIP, 5 µg), gentamicin (GEN, 10 µg), tetracycline (TET, 30 µg), 
streptomycin (STR, 10 µg), amikacin (AMK, 30 µg), trimethoprim-sulfamethoxazol (SXT, 
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25 µg), chloramphenicol (CHL, 30 µg), tobramycin (TOB, 10 µg), kanamycin (KAN, 30 µg), 
aztreonam (ATM, 30 µg), imipenem (IPM, 10 µg), and nitrofurantoin (NIT, 300 µg). The 
interpretation of the inhibition zone length followed the Clinical and Laboratory Standards 
Institute (CLSI) recommendations and breakpoints for Enterobacteriaceae (CLSI, 2012). 
 
2.5. Data analysis 
The prevalence of AMR regarding each AM was calculated by dividing the number 
of resistant E. coli isolates by the total number of E. coli tested. The potential risk markers 
obtained from the questionnaire were analyzed as categorical variables as follows: 
dichotomous variables, such as species (canine, feline), gender (male, female), reason for 
veterinary visit (routine check-up, illness signs), habitat type (indoor, mixed), diet 
(commercial, mixed), previous quinolone treatments (yes, no), health professionals 
owners (yes, no), owners submitted to previous antimicrobial treatments (yes, no), 
cohabitant pets (yes, no), coprophagy habits (yes, no); the exposure of the animal to any 
previous antimicrobial treatment was transformed into a categorical variable with three 
levels: “none”, “just one”, and “two or more”. Age was also categorized with three levels: 
“young” (before 2 years of age), “adult” (between 2 and 10 years old), and “old” (with more 
than 10 years old). The outcome in the analysis was the result of AMR which was 
dichotomized in either resistant or sensitive; intermediate results were categorized as 
sensitive. Using the European Food Safety Authority criteria, each antimicrobial was 
further classified into one of the following categories of prevalence of AMR: extremely 
high: >70%; very high: 50-70%; high: 20-50%; moderate: 10-20%; low: 1-10%; very low: 
0.1-1% and rare: <0.1% (EFSA and ECDPC, 2013).  
A descriptive analysis of AMR prevalence and frequency of risk markers was 
conducted. To analyze these markers and to assess the strength of their association with 
the AMR, a Multilevel Generalized Linear Mixed Model (GLMM) was used.  
The logit link function was used to model the probability of occurrence of 
resistance to an antibiotic. To take into account the multilevel structure of the data in 
which more than one E. coli strain (i) was isolated from each animal (j), a two level 
structure in the data was assumed in which E. coli strains (first level) were nested within 
the animal from which they were isolated (second level). 
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The data were modeled in the following way: 
 
𝑌 = { 
0 (𝑛𝑜 𝐴𝑀𝑅) 
1 (𝐴𝑀𝑅)
 Where Y is the response variable. 
 
Pr(Y) = pij, i = 1, …, 396 and j = 1, ..., 100. 
 
The generic model used the following equation: 𝑙𝑜𝑔𝑖𝑡(𝑝𝑖𝑗) = 𝑎 + 𝑐𝑗 + 𝛽 𝑎𝑛𝑖𝑚𝑎𝑙 𝑣𝑎𝑟𝑖𝑎𝑏𝑙𝑒𝑠𝑗 
The model, the animal (the pet) was allowed to be random. The second level random 
effect is given by cj ∼ N(0,σ2 ) where σ2 is the variance of the random effects at the 
animal level.  
 
The basic multivariable multilevel model was as follows: 
 
𝑙𝑜𝑔𝑖𝑡(𝑝𝑖𝑗) = 𝑎 + 𝑐𝑗 + 𝛽1𝑆𝑝𝑒𝑐𝑖𝑒𝑠𝑗 + 𝛽2𝐴𝑔𝑒𝑗 + 𝛽3𝐺𝑒𝑛𝑑𝑒𝑟𝑗 + 𝛽4𝑅𝑒𝑎𝑠𝑜𝑛 𝑜𝑓 𝑣𝑖𝑠𝑖𝑡𝑗 + 𝛽5𝐻𝑎𝑏𝑖𝑡𝑎𝑡𝑗
+  𝛽6𝐷𝑖𝑒𝑡𝑗 + 𝛽7𝑁𝑢𝑚𝑏𝑒𝑟 𝐴𝑀 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡𝑠𝑗
+ 𝛽8𝑃𝑟𝑒𝑣𝑖𝑜𝑢𝑠 𝑄𝑢𝑖𝑛𝑜𝑙𝑜𝑛𝑒𝑠 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡𝑠𝑗 + 𝛽9𝑂𝑤𝑛𝑒𝑟
′𝑠 𝑝𝑟𝑜𝑓𝑒𝑠𝑠𝑖𝑜𝑛𝑗
+ 𝛽10𝑂𝑤𝑛𝑒𝑟
′𝑠 𝐴𝑀 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡𝑠𝑗 + 𝛽11𝐶𝑜ℎ𝑎𝑏𝑖𝑡𝑎𝑛𝑡𝑠 𝑃𝑒𝑡𝑠𝑗
+ 𝛽12𝐶𝑜𝑝𝑟𝑜𝑝ℎ𝑎𝑔𝑦 ℎ𝑎𝑏𝑖𝑡𝑠𝑗 
 
Variables codes are presented in Tables 4 to 6. 
 
A three step procedure was taken as follows: firstly, a univariable multilevel GLMM 
analysis was conducted to assess the individual relationship between each potential risk 
factor and the presence of AMR; a second step was performed to conduct a multivariable 
multilevel GLMM analysis with all the variables that had a p < 0.15 in the previous 
analyses followed by a manual backward and forward procedure to obtain a final model 
where each factor effect was adjusted for the remaining factors. Only factors with a p < 
0.05 were retained in the final model. The data were analyzed using the procedure GEE in 
the SPSS Software V. 21.0 (IBM SPSS statistical 21 package, IBM Corporation, NY). 
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3. Results 
A total of 78 dogs and 22 cats belonging to 100 distinct households were enrolled. 
Overall 396 E. coli isolates were obtained, 307 (77.5%) were isolated from dogs and 89 
(22.5%) from cats, ranging from two to five per animal; on average, 3.96 isolates per 
animal were obtained. 
 
3.1. Antimicrobial resistance profiles 
Our results showed that 28.8% of the isolates were susceptible to all compounds; 
the median number of AMR among the isolates was three and the isolate in the 75th 
percentile harbored seven resistances. Extreme resistance towards 14 or 15 AM was 
present in five isolates (1,3 %). The histogram displaying the absolute number of 
resistances suggests the existence of two or perhaps three subpopulations of E. coli (Fig. 
1): one group with less than four resistances, a second one with five to 10 resistances, 
and a conceivable third group with more than 10 resistance results. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.1. Frequency of antimicrobial resistance in Escherichia coli isolates (n=396). 
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3.2. Antimicrobial resistance prevalence 
The prevalence of AMR varied from 0% found for nitrofurantoin and imipenem up 
to 51.3% (+/- 0.049) for ampicillin. After categorization according to the EFSA (EFSA and 
ECDPC, 2013) recommendations, 5.3% (+/- 0.022) of the tested AM were in the very high 
resistance category; 31.6% (+/- 0.046) in the high resistance group and a similar 
proportion were in the moderate resistance category, as displayed in Table 1. 
 
3.3. Distribution of potential risk markers associated with pets 
The frequency of each tested potential risk marker is shown in Table 2. After 
comparing the factors species, age, sex and reason for the visit, it was clear that the 
population of pets enrolled in our study resembles the population of cats and dogs 
attending the hospital. Twenty-three dogs (29.5 %) and 15 cats (68.2%) were healthy 
animals admitted for regular check-up or prophylactic actions, while the remaining animals 
attended the hospital for clinical reasons. 
 
3.4. Distribution of potential risk markers among E. coli isolates 
The distribution of potential risk markers amongst E. coli isolates are displayed in 
Table 3. The largest numbers of isolates were obtained from pets owned by non-health 
professionals (n = 304; 76.8%) and animals with outdoor access (n = 302; 76.3%). Some 
characteristics associated with categories with small proportion of isolates were having 
just one antimicrobial treatment (n = 81; 20.5%), being older than 10 years (n = 93; 
23.5%) and living indoor (n =9 4; 23.7%). 
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Table 1. Categorization of the tested antimicrobials (AM) in Escherichia coli isolates 
according to EFSA risk categories for prevalence of resistances. 
 
EFSA Risk 
Categories 
AM 
Prevalence of 
resistance 
+/- C.I. 
Frequency of 
AM in each 
category 
+/- C.I. 
Extremely High 
 
0.0 - 0.0 - 
Very High AMP 51.3 0.049 5.3 0.022 
High 
CEF 46.7 0.049 
31.6 0.046 
NAL 35.9 0.047 
CIP 29.5 0.045 
TET 45.2 0.049 
STR 43.4 0.049 
SXT 36.4 0.047 
Moderate 
AMC 12.1 0.032 
31.6 0.046 
CAZ 13.6 0.034 
CTX 14.6 0.035 
CHL 18.2 0.038 
KAN 13.9 0.034 
ATM 17.7 0.038 
Low 
FOX 5.8 0.023 
15.8 0.036 GEN 5.8 0.023 
TOB 3.0 0.017 
Very Low AMK 0.5 0.017 5.3 0.022 
Rare 
NIT 0.0 - 
10.5 0.030 
IPM 0.0 - 
Legend: AM – antimicrobial agent; C.I. – Confidence interval; AMP – ampicillin; AMC – amoxicillin-clavulanic acid; CEF – 
cephalothin; FOX – cephoxitin; CAZ – ceftazidime; CTX – cefotaxime; NAL – nalidixic acid; CIP – ciprofloxacin; GEN – 
gentamicin; NIT – nitrofurantoin; TET – tetracycline; STR – streptomycin; AMK – amikacin; SXT – trimethoprim-
sulfamethoxazol; CHL – chloramphenicol; TOB – tobramycin; KAN – kanamycin; IPM – imipenem; ATM – aztreonam. 
Values are expressed in percentages. 
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Table 2. Distribution of potential risk marker categories among pets (n=100). 
Risk marker Category Dogs  % Dogs Cats  % Cats 
Dogs + 
Cats 
Species  78 
 
22 
 
100 
Age 
< 2 years 24 30.8 9  40.9 33 
2 - 10 years 34 43.6 11 50.0 45 
> 10 years 20 25.6 2 9.1 22 
Gender 
Female 47 60.3 9 40.9 56 
Male 31 39.7 13 59.1 44 
Reason for veterinary 
visit 
Check up 23 29.5 15 68.2 38 
Illness 55 70.5 7 31.8 62 
Habitat Type 
Indoor 9 11.5 15 68.2 24 
Mixed 69 88.5 7 31.8 76 
Diet 
Commercial 25 32.1 10 45.5 35 
Mixed 53 67.9 12 54.5 65 
Animal Antimicrobial 
Treatments 
None 21 26.9 17 77.3 38 
Just One 19 24.4 3 13.6 22 
Two/more 38 48.7 2 9.1 40 
Animal Quinolone 
Treatments 
Yes 28 35.9 2 9.1 30 
No 50 64.1 20 90.9 70 
Owners Health 
Professionals 
Yes 16 20.5 6 27.3 22 
No 62 79.5 16 72.7 78 
Owners Antimicrobial 
Treatments 
Yes 38 48.7 6 27.3 44 
No 40 51.3 16 72.7 56 
Cohabitant Pets 
Yes 36 46.2 16 72.7 52 
No 42 53.8 6 27.3 48 
Coprophagy Habits 
Yes 29 37.2 4 18.2 33 
No 49 62.8 18 81.8 67 
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Table 3. Distribution of the Escherichia coli isolates (n=396) of Canine (n=307) and Feline 
(n=89) origin by potential risk marker categories. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Risk Marker Category 
Canine 
Isolates 
Feline 
Isolates 
Total Isolates 
(%) 
Age 
< 2 years 85 32 117 (29.5) 
2 - 10 years 135 51 186 (47.0) 
> 10 years 87 6 93 (23.5) 
Gender 
Female 185 37 222 (56.1) 
Male 122 52 174 (43.9) 
Reason for veterinary 
visit 
Check up 81 64 145 (36.6) 
Illness 226 25 251 (63.4) 
Habitat Type 
Indoor 35 59 94 (23.7) 
Mixed 272 30 302 (76.3) 
Diet 
Commercial 107 34 141 (35.6) 
Mixed 200 55 255 (64.4) 
Animal Antimicrobial 
Treatments 
None 71 67 138 (34.8) 
Just One  69 12 81 (20.5) 
Two or more 167 10 177 (44.7) 
Animal Quinolone 
Treatments 
Yes 121 10 131 (33.1) 
No 186 79 265 (66.9) 
Owners Health 
Professionals 
Yes 65 27 92 (23.2) 
No 242 62 304 (76.8) 
Owners Antimicrobial 
Treatments 
Yes 162 25 187 (47.2) 
No 145 64 209 (52.8) 
Cohabitant Pets 
Yes 142 66 208 (52.5) 
No 165 23 188 (47.5) 
Coprophagy Habits 
Yes 119 18 137 (34.6) 
No 188 71 259 (65.4) 
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3.5. Antimicrobial resistance and potential risk markers 
The frequencies of AMR for each potential risk marker are displayed in Table 4. 
None isolate displayed resistance to nitrofurantoin or imipenem; therefore these two AM 
were excluded from further analyses. The AMR proportions were calculated based on all 
isolates (n = 396).  
 
Table 4. Proportion of antimicrobial resistance (%) distributed by potential risk marker 
categories. 
Risk Markers AMP AMC CEF FOX CAZ CTX NAL CIP GEN TET STR SXT CHL KAN ATM 
Species Canine 58.3 15.0 53.1 7.5 14.7 18.9 39.1 35.2 7.2 47.6 45.6 39.4 20.2 14.0 20.8 
Species  Feline 27,0 2.2 24.7 0.0 10.1 0.0 24.7 10.1 1.1 37.1 36.0 25.8 11.2 13.5 6.7 
Age: < 2 years 47,0 2.6 37.6 0.0 11.1 14.5 25.6 25.6 1.7 35.9 35.0 30.8 12.8 6.0 16.2 
Age: 2 - 10 years 44.6 9.1 40.3 5.4 10.2 12.4 35.5 28.5 5.4 45.2 44.6 34.9 18.8 17.2 14.0 
Age: > 10 years 69.9 30.1 71.0 14,0 23.7 19.4 49.5 36.6 11.8 57.0 51.6 46.2 23.7 17.2 26.9 
Gender Female 45.0 10.8 44.1 4.1 11.3 14.4 34.2 27.5 6.3 45.5 40.1 36,0 11.3 14.9 16.7 
Gender Male 59.2 13.8 50.0 8.0 16.7 14.9 37.9 32.2 5.2 44.8 47.7 36.8 27.0 12.6 19.0 
Reason: Check up 38.6 4.1 30.3 1.4 4.8 3.4 23.4 17.2 1.4 34.5 30.3 33.1 9.7 11.7 6.9 
Reason: Illness 58.6 16.7 56.2 8.4 18.7 21.1 43.0 36.7 8.4 51.4 51.0 38.2 23.1 15.1 23.9 
Habitat: Indoor 37.2 2.1 33.0 0.0 13.8 4.3 39.4 25.5 2.1 48.9 41.5 23.4 20.2 17.0 11.7 
Habitat: Mixed 55.6 15.2 51.0 7.6 13.6 17.9 34.8 30.8 7.0 44.0 44.0 40.4 17.5 12.9 19.5 
Diet: Commercial 44.7 12.8 46.1 9.2 16.3 11.3 34.0 24.1 0.0 44.7 34.0 34.0 13.5 5.7 16.3 
Diet: Mixed 54.9 11.8 47.1 3.9 12.2 16.5 36.9 32.5 9.0 45.5 48.6 37.6 20.8 18.4 18.4 
AM Tx: None 40.6 5.1 32.6 0.7 4.3 6.5 18.1 13.8 3.6 31.2 29.0 29.7 10.9 11.6 6.5 
AM Tx: One 45.7 0.0 40.7 0.0 11.1 17.3 44.4 44.4 7.4 48.1 43.2 38.3 19.8 16.0 22.2 
AM Tx: 2 or + 62.1 23.2 60.5 12.4 22.0 19.8 45.8 35.0 6.8 54.8 54.8 40.7 23.2 14.7 24.3 
Quinolone Tx: Yes 77.1 19.1 69.5 12.2 32.8 33.6 67.2 56.5 13.0 63.4 64.9 51.1 34.4 21.4 42.0 
Quinolone Tx: No 38.5 8.7 35.5 2.6 4.2 5.3 20.4 16.2 2.3 36.2 32.8 29.1 10.2 10.2 5.7 
O. Prof.: Health Prof. 65.2 23.9 55.4 6.5 7.6 7.6 37.0 34.8 1.1 56.5 55.4 53.3 19.6 10.9 10.9 
O. Prof.: Others 47.0 8.6 44.1 5.6 15.5 16.8 35.5 28.0 7.2 41.8 39.8 31.2 17.8 14.8 19.7 
O. AM Tx: Yes 54.5 15.0 50.8 6.4 14.4 18.7 43.9 36.9 9.1 47.6 50.8 40.1 19.8 16.0 19.3 
O. AM Tx: No 48.3 9.6 43.1 5.3 12.9 11.0 28.7 23.0 2.9 43.1 36.8 33.0 16.7 12.0 16.3 
Cohabit. Pets: Yes 51.4 15.9 45.7 7.7 13.0 17.8 38.5 34.1 7.7 46.6 46.6 43.3 20.2 15.4 21.2 
Cohabit. Pets: No 51.1 8.0 47.9 3.7 14.4 11.2 33.0 24.5 3.7 43.6 39.9 28.7 16.0 12.2 13.8 
Coprophagy: Yes 67.9 26.3 56.9 13.1 19.7 22.6 48.9 42.3 10.9 57.7 57.7 54.0 23.4 16.8 27.7 
Coprophagy: No 42.5 4.6 41.3 1.9 10.4 10.4 29.0 22.8 3.1 38.6 35.9 27.0 15.4 12.4 12.4 
Legend: AM - antimicrobial; TX - treatment; O. - owner; Prof. - professional; Cohabit.- cohabitant; AMP – ampicillin; AMC – 
amoxicillin-clavulanic acid; CEF – cephalothin; FOX – cephoxitin; CAZ – ceftazidime; CTX – cefotaxime; NAL – nalidixic 
acid; CIP – ciprofloxacin; GEN – gentamicin; NIT – nitrofurantoin; TET – tetracycline; STR – streptomycin; SXT – 
trimethoprim-sulfamethoxazol; CHL – chloramphenicol; KAN – kanamycin; IPM – imipenem; ATM – aztreonam.  
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The lowest AMR rates were found in young indoor animals nourished with 
commercial diet and submitted to a single previous antimicrobial treatment. In this latest 
group, there were no isolates resistant to amoxicillin-clavulanic acid and cephoxitin; no 
cephoxitin-resistant isolates were found in cats or in young or indoor animals; finally, no 
cefotaxime-resistant isolates were found in cats and no gentamicin-resistant isolates were 
recovered from animals fed with commercial diet. 
 
3.6. Results of the multilevel univariable analysis 
Table 5 displays the results of the multilevel univariable analysis. Only Odds Ratio 
(OR) for the variables and categories in which the p value was lower than 0.15 are shown. 
The markers that presented a significant (p < 0.05) increased risk of resistance were the 
following: being a dog (for ampicillin, cephalothin and ciprofloxacin); previous exposure to 
quinolone treatments (for ampicillin, cephalothin, ceftazidime, cefotaxime, nalidixic acid, 
ciprofloxacin, gentamicin, tetracycline, streptomycin, trimethoprim-sulfamethoxazol, 
chloramphenicol and aztreonam); pets being owned by health professional workers (for 
amoxicillin-clavulanic acid); or  having coprophagic habits (for ampicillin, amoxicillin-
clavulanic acid, cephoxitin, nalidixic acid, ciprofloxacin, tetracycline, streptomycin, 
trimethoprim-sulfamethoxazol and aztreonam). Protective markers were the following: 
young age(with less than 10 years old), for ampicillin, amoxicillin-clavulanic acid and 
cephalothin; being a female for chloramphenicol; commercial diet, for kanamycin; being 
presented for checkup, for ampicillin, amoxicillin-clavulanic acid, cephalothin, cefotaxime, 
nalidixic acid, ciprofloxacin, tetracycline, streptomycin and aztreonam; and, absence of 
previous antimicrobial treatments, for ampicillin, amoxicillin-clavulanic acid, cephalothin, 
ceftazidime, nalidixic acid, ciprofloxacin, tetracycline, streptomycin and aztreonam. Only in 
the case of amikacin and tobramycin there was not found any significant risk marker 
association with AMR and for this reason they were not included in the subsequent 
multilevel multivariable analysis. 
 
3.7. Results of the multilevel multivariable analysis 
The final model, obtained with a multilevel multivariate analysis after manual 
backward and forward variable selection, resulted in a robust model retaining only the 
variables that, after adjustment for all the other variables remained significant at p < 0.05 
(Table 6). In this analysis, ampicillin was the antimicrobial agent whose resistance was 
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significantly associated with the highest number of markers. 5 out of 12 (“species”, 
“gender”, “previous quinolone treatment”, “health professionals owners” and “coprophagic 
habits”). Resistances to amoxicillin-clavulanic acid and chloramphenicol were both 
significantly associated with three and two different markers, respectively.  Resistance to 
ciprofloxacin, streptomycin and trimethoprim-sulfamethoxazol showed an association with 
two similar markers (“previous quinolone treatment” and “coprophagic habits”), whereas 
AMR to cephalothin, ceftazidime, cefotaxime, nalidixic acid, gentamycin, tetracycline, and 
aztreonam retained one significant association (“previous quinolone treatment”). Finally, 
cephoxitin resistance was associated with coprophagy and kanamycin with mixed diet. 
 “Previous quinolone treatments” and “coprophagic habits” were significantly 
related with AMR in 12 and 6 out of the 15 antimicrobial agents tested, respectively. 
According to the model, pets that had been submitted to prior quinolone treatments have 
a significant high risk of being colonized by E. coli resistant to ceftazidime, OR 16.78, 
(2.33-120.74);  cefotaxime, OR 22.01, (3.15-154.01); nalidixic acid, OR 13.51, (3.83-
47.61) and aztreonam, OR 19.18, (3.67-100.14). Animals with coprophagic habits are at a 
higher risk of harboring E. coli isolates resistant to amoxicillin-clavulanic acid OR 10.35, 
(2.68-40.59) and cephoxitin, OR 11.21, (1.26-99.64). (Table 6). The significance level of 
each OR can be read from Table 6, by the number of asterisks associated: * - < 0.05; ** - 
< 0.01; *** - < 0.001. 
Overall, the risk markers significantly associated with AMR were: i) previous 
treatment with quinolones (12 out of 15) and, ii) coprophagic habits (6 out of 15). The 
other variables were only sporadically associated with some AMR: i) canine species 
(ampicillin); ii) male gender (ampicillin, chloramphenicol); iii) illness (amoxicillin-clavulanic 
acid and chloramphenicol); iv) mixed diet (kanamycin) and v) health professionals owners 
(ampicillin, amoxicillin-clavulanic acid). 
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Table 5. Risk markers for antimicrobial resistance of E. coli isolates from the univariable multilevel analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend: OR – The Odds ratio significance level is given by the number of asterisks: * - < 0.05; ** - < 0.01; *** - <0.001; AM - antimicrobial; TX - treatment; O. - owner; Prof. – profession; Health Prof. 
- healthcare professional; Cohabit.- cohabitant; AMP – ampicillin; AMC – amoxicillin-clavulanic acid; CEF – cephalothin; FOX – cephoxitin; CAZ – ceftazidime; CTX – cefotaxime; NAL – nalidixic 
acid; CIP – ciprofloxacin; GEN – gentamicin; NIT – nitrofurantoin; TET – tetracycline; STR – streptomycin; SXT – trimethoprim-sulfamethoxazol; CHL – chloramphenicol; KAN – kanamycin; IPM – 
imipenem; ATM – aztreonam. 
Risk Markers 
AMP AMC CEF FOX CAZ CTX NAL CIP GEN TET STR SXT  CHL KAN ATM 
OR OR OR OR OR OR OR OR OR OR OR OR  OR OR OR 
Species Canine 6.63** 7.08 5.37** 
   
2.43 5.83* 
    
 
  
4.76 
Species  Feline 
            
 
   
Age: < 2 years 0.3 0.06** 0.14** 
 
0.42 
 
0.26 0.53 
 
0.29 
  
 
   
Age: 2 - 10 years 0.24* 0.17* 0.16** 
 
0.28 
 
0.46 0.61 
 
0.52 
  
 
   
Age: > 10 years 
            
 
   
Gender Female 0.4 
           
 0.25* 
  
Gender Male 
            
 
   
Reason: Check up 0.30* 0.22* 0.23** 
 
0.26 0.14* 0.35* 0.32* 
 
0.36* 0.30* 
 
 0.36 
 
0.23* 
Reason: Ilness 
            
 
   
Habitat: Indoor 0.31 0.13 0.33 
  
0.16 
     
0.38  
   
Habitat: Mixed 
            
 
   
Diet: Commercial 
          
0.42 
 
 
 
0.24* 
 
Diet: Mixed 
            
 
   
AM Tx: None 0.30* 0.19* 0.21** 0.10 0.17* 0.26 0.20** 0.25* 
 
0.24* 0.22** 
 
 
  
0.19* 
AM Tx: One 0.35 0,00 0.31 0.00 0.41 0.78 0.89 1.59 
 
0.66 0.475 
 
 
  
0.97 
AM Tx: 2 or + 
            
 
   
Quinolone Tx: Yes 10.01*** 
 
7.71*** 4.5 15.94*** 13.84*** 14.92*** 12.28*** 4.73* 4.76** 6.98*** 3.43*  6.42** 2.4 20.79*** 
Quinolone Tx: No 
            
 
   
O.Prof.:Health Prof. 2.7 4.69* 
          
 
   
O. Prof.:Others 
            
 
   
O. AM Tx: Yes 
      
2.51 2.23 
  
2.65 
 
 
   
O. AM Tx: No 
            
 
   
Cohabit. Pets: Yes 
            
 
   
Cohabit. Pets: No 
            
 
   
Coprophagy: Yes 4.14** 10.43** 2.39 10.98* 
 
3.22 3.22* 3.61* 3.81 3.07* 3.79* 4.77**  
  
3.43* 
Coprophagy: No 
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Table 6. Risk markers for antimicrobial resistance of E. coli isolates from the multilevel multivariable final model. 
 
Risk Markers 
AMP AMC CEF FOX CAZ CTX NAL CIP GEN TET STR SXT CHL KAN ATM 
OR OR OR OR OR OR OR OR OR OR OR OR OR OR OR 
Species Canine 5.16*                             
Species  Feline                               
Gender Female 0.35*                       0.28*     
Gender Male                               
Reason: Check up   0.16*                     
 
    
Reason: Illness                               
Diet: Commercial                           0.22*   
Diet: Mixed                               
Quinolone Tx: Yes 6.02**   4.68*   16.78** 22.01** 13.51*** 9.05** 4.73* 4.20** 4.55* 2.87* 4.79*   19.18*** 
Quinolone Tx: No                               
O. Prof.: Health Prof. 3.95* 6.41*                           
O. Prof.: Others                               
Coprophagy: Yes 2.80* 10.35**   11.21*       3.12*     3.20* 3.73*       
Coprophagy: No                               
 
Legend: OR – The Odds ratio significance leve lis given by the number of asterisks: * - < 0.05; ** - < 0.01; *** - <0.001; TX - treatment; O. - owner; Prof. – profession; Health Prof. - healthcare 
professional; Cohabit.- cohabitant; AMP – ampicillin; AMC – amoxicillin-clavulanic acid; CEF – cephalothin; FOX – cephoxitin; CAZ – ceftazidime; CTX – cefotaxime; NAL – nalidixic acid; CIP – 
ciprofloxacin; GEN – gentamicin; NIT – nitrofurantoin; TET – tetracycline; STR – streptomycin; SXT – trimethoprim-sulfamethoxazol; CHL – chloramphenicol; KAN – kanamycin; IPM – imipenem; 
ATM – aztreonam. 
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4. Discussion 
Given the remarkable increase of AMR worldwide and the enormous difficulties 
and unsuccessful strategies to restrain its use, all efforts aiming to enlarge the knowledge 
in some of the many branches of this issue are of utmost importance. The present work 
was designed to assess the prevalence of AMR in enteric E. coli isolated from domestic 
cats and dogs in the region of Porto, Portugal, and to study potential risk markers for the 
presence of AMR in those isolates. This was accomplished with a GLMM, taking into 
account the multilevel structure of the data. 
The proportions of AMR observed against ampicillin, cephalothin, tetracycline, 
streptomycin, trimethoprim-sulfamethoxazol, nalidixic acid, and ciprofloxacin were higher 
than previously reported (Costa et al., 2008; Murphy et al., 2009; Leonard et al., 2012). 
According to the categories proposed by EFSA (EFSA and ECDPC, 2013), 36.9% of the 
AM tested were assigned to the groups of high or very high resistance (Table 1). 
Interestingly none of the AM tested was classified in the extremely high category.  In a 
study comprising fecal samples of 565 stray and 312 hospitalized dogs, Nam et al. (2010), 
reported generally higher AMR rates, however, this observation was already reached by 
those authors that, according to Korea Health Products Association data (about the 
amounts of antimicrobials usage in pets), believed to be related with the categories and 
elevated antimicrobials consumption rates in the country.  
Considering that no antimicrobial was administered to the animals enrolled in the 
present study in the four months prior to sampling, our results corroborate the hypothesis 
that the reversibility of resistance in the absence of AM can be a slow process, probably 
due to compensatory evolution and cost-free resistance mechanisms (Andersson and 
Hughes, 2009). Although it could be stated that the Porto city area follows the urban trend 
to higher pet longevity, better veterinary care and widespread use of antibiotics in 
companion animal treatments, there are no evidences that such characteristics are in any 
way different from other studied areas. It has been demonstrated, however, that the Porto 
region suffers from a high level of environment contamination with antimicrobial resistance 
determinants (Novais et al., 2005; Simões et al., 2010; Flores et al., 2013), making 
plausible to assume that resistance acquisitions could be multifactorial (Martínez, 2012) 
and thus environment contamination exposure could also contribute for the high AMR 
rates exhibited.  
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Two of the variables influencing E. coli AMR deserve a special attention due to 
their relation with resistance to several antimicrobials. These risk markers are “prior 
quinolone treatment” and “coprophagic habits”. The discussion of these markers is 
undertaken subsequently. 
By showing a coprophagic behavior the animal ingests gut microflora, including 
multidrug-resistant E. coli strains, from himself, which means a re-inoculation 
(autocroprophagy), or from other animals (allocoprophagy). Those strains, from 
autocoprophagy in particular, are expected to be straightforwardly adapted for prolonged 
colonization. Furthermore, feces from animals undergoing AM treatments, especially with 
poor oral bioavailability, may contain residual concentrations of the drug that are high 
enough to pressure the emergence and dissemination of AMR (Thaller et al., 2010; 
Toutain et al., 2010). Finally, several studies have already shown that there is a high level 
of horizontal gene transfer (HGT) within the intestine, and that its warm and nutrient rich 
environment makes it an ideal location for such phenomena (Lester et al., 2006; 
Hammerum and Heuer, 2009; Jakobsson et al., 2010). 
Among the 15 studied antimicrobials, 12 revealed rates of resistance that were 
related to previous quinolone treatments. In fact, earlier quinolone exposure had already 
been pointed out as a risk marker for the emergence of AMR in E. coli isolated from food 
animals (Moniri and Dastehgoli, 2005) and humans (Cheong et al., 2001; McDonald et al., 
2001; Lastours et al., 2010). This occurrence has been explained by the possible 
association of multiple antimicrobial resistance genes on mobile genetic elements 
(Moreno et al., 2008; Strahilevitz et al., 2009). Additionally, a strong association of 
plasmid-mediated quinolone resistance (PMQR) determinants with extended–spectrum–
β–lactamases (ESBLs) or AmpC–type–β–lactamases has been reported (Moreno et al., 
2008; Hammerum and Heuer, 2009; Strahilevitz et al., 2009; Rawat and Nair, 2010). 
These two types of resistance genes are often co-localized on the same plasmid, along 
with genetic determinants of other antimicrobial agents, such as aminoglycosides, 
trimethoprim, sulphonamides, tetracyclines and chloramphenicol (Jacoby, 2009; 
Strahilevitz et al., 2009; Rawat and Nair, 2010; Zhao et al., 2010). 
The significantly higher risk for ampicillin and amoxicillin-clavulanic acid 
resistances in pets whose owners are healthcare workers could be due to the combination 
of two driving forces. Firstly, since resistance genetic determinants for aminopenicillins 
circulate quite often among medical staff and facilities, pets are at increased risk to 
acquire antimicrobial-resistant E. coli from these owners (Hammerum and Heuer, 2009; 
Kalter et al., 2010; Martins da Costa et al., 2013). Secondly, the transfer of specific 
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resistance determinants to endogenous strains may be seriously enhanced by the 
recurrent exposure to the most prescribed oral antimicrobial drug in Portugal, amoxicillin-
clavulanic acid (DGAV, 2011).  
At the univariable level, the model used in the present study showed a clear and 
positive association between previous antimicrobial exposure and AMR. This was also 
reported by Moyaert et al. (2006), whose work with hospitalized animals retrieved 
frequencies of AMR quite similar to the ones from our study, which, in turn, included 
almost two thirds (62%) of patients with chronic conditions and, consequently, recurrently 
exposed to antimicrobial treatments. In fact, the animals reporting previous treatments in 
our study represented a group of risk in opposition to the “no previous antimicrobial 
treatment” group. A similar effect was observed at the variable “age” for the β-lactamics 
ampicillin, amoxicillin-clavulanic acid and cephalothin. So, younger and healthy animals 
carry less resistant E. coli strains, which may be linked with fewer opportunities of contact 
with antimicrobials. This, added to fewer cases of “coprophagic habits”, is also a plausible 
explanation for the lower prevalence of antibiotic resistance in cats comparing with dogs 
that had 5.16 higher risk of carrying ampicillin-resistant E. coli. 
Finally, at the univariable level, the different risk of contamination by multidrug-
resistant E. coli in outdoor compared with indoor animals was not statistically significant. 
However, as found by Boothe (2012), being a male was considered a risk marker for 
resistance to ampicillin and chloramphenicol. 
The limitations of the study are mainly related with the number of pets enrolled 
which was not calculated in advance because the purpose was to include the higher 
number of animals as possible given the time and the resources available. However, 
given that the selection process was random, the pets investigated represent the 
population of the hospital and an important factor of external validity was assured. The 
statistical analysis provides the significance necessary to assess the risk markers. 
Concerning the data collection, the questionnaires were performed by the same person 
and microbiological isolation, identification and antimicrobial resistance determination 
followed internal quality control procedures aimed to ensure reproducibility (consolidated 
methods performed by trained personnel) and accuracy (quality control of isolation and 
antimicrobial resistance media and internal control strains with known resistance pattern). 
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5. Conclusion 
The present survey showed increased risk of AMR for enteric E. coli strains among 
the pets with record of previous quinolone treatments, which is in line with the results of 
several other reports in different animal species. The pets expressing a coprophagic 
behavior showed an important increase in the risk of AMR for enteric E. coli strains which 
points out the important role that the pet’s owners shall play by educating their animals to 
control this behavior. Other markers like gender, species, reason for check-up were found 
statistically significant, but for a small number of antimicrobials, living room for further 
research of risk markers. 
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Abstract 
Antimicrobials have been falling to resistance and, as in human medicine, 
veterinarians are running out of options due to the high prevalence of infections found in 
companion animals caused by resistant microorganisms. 
The present study aimed to determine the antimicrobial resistance profile of faecal 
enterococci isolated from pets, and investigate potential risk factors for antimicrobial 
resistance in those isolates associated with animals’ characteristics, such as health 
status, individual habits, home environment, previous therapeutic events and owners’ 
behaviour. 
A total of 91 pets (74 dogs and 17 cats) were selected, using a systematic random 
procedure from the ordinary population of animals attending the Veterinary Hospital of 
Porto University, from September 2009 to May 2012. Animal owners, who allowed the 
collection of fecal samples from their pets, answered a questionnaire to collect information 
about the factors that could influence the AMR of fecal enterococci.  Kanamycin Aesculin 
Azide Agar (Oxoid) (KAA) and Slanetz and Bartley Medium (Oxoid) (SB) were employed 
for enterococci isolation and disc diffusion method was used to determine antimicrobial 
susceptibility. The data were analyzed using a multilevel, univariable and multivariable 
generalized linear mixed model (GLMM). 
From the 315 enterococci isolates obtained, 258 (81.9%) were obtained from dogs 
and the remaining 57 (18.1%) from cats. Sixty one per cent of the isolates were 
considered multi-drug resistant whereas only 9.2% were susceptible to all antimicrobials 
tested. Resistances found against tetracycline (67.0%), rifampicin (60.3%), azithromycin 
(58.4%), quinupristin/dalfopristin (54.0%) and erythromycin (53.0%), are causes for 
substantial concern. Previous quinolone treatments and coprophagic habits were the 
features more consistently associated with the presence of AMR to 3 and 7, respectively, 
out of the 9 antimicrobials assessed for risk factors.  
The emergence and dissemination of AMR is a serious problem. Assessing the 
risk factors that determine the presence of drug-resistant bacteria in pets, a very close 
source of resistance determinants to humans, is crucial for the implementation of safer 
management procedures for pets and harmless selection of antimicrobial substances for 
the veterinary practitioners.  
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1. Introduction 
During the last decades, the progress in veterinary medicine and the increased of 
social responsibilities for welfare and health of pets have conducted to a rise in pets 
longevity with a substantial augment in oncologic and geriatric pet patients, which have 
more propensity to chronic, debilitating and immunocompromising conditions and higher 
predisposition for needing antimicrobial (AM) treatments (da Costa et al., 2013). As in 
human medicine, AMs have been falling to resistance, and veterinarians are running out 
of options due to the high prevalence of infections found in companion animals caused by 
resistant microorganisms (Shaheen et al., 2013; Prescott, 2014). In addition, the close 
contact between companion animals and humans builds up a unique and critical aspect 
related to antimicrobial resistance (AMR) that creates opportunities for inter-species 
transmission of (multidrug) resistant bacteria (Leite-Martins et al., 2014). Therefore, small 
animal veterinarians must play an important role in the global approach for combating 
AMR. Monitoring AMR of pet isolates, as well as of the factors that regulate its 
emergence, are essential for assisting veterinary practitioners undertaking safer 
antimicrobial prescription. Without it the clinician tend to favor recent and with wider 
activity AMs.  
Enterococci are common commensals of the intestinal microbiota of people and 
animals, however, they have emerged as one of the fourth most prevalent nosocomial 
pathogens worldwide, mostly because of their high resistance to antimicrobials, putative 
virulence traits and ability to form biofilm (Damborg et al., 2009; Gosh et al., 2011; Kwon 
et al., 2012; Tremblay et al., 2013; Werner et al., 2013). Gosh et al. (2011) found that 
dogs, after being released from intensive care units and on antimicrobial treatment, 
harboured a large community of multidrug-resistant enterococci.  
Thus, monitoring regularly the level of AMR in pathogens and normal flora has 
been recommended by the World Health Organization. Although some national and 
international surveillance programs on AMR have been established for food-producing 
animals (SENTRY, SCOPE, SWEDRES, SVARM, FAO, DANMAP and NARMS), pet 
animals are ordinarily not included in such programs (Gosh et al., 2011). The European 
Centre for Disease Prevention and Control, trough the Antimicrobial Resistance task force 
that encloses 53 countries, adopted a strategic action plan with tactical objectives and 
measures to protect specific key areas in order to restrain AMR spread (EFSA and 
ECDPC, 2013). However, surveillance programs should take into account the role of pets 
in AMR dissemination and analyze potential AMR-influencing factors, such as cohabitants 
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(humans and other pets) clinical antimicrobial records histories, domestic aggregate 
features and habits. 
The aims of the present study were i) characterize AMR in faecal enterococci 
isolated from pets and ii) assess possible risk factors for that AMR associated with the 
health status and individual habits of the animals, some household characteristics as well 
as the presence and lifestyle of cohabitants (humans and other pets), especially in what 
concerns previous exposure to antimicrobials.  
 
 
2. Materials and methods 
 
2.1. Enrolment and sampling 
The purpose of the study was reported to the eligible owners before requesting 
their collaboration. In order to collect a range of animals that could be representative of all 
pets visiting UPVET (Veterinary Hospital of Porto University, Portugal), a random 
systematic sampling procedure was adopted: only one pet a day was selected at a 
random hour, on Mondays or Tuesdays, from September 2009 to May 2012. Eligibility 
criteria required that the core animal have not taken any antimicrobial drugs (AM) during 
the 4 months preceding the selection. All participants were asked to sign a term of 
acceptance, to fill a questionnaire and to allow the collection of faecal samples (rectal 
swabs) from their pets. Approval was obtained from the Ethics Committee of the Abel 
Salazar Institute for the Biomedical Sciences, University of Porto. 
 
2.2. Questionnaire 
The questionnaire was designed with the aim of gathering information about 
possible risk factors for AMR acquisition by enterococci. Questionnaires used in previous 
studies about humans (Kalter et al., 2010; Lastours et al., 2010) and animals (Akwar et 
al., 2007; Ahmed et al., 2012; Boothe, 2012) were taken into consideration. The 
questionnaire included variables regarding individual characteristics of each animal like 1) 
species, 2) gender and 3) age and  daily habits like 4) access to the outside environment 
(indoor habitat was assigned to those animals with very restricted access outdoor), 5) 
feeding (commercial food refers to the animals that were fed on strictly commercial dry or 
wet food) and 6) coprophagic habits (ingestion of feces, either their own or from other 
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animals), 7) previous systemic antimicrobial treatments with particular emphasis on 8) 
previous systemic quinolone treatments. Information on other potential risk factors like the 
9) existence of cohabitant pets in the household, 10) previous antimicrobial treatments of 
human cohabitants, 11) the existence of “healthcare professionals” (human or veterinary 
hospitals, clinics or health centers workers) among the human cohabitants. The pets’ 
health status was assessed through the 12) “reason for veterinary visit”; this information 
was given by the veterinary doctor based on the signs presented by the animal at the time 
of the examination. 
 
2.3. Enterococci isolation 
Faecal samples were collected by introducing saline-moistened swabs, with 
circular movements, into the rectum of each animal. The swabs were immediately 
immersed on Buffered Peptone Water (Oxoid, Basingstoke, UK) (BPW), transported to the 
laboratory and stored at room temperature for 30 minutes. From that suspension, an 
aliquot of 5 µl was streaked on Kanamycin Aesculin Azide Agar (Oxoid) (KAA) and 
Slanetz and Bartley Medium (Oxoid) (SB) for enterococci isolation. Plates were incubated 
at 37°C for 24 and 48 hours, respectively. After careful magnifier examination, two to five 
colonies with the typical appearance of enterococci were selected on the basis of colony 
size and morphology, trying to cover all morphologically different colonies (Leite-Martins et 
al., 2014).  
 
2.4. Antimicrobial susceptibility test 
Antimicrobial susceptibility testing of each isolated enterococci was carried out by 
the disk diffusion assay, following guidelines provided by the “Clinical and Laboratory 
Standards Institute” (CLSI, 2012). A total of 12 antimicrobial agents were tested using 
antimicrobial impregnated disks (Oxoid) with: ampicillin (AMP, 25 µg), tetracycline (TET, 
30 µg), rifampicin (RIF, 5 µg), gentamicin (GEN, 10 µg), chloramphenicol (CHL, 30  µg), 
ciprofloxacin (CIP, 5 µg), erythromycin (ERY, 15 µg), azithromycin (AZM, 15 µg), 
teicoplanin (TEC, 30 µg), vancomycin (VAN, 30 µg), quinupristin/dalfopristin (QD, 15 µg) 
and nitrofurantoin (NIT, 300 µg). The antimicrobial drugs were selected in order to include 
those regularly used in both human and veterinary medicine and to provide diversity by 
representing different antimicrobial classes. (Damborg et al., 2009; Jackson et al., 2009; 
EFSA and ECDPC, 2013). The interpretation of the inhibition zone length followed the 
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CLSI recommendations and breakpoints for enterococci. (CLSI, 2012). Multidrug-resistant 
bacteria were considered according to previous definition (Magiorakos et al., 2011).   
 
 
2.5. Data analysis 
The prevalence of AMR for each AM was calculated by dividing the number of the 
respective AM-resistant enterococci isolates by the total number of enterococci tested. 
The potential risk factors obtained from the questionnaire were transformed into 
categorical variables as follows: dichotomous variables - species (canine, feline), gender 
(male, female), reason for veterinary visit (routine check-up, illness signs), habitat type 
(indoor, mixed), food type (commercial, mixed), previous quinolone treatments (yes, no), 
health professionals owners (yes, no), owners submitted to previous antimicrobial 
treatments (yes, no), cohabitant pets (yes, no), coprophagy habits (yes, no). The historical 
record of the animal having previous antimicrobial treatments was transformed into three 
categories: “none”, “just one” and “two or more” treatments; the age was also transformed 
in three categories: “young” animals with less than 2 years of age, “adult” animals 
between 2 and 10 years and “old” animals with more than 10 years. The result of AMR is 
the outcome of the models and was dichotomized in resistant or sensitive; intermediate 
results were categorized as sensitive. According to the European Food Safety Authority 
criteria, each antimicrobial was further classified into one of the following categories of 
prevalence of AMR: extremely high: > 70%; very high: 50-70%; high: 20-50%; moderate: 
10-20%; low: 1-10%; very low: 0.1-1% and rare: <0.1% (EFSA and ECDPC, 2013). 
A descriptive analysis of both AMR prevalence and frequencies of risk factors was 
performed. A Multilevel Generalized Linear Mixed Model (GLMM) was used to analyze the 
potential risk factors for AMR and to assess the strength of their associations.  
The logit link function was used to model the probability of occurrence of 
resistance to an antibiotic. To take into account the multilevel structure of the data in 
which more than one enterococci strain (i) was isolated from each animal (j), a two level 
structure in the data was assumed in which enterococci strains (first level) were nested 
within the animal from which they were isolated (second level). 
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The data were modeled in the following way: 
𝑌 = { 
0 (𝑛𝑜 𝐴𝑀𝑅) 
1 (𝐴𝑀𝑅)
 Where Y is the response variable. 
 
Pr(Y) = pij, i = 1, …, 315 and j = 1, ..., 91. 
 
The generic model used the following equation: 𝑙𝑜𝑔𝑖𝑡(𝑝𝑖𝑗) = 𝑎 + 𝑐𝑗 + 𝛽 𝑎𝑛𝑖𝑚𝑎𝑙 𝑣𝑎𝑟𝑖𝑎𝑏𝑙𝑒𝑠𝑗 
The model, the animal (the pet) was allowed to be random. The second level random 
effect is given by cj ∼ N(0,σ2 ) where σ2 is the variance of the random effects at the 
animal level.  
 
The basic multivariable multilevel model was as follows: 
𝑙𝑜𝑔𝑖𝑡(𝑝𝑖𝑗) = 𝑎 + 𝑐𝑗 + 𝛽1𝑆𝑝𝑒𝑐𝑖𝑒𝑠𝑗 + 𝛽2𝐴𝑔𝑒𝑗 + 𝛽3𝐺𝑒𝑛𝑑𝑒𝑟𝑗 + 𝛽4𝑅𝑒𝑎𝑠𝑜𝑛 𝑜𝑓 𝑣𝑖𝑠𝑖𝑡𝑗 + 𝛽5𝐻𝑎𝑏𝑖𝑡𝑎𝑡𝑗
+  𝛽6𝐷𝑖𝑒𝑡𝑗 + 𝛽7𝑁𝑢𝑚𝑏𝑒𝑟 𝐴𝑀 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡𝑠𝑗
+ 𝛽8𝑃𝑟𝑒𝑣𝑖𝑜𝑢𝑠 𝑄𝑢𝑖𝑛𝑜𝑙𝑜𝑛𝑒𝑠 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡𝑠𝑗 + 𝛽9𝑂𝑤𝑛𝑒𝑟
′𝑠 𝑝𝑟𝑜𝑓𝑒𝑠𝑠𝑖𝑜𝑛𝑗
+ 𝛽10𝑂𝑤𝑛𝑒𝑟
′𝑠 𝐴𝑀 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡𝑠𝑗 + 𝛽11𝐶𝑜ℎ𝑎𝑏𝑖𝑡𝑎𝑛𝑡𝑠 𝑃𝑒𝑡𝑠𝑗
+ 𝛽12𝐶𝑜𝑝𝑟𝑜𝑝ℎ𝑎𝑔𝑦 ℎ𝑎𝑏𝑖𝑡𝑠𝑗 
Variables codes are presented in Tables 3 to 5. 
 
A three step procedure was taken as follows: firstly, a univariable multilevel GLMM 
analysis was conducted to assess the individual relationship between each potential risk 
factor and the presence of AMR; a second step was performed to conduct a multivariable 
multilevel GLMM analysis with all the variables that had a p < 0.15 in the previous 
analyses followed by a manual backward and forward procedure to obtain a final model 
where each factor effect was adjusted for the remaining factors. Only factors with a p < 
0.05 were retained in the final model. The data were analyzed using the procedure GEE in 
the SPSS Software V. 21.0 (IBM SPSS statistical 21 package, IBM Corporation, NY). 
 
 
3. Results 
A total of 91 pets (74 dogs and 17 cats), one per household, were enrolled in the 
present study. Out of the 315 isolates of enterococci, 258 (81.9%) were obtained from 
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dogs and the remaining 57 (18.1%) from cats. The number of isolates from each animal 
ranged from 2 to 5 with an average of 3.46 per pet.  
 
3.1. Presence of multidrug-resistant enterococci 
Only 9.2% of the isolates were susceptible to all antimicrobials tested. According to 
previous definition of multidrug resistance (Magiorakos et al., 2011), the majority (61.9%) 
of enterococci isolates was considered multidrug-resistant; 50% showed resistance to 
three AM and 75% were resistant to six AM. Two isolates (0.6%) and three isolates (1%) 
showed resistance towards 9 and 8 AM, respectively. The histogram of these isolates 
displayed by the absolute number of resistances per isolate suggests the existence of two 
sub-populations of enterococci and is shown in Fig. 1: one group with less than three 
resistances and a second group with more than 5 resistances. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Incidence of antimicrobial resistance in isolated enterococci (n=315). 
 
3.2. Antimicrobial resistance prevalence 
The prevalence of AMR per antimicrobial varied from 1.0% found in vancomycin 
up to 67.0% for tetracycline. After categorization according to the EFSA (EFSA and 
ECDPC, 2013) recommendations, 41.7% of the AM tested were at the very high 
resistance category and a similar proportion of antimicrobials showed a low level 
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resistance. Again a bimodal pattern seems to occur. The high and moderate resistance 
categories harbored 8.3% of the tested AM each, as displayed in Table 1. 
Table 1. Categorization of antimicrobial (AM) resistance profile in the isolated 
enterococci according to the EFSA risk categories for prevalence of resistances and 
proportion of AM in each category. 
 
EFSA Risk 
Categories 
AM 
Prevalence 
of resistance 
C.I. 
Frequency of 
AM in each 
category 
C.I. 
Extremely High 
 
0.0 - 0.0 - 
Very High 
TET 67.0 0.046 
41.7 0.049 
RIF 60.3 0.048 
AZM 58.4 0.049 
QD 54.0 0.049 
ERI 53.0 0.049 
High CIP 29.5 0.045 8.3 0.027 
Moderate AMP 12.1 0.032 8.3 0.027 
Low 
NIT 9.2 0.028 
41.7 0.049 
GEN 6.3 0.024 
CHL 6.3 0.024 
TEC 2.2 0.014 
VAN 1.0 0.010 
Very Low 
 
0.0 - 0.0 - 
Rare 
 
0.0 - 0.0 - 
 
Legend: AM – antimicrobial agent; C.I. – confidence interval; AMP – ampicillin; TET – tetracycline; RIF - rifampicin; GEN – 
gentamicin; CHL - chloramphenicol; CIP – ciprofloxacin; ERI - erythromycin; AZM - azithromycin; TEC – teicoplanin; VAN - 
vancomycin; QD - quinupristin/dalfopristin; NIT – nitrofurantoin. Values are expressed in percentages. 
 
 
3.3. Descriptive analysis of risk factors and pets 
The allocation of pets and percentage of isolates into the different categories of 
potential risk factors is presented in Table 2. The proportions of antimicrobial resistant 
strains for each potential risk factor are displayed in Table 3. The AMR proportions were 
calculated based in all enterococci isolates (n=315). The overall data displayed lower 
resistance numbers in potential risk factors for AMR labeled into the moderate and low 
resistance level categories (EFSA and ECDPC, 2013). 
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Table 2. Distribution of pets (n=91) among potential risk factor categories and enterococci 
isolates in percentage of the total number of isolates (n=315). 
 
Risk factor Category Dogs % isolates Cats % isolates 
Total 
Pets 
Isolates 
(%) 
Species  74 
 
17 
 
91 100 
Age 
< 2 years 22 24.1 8 8.3 30 32.4 
2 - 10 years 30 34.3 8 8.9 38 43.2 
> 10 years 22 23.5 1 1.0 23 24.4 
Gender 
Female 43 48.6 10 10.2 53 58.7 
Male 31 33.3 7 7.9 38 41.3 
Reason for 
veterinary 
visit 
Check up 23 24.8 11 11.7 34 36.5 
Illness 51 57.1 6 6.3 57 63.5 
Habitat Type 
Indoor 7 7.6 13 13.7 20 21.3 
Mixed 67 74.3 4 4.4 71 78.7 
Food Type 
Commercial 23 26.3 7 6.7 30 33.0 
Mixed 51 55.6 10 11.4 61 67.0 
Animal 
Antimicrobial 
Treatments 
None 21 21.0 13 13.7 34 34.6 
Just One 15 17.5 2 1.9 17 19.4 
Two or more 38 43.5 2 2.5 40 46.0 
Animal 
Quinolone 
Treatments 
Yes 27 30.2 2 2.5 29 32.7 
No 47 51.7 15 15.6 62 67.3 
Owners 
Health 
Professional
s 
Yes 15 15.9 5 4.8 20 20.6 
No 59 66.0 12 13.3 71 79.4 
Owners 
Antimicrobial 
Treatments 
Yes 35 42.9 4 4.4 39 47.3 
No 39 39.0 13 13.7 52 52.7 
Cohabitant 
Pets 
Yes 33 40.0 13 13.7 46 53.7 
No 41 41.9 4 4.4 45 46.3 
Coprophagy 
Habits 
Yes 29 32.7 4 4.4 33 37.1 
No 45 49.2 13 13.7 58 62.9 
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Table 3. Antimicrobial resistant isolates distribution by potential risk factor categories 
(n=315).  
Variables Category 
% of resistant isolates / antimicrobial 
AMP TET RIF GEN CHL CIP ERI AZM TEC VAN QD NIT 
Species 
Canine 12.1 55.9 47.9 6.0 5.4 25.1 44.8 49.8 2.2 1.0 44.1 7.9 
Feline 0.0 11.1 12.4 0.3 1.0 4.4 8.3 8.6 0.0 0.0 9.8 1.3 
Age 
< 2 years 1.9 17.8 16.8 1.6 3.5 4.8 14.6 14.3 0.6 0.6 15.6 2.2 
2 - 10 years 3.5 29.8 29.5 2.5 0.3 13.3 22.2 28.9 1.0 0.0 25.7 3.8 
> 10 years 6.7 19.4 14.0 2.2 2.5 11.4 16.2 15.2 0.6 0.3 12.7 3.2 
Gender 
Female 7.3 39.4 35.6 2.5 6.0 15.9 32.7 35.2 1.3 0.6 28.9 6.3 
Male 4.8 27.6 24.8 3.8 0.3 13.7 20.3 23.2 1.0 0.3 25.1 2.9 
Reason for 
veterinary 
visit 
Check up 3.8 22.9 19.4 2.9 1.9 6.3 18.4 18.4 0.3 0.6 18.4 4.1 
Ilness 8.3 44.1 41.0 3.5 4.4 23.2 34.6 40.0 1.9 0.3 35.6 5.1 
Habitat Type 
Indoor 1.0 14.3 13.7 0.6 1.0 6.7 10.5 10.5 1.6 0.3 9.5 1.6 
Mixed 11.1 52.7 46.7 5.7 5.4 22.9 42.5 47.9 0.6 0.6 44.4 7.6 
Food Type 
Comercial 5.4 23.2 18.4 3.2 2.5 12.1 18.7 19.7 0.6 0.3 16.8 4.4 
Mixed 6.7 43.8 41.9 3.2 3.8 17.5 34.3 38.7 1.6 0.6 37.1 4.8 
Animal 
Antimicrobial 
Treatments 
None 0.3 21.0 20.3 2.2 1.3 5.4 14.0 16.5 0.3 0.6 15.9 2.5 
Just One 1.6 14.3 12.4 1.3 2.5 5.4 10.2 11.1 1.3 0.0 11.7 1.9 
Two or more 10.2 31.7 27.6 2.9 2.5 18.7 28.9 30.8 0.6 0.3 26.3 4.8 
Animal 
Quinolone 
Treatments 
Yes 5.4 25.7 20.0 2.9 5.1 18.1 22.5 23.2 1.3 0.6 20.0 3.2 
No 6.7 41.3 40.3 3.5 1.3 11.4 30.5 35.2 1.0 0.3 34.0 6.0 
Owners 
Health 
Professionals 
Yes 3.2 12.7 10.5 1.3 1.6 5.7 11.4 11.4 0.0 0.0 10.5 2.9 
No 8.9 54.3 49.8 5.1 4.8 23.8 41.6 47.0 2.2 1.0 43.5 6.3 
Owners 
Antimicrobial 
Treatments 
Yes 4.4 32.1 27.3 4.1 4.4 12.7 27.6 30.5 2.2 0.6 26.3 4.4 
No 7.6 34.9 33.0 2.2 1.9 16.8 25.4 27.9 0.0 0.3 27.6 4.8 
Cohabitant 
Pets 
Yes 5.4 38.4 32.7 4.8 6.3 16.8 30.5 33.7 0.6 0.6 27.6 4.8 
No 6.7 28.6 27.6 1.6 0.0 12.7 22.5 24.8 1.6 0.3 26.3 4.4 
Coprophagy 
Habits 
Yes 7.0 29.8 25.7 4.1 5.4 15.6 25.7 27.0 0.0 0.3 22.2 4.4 
No 5.1 37.1 34.6 2.2 1.0 14.0 27.3 31.4 2.2 0.6 31.7 4.8 
Legend: AMP – ampicillin; TET – tetracycline; RIF - rifampicin; GEN – gentamicin; CHL - chloramphenicol; CIP – 
ciprofloxacin; ERI - erythromycin; AZM - azithromycin; TEC – teicoplanin; VAN - vancomycin; QD - quinupristin/dalfopristin; 
NIT – nitrofurantoin. 
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3.4. Results of the multilevel univariable analysis 
Table 4 displays the results of the multilevel univariable analysis. Only variables 
and categories with Odds Ratio (OR) lower than 0.15 are presented. The factors 
demonstrating a significant (p < 0.05) increased risk of resistance were: being a female 
(for chloramphenicol); living indoor (for teicoplanin); having received previous quinolone 
treatments (for tetracycline, chloramphenicol, ciprofloxacin, erythromycin and 
azithromycin); being owned by persons who have already done antimicrobial treatments 
(for chloramphenicol and azithromycin) and having coprophagic habits (for tetracycline, 
rifampicin, gentamycin, chloramphenicol, ciprofloxacin, erythromycin and azithromycin). 
Protective factors (p < 0.05) were: being younger than 2 years (for tetracycline, 
ciprofloxacin and azithromycin), younger than 10 years old (for ampicillin and 
erythromycin) or having between 2 and 10 years old (for chloramphenicol). Regarding the 
reason to visit the veterinary, coming for check-up appears also a protective factor (for 
rifampicin, ciprofloxacin and azithromycin); as well as have never taken antimicrobial 
treatments (for ampicillin, ciprofloxacin, erythromycin and azithromycin). Only 
quinupristin/dalfopristin, vancomycin and nitrofurantoin resistances failed to be 
significantly associated with any potential risk factor and by this reason these 
antimicrobials were excluded from the subsequent multilevel multivariable analysis.  
 
3.5. Results of the multilevel multivariable analysis 
The variables included in the multilevel multivariable model were selected from the 
previous univariable analysis, when a p < 0.15 was considered. The final model was 
obtained from a multilevel multivariate analysis after manual backward and forward 
variable selection and resulted in a robust model. Only the variables that, after adjustment 
for all the other variables remained significant at p < 0.05, were kept in this model (Table 
5). The final model showed that the factors demonstrating a significant (p < 0.05) 
increased risk of resistance were: being a female (for chloramphenicol); living indoor (for 
teicoplanin); having received one previous antimicrobial treatment (for chloramphenicol), 
having received previous quinolone treatments (for chloramphenicol, ciprofloxacin and 
azithromycin) and having coprophagic habits (for tetracycline, rifampicin, gentamycin, 
chloramphenicol, ciprofloxacin, erythromycin and azithromycin). Protective factors were: 
being a female (for gentamycin) and have not been treated with any antimicrobial (for 
ampicillin and erythromycin).  
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Table 4. Risk factors for antimicrobial resistance of enterococci isolates displayed from 
the univariable multilevel analysis.  
 
Legend: OR – Odds ratio; * – p value (* - <0.05; ** - <0.01; *** - <0.001); AM - antimicrobial; TX - treatment; O. - owner; 
Prof. - professional; Cohabit.- cohabitant; AMP – ampicillin; TET – tetracycline; RIF - rifampicin; GEN – gentamicin; CHL - 
chloramphenicol; CIP – ciprofloxacin; ERI - erythromycin; AZM - azithromycin; TEC – teicoplanin. 
  
Risk Factors 
AMP TET RIF GEN CHL CIP ERI AZM TEC 
OR OR OR OR OR OR OR OR OR 
Species Canine 
       
1.73 
 
Species  Feline 
         
Age: < 2 years 0.11** 0.22* 0.81 
 
1.04 0.11** 0.42** 0.48* 
 
Age: 2 - 10 years 0.22* 0.54 1.62 
 
0.06* 0.43 0.54* 1.22 
 
Age: > 10 years 
         
Gender Female 
   
0.44 14.77* 
    
Gender Male 
         
Reason: Check up 
  
0.62* 
  
0.26* 
 
0.60* 
 
Reason: Ilness 
         
Habitat: Indoor 0.27 
     
0.46 0.62 9.92** 
Habitat: Mixed 
         
Food: Commercial 
   
2.14 
     
Food: Mixed 
         
AM Tx: None 0.04** 
   
0.65 0.21** 0.40** 0.45** 0.66 
AM Tx: One 0.18 
   
2.59 0.42 0.66 0.67 5.02 
AM Tx: 2 or + 
         
Quinolone Tx: Yes 
 
2.93* 
 
4.50 9.56*** 9.47*** 2.68*** 2.21** 
 
Quinolone Tx: No 
         
O. Prof.: Health 
Prof.   
0.61 
      
O. Prof.: Others 
         
O. AM Tx: Yes 
    
2.77* 
 
1.51 1.61* 
 
O. AM Tx: No 
         
Cohabit. Pets: Yes 
  
2.06 
   
1.39 1.57 
 
Cohabit. Pets: No 
         
Coprophagy: Yes 3.09 3.83** 1.84* 3.96** 11.05*** 3.64** 2.93*** 2.66*** 
 
Coprophagy: No 
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Table 5. Risk factors for antimicrobial resistance of enterococci isolates displayed from 
the multilevel multivariable final model. 
 
Legend: OR – Odds ratio; * – p value (* - <0.05; ** - <0.01; *** - <0.001); AM - antimicrobial; TX - treatment; O. - owner; 
Prof. - professional; Cohabit.- cohabitant; AMP – ampicillin; TET – tetracycline; RIF - rifampicin; GEN – gentamicin; CHL - 
chloramphenicol; CIP – ciprofloxacin; ERI - erythromycin; AZM - azithromycin; TEC – teicoplanin. 
 
 
4. Discussion  
In this study, we aimed to establish the prevalence of AMR against 12 
antimicrobials in 315 faecal enterococci isolated from dogs and cats attending UPVET. 
The use of a GLMM multilevel model to analyse the data allowed the identification of risk 
factors significantly associated with the presence of AMR within the sampled population. 
A random systematic sampling procedure was adopted, in order to collect a range 
of animals representative of all pets visiting the hospital. After comparing the factors 
species, age, sex and reason for the visit from our sample with that from the UPVET 
population, it was concluded that the population of pets enrolled, resembles that of the 
pets attending the UPVET hospital. The existence of two enterococci sub-populations was 
suggested through the histogram exhibiting the incidence of the AMR in total enterococci 
Risk Factors 
AMP TET RIF GEN CHL CIP ERI AZM TEC 
OR OR OR OR OR OR OR OR OR 
Gender Female 
   
0.35* 16.04* 
    
Gender Male 
         
Habitat: Indoor 
        
10.33* 
Habitat: Mixed 
         
AM Tx: None 0.06* 
   
13.15 
 
0.36* 
  
AM Tx: One 0.26 
   
9.66* 
 
0.72 
  
AM Tx: 2 or + 
         
Quinolone Tx: Yes 
    
22.72** 8.39*** 
 
1.94*** 
 
Quinolone Tx: No 
         
Coprophagy: Yes 
 
3.01* 2.56 3.96** 10.46* 2.75* 3.82** 2.42*** 
 
Coprophagy: No 
         
Risk Factor 
Patterns  
A A 
  
B 
 
B 
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isolated (Figure 1), one categorized at the very high resistance level and other at the low 
resistance level (EFSA and ECDPC, 2013), reinforcing the bimodal pattern that was 
supposed to occur. 
Enterococci infections are unusual in dogs and cats. However, the extent of AMR 
in enterococci from companion animals should be monitored to provide baseline 
information and to fully assess the role that these animals could have as reservoirs of 
resistant bacteria and their potential impact on humans and on the environment. A 
considerable proportion of the enterococci displayed resistance to tetracyclines, 
macrolides, clindamycin, rifampin and fluoroquinolones. It seems likely that these 
resistances have emerged among enterococci that were colonizing animals to which 
antimicrobials were given for other reasons. Antimicrobial therapy affects not only the 
target pathogen but also commensal inhabitants of the host, namely those from the gut 
microbiota (Jackobsson et al., 2010). The extent of the impact on non-target microbial 
populations depends on the particular drug used, on its mode of action and on the degree 
of resistance in the community (Jernberg et al., 2010). Colonizing bacteria may actually be 
more capable of developing resistance because they coexist with multiple other bacterial 
species and therefore have access to their resistance genes. 
Some studies aimed to monitor bacterial susceptibility to antimicrobials among 
faecal enterococci isolated from pets were previous performed (Poeta et al., 2006; 
Damborg et al., 2009; Jackon et al., 2009; Ghosh et al., 2011; Hamilton et al., 2013). AMR 
frequencies found in the present survey were overall higher when compared with the 
above studies, with the exception for Ghosh et al., (2011), probably because intensive 
care unit animals under antimicrobial treatment were sampled. The work from the North of 
Portugal (Poeta et al., 2006) was realized just with healthy animals, a possible reason for 
lower AMR frequencies when compared with the ones we obtained. The Porto region is 
known to have a high level of antimicrobial environment contamination (Flores et al., 
2013), a potential contribution for our pool of animals to have higher AMR resistance rates 
when compared with the other previous comparable studies.  
The multilevel univariable model (Table 4) displayed several risk factors. The final 
form obtained from the statistical analysis, using a multilevel multivariable model (Table 
5), resulted in an important reduction in the number of significant risk factors (p < 0.05), 
when compared with the initial multilevel invariable model. Strong risk factors as “Previous 
Quinolone Treatments” and “Coprophagy habits” were practically maintained, promoting 
AMR in 3 and 7 drugs through the multivariable final model, respectively. Other factors 
such as “Age”, “Reason for the Veterinary Visit” or “Owners’ AM Tx” lost their strength. 
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However, the fact that these risk factors were significant at the univariable model, may 
suggest that the design of further risk factor studies, in the future, should take into 
consideration these results to clarify their importance.  
Two distinct patterns of risk factors could be proposed (Table 5): pattern A) which 
associates coprophagic behaviors with AMR to tetracycline and rifampicin, and pattern B) 
that connects animals with coprophagic habits and previously treated with quinolones to 
be at a higher risk for harboring isolates resistant to ciprofloxacin and azithromycin. 
The direct ingestion of resistant bacteria is a way to acquire AMR (Lastours et al., 
2010). Coprophagy, which comprises the ingestion of intestine inhabitants 
straightforwardly adapted for prolonged colonization (mainly in autocoprophagy), can be 
seen as a form of amplifying the variability of bacterial cells as well as resistance 
determinants. Several studies have already shown that the transfer of resistance genes 
can occur at a high level within the intestine, (Lester et al., 2006; Jackobsson et al., 2010; 
Jernberg et al., 2010), which is the ideal location for such phenomena to occur, since it 
provides a warm and nutrient-rich environment with large numbers of bacterial cells 
potentially able to develop resistance mechanisms and exchange resistance 
determinants. Enterococci have natural gene transfer mechanisms that allow the 
acquisition of multiple resistances (Jackson et al., 2009). Furthermore, since some faeces 
may contain extremely high concentrations of antimicrobials, especially of drugs with poor 
oral bioavailability, eating faeces may lead to drug transfer between animals 
(allocoprophagy) or within the same animal (autocoprophagy), enhancing the emergence 
and dissemination of AMR (Thaller et al., 2010; Toutain et al., 2010).  
Pets’ intestinal colonization by ciprofloxacin and/or azithromycin-resistant 
enterococci seems to be highly influenced by pets’ “Previous Quinolone Treatments”. 
Some authors (Yasufuku, 2011; Dalhff, 2012; Lee, 2013) had already found a significant 
positive statistical correlation between the previous use of fluoroquinolones and 
enterococci resistance to quinolones, in humans. As resistance to macrolides 
(azithromycin), streptogramins and tetracyclines can be co-selected by fluoroquinolone 
agents (Poole, 2005; Zechini and Versace, 2009; Dalhff, 2012), this could explain the 
observed relation between prior quinolone treatments and azithromycin resistance. 
Previous studies displayed similarities between human and pet enterococci 
isolates (Damgorg et al., 2009; Kwon et al., 2012; Tremblay et al., 2013), however our 
data failed to find any significance for animals belonging to health professionals or people 
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already exposed to antimicrobial treatments; this result may be explained by the low 
number of animals analysed in those groups (Table 2). 
Animals younger than two years old were at lower risk of being colonized by 
enterococci resistant to ampicillin, tetracycline, ciprofloxacin, erythromycin and 
azithromycin. This could be explained through the less time and few opportunities that 
younger animals have to had antimicrobial treatments or to have contacted resistance 
genetic determinants from the pool of ambient contamination, a well-known source of 
AMR determinants acquisition (Andersson and Hughes, 2010; Martínez, 2012; Flores et 
al., 2013),. 
Regular monitoring of the level of AMR in pathogens and normal flora has been 
recommended by the World Health Organization and pets, sharing so many aspects of 
their lifes with the owners, should have an important place on that. 
Studies in this field are needed in order to understand the mechanisms involved in 
the emergence, spread, maintenance and evolution of antimicrobial resistance. The 
present data may just pretend to alert and reinforce the attention to one small piece of the 
enormous AMR puzzle.  
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Abstract 
Advances in veterinary medicine are largely associated with recourse to 
antimicrobial therapies, paving the way to the emergence of resistant bacteria, potentially 
able to spread globally. The aim of this study was to elucidate the manner in which shared 
environments between pets receiving antimicrobial treatments and their owners can 
potentiate the spread of antimicrobial-resistant Escherichia coli. Three domestic 
aggregates (DA), including pets, owners and household environment were studied. Each 
core pet had history of previous antimicrobial therapies. Overall, 231 E. coli isolates were 
recovered and analyzed by antimicrobial susceptibility testing. Subsequently, some 
isolates were eligible to carry out ERIC-PCR and PFGE analyses, in order to evaluate 
their genetic relatedness. The three core dogs presented multidrug-resistant E. coli clones 
disseminated over various body sites. In DA A and B, clonal disseminations among 
animals, owners and household surfaces were observed.  In conclusion, results 
highlighted the spread of multidrug-resistant E. coli within household.  
Key words: antimicrobial resistance, Escherichia coli spread, pets, humans, household 
surfaces.  
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1. Introduction 
Antimicrobial resistance (AMR) is a major public health problem worldwide and will 
probably be the main global concern of the next decade (Carlet, et al., 2012). The 
phenomenon of AMR is a complex problem involving several bacterial species, resistance 
mechanisms, transfer mechanisms and reservoirs (Guardabassi et al., 2004). Although 
the major consequences of AMR are more noticeable in the clinical setting, emergence 
and dissemination of resistance is mainly to happen in the environmental microbiota, 
where studies aimed to fully understand the cycle of acquisition of resistance by human 
pathogens are needed (Martínez, 2012). 
The notorious improvement of companion animals’ medical assistance was 
accompanied by the appearance of veterinary hospitals and the adoption of clinical 
procedures similar to the ones used in human medicine. Hospitalized pets under antibiotic 
treatment have provided a scenario that strongly favors the occurrence and dissemination 
of AMR (Hall et al., 2013) similar to what happens in human clinical settings. When these 
animals are discharged and go home, due to the close contact and contempt in hygiene 
practices between owners and their pets, they can easily transfer antimicrobial-resistant 
strains (Guardabassi et al., 2004; Lloyd, 2007; Murphy et al., 2009) directly (via contact 
with skin, saliva or feces) or indirectly (via the household environment) to their animal or 
human cohabitants (Martins et al., 2013). 
Escherichia coli can be used to track the evolution of antibiotic resistance in 
different ecosystems not only due to its important role as acceptor and donor of 
transmissible drug resistance genes, from and to pathogenic bacteria (van den Bogaard 
and Stobberingh, 2000; Sáenz et al., 2004), but also because it is commonly found in the 
intestinal tract of humans and animals and widely spread in fecal contaminated water, soil 
and food (Costa et al., 2008; Murphy et al., 2009; da Costa et al., 2013). 
The above concerns led us to pursue three hypotheses throughout the present 
work: i) the possibility of E. coli from dog feces to colonize other body sites of the animal; 
ii) the ability of that same E. coli disseminate to household surfaces and objects and iii) 
the occurrence of intra-species and inter-species E. coli transmission within the same 
domestic aggregate. 
Accordingly, we conducted a cross-sectional point prevalence survey of E. coli 
colonization patterns in three domestic aggregates. Cefotaxime supplemented media was 
utilized to facilitate the recovery of low-frequency clones and enterobacterial repetitive 
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intergenic consensus-polymerase chain reaction (ERIC-PCR) and pulsed-field gel 
electrophoresis (PFGE) were the tools used to assess E. coli genetic diversity from 
humans, pets and household surfaces. 
 
 
2. Materials and Methods 
 
2.1. Study design and compliance 
Domestic Aggregates (DA) integrating this study emerged from the universe of 
clients of the Veterinary Hospital of the University of Porto (UPVet). Eligibility criteria for 
this study branch required that the core pet (the animal visiting the hospital), from the 
applicant domestic aggregate (including owners and other pets), had been submitted to at 
least one antimicrobial treatment over the previous 6 months. The owners were asked to 
sign in a term of acceptance; to fill a questionnaire about intrinsic and environmental 
variables of each one of the DA elements, including human and veterinary medical 
information regarding antibiotic exposure; to bring their own stool samples and to allow 
the collection of swabs from their hands; fecal, urinary and oral secretions samples and 
skin and fur swabs from their pets as well as swabs from commonly touched household 
objects and surfaces (light switches, door knobs, TV remote control, mobile phones, 
banister, refrigerator door handle, kitchen floor, pets beds, leash, food and water 
recipients). Approval was obtained from the Ethics Committee of the Abel Salazar Institute 
for the Biomedical Sciences, University of Porto. 
 
2.2. Escherichia coli isolation 
Fecal samples were immediately diluted 1:10 in saline buffer and stored at room 
temperature for 30 min. From the initial suspension, an aliquot of 5 µl was streaked on 
Tryptone Bile X-glucuronide agar (TBX; Biokar Diagnostics, Allonne, Beauvais, France) 
and 100 µl were spread on the same culture media containing 2 μg/ml of cefotaxime 
(Sigma-Aldrich, St. Louis, MO, USA). The urine was applied directly by streaking 5 µl on 
TBX agar and 100 µl on TBX containing cefotaxime. The swabs were immersed on 
Buffered Peptone Water (BPW; Oxoid, Basingstoke, Hampshire, England) for 30 min at 
room temperature and, subsequently, 100 µl were spread on non-supplemented and 
cefotaxime-supplemented TBX agar plates. 
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Plates were incubated overnight at 37°C. A maximum of five colonies with typical 
appearance of E. coli were selected from each non-supplemented TBX agar plate and all 
colonies presenting different morphologies were additionally picked from the cefotaxime 
supplemented TBX agar plates. Standard biochemical methods were used for the 
confirmation of E. coli isolates (Berge et al., 2006). The described procedure was adapted 
from standard protocols (Costa et al., 2008; Martins et al., 2013) used in related studies 
aiming to achieve the most reliable and accurate E. coli detection. 
 
2.3. Antimicrobial susceptibility characterization 
Disk diffusion assay, following CLSI guidelines (CLSI, 2012), was performed to 
assess the antimicrobial susceptibility of each isolate. Selected antimicrobial drugs 
included those regularly used in both human and veterinary medicine and were 
representative of different antimicrobial classes. A total of 19 antimicrobial agents (Oxoid) 
were tested: ampicillin (AMP, 10 µg), amoxicillin-clavulanic acid (AMC, 30 µg), aztreonam 
(ATM, 30 µg), cephalothin (CEF, 30 µg), ceftazidime (CAZ, 30 µg), cefotaxime (CTX, 30 
µg), cefoxitin (FOX, 30 µg), imipenem (IPM, 10 µg), gentamicin (GEN, 10 µg), amikacin 
(AMK, 30 µg), streptomycin (STR, 10 µg), tobramycin (TOB, 10 µg), kanamycin (KAN, 30 
µg), ciprofloxacin (CIP, 5 µg), nalidixic acid (NAL, 30 µg), tetracycline (TET, 30 µg), 
chloramphenicol (CHL, 30 µg), trimethoprim-sulfamethoxazol (SXT, 25 µg) and 
nitrofurantoin (NIT, 300 µg).  
 
2.4. DNA extraction and E. coli phylogenetic group determination 
Multidrug-resistant bacteria were considered according to previous reported 
definition (Magiorakos et al., 2011). Criteria designed for selecting the group of isolates, 
from each DA, eligible for genetic analysis were: i) multidrug-resistant E. coli with different 
antimicrobial resistance patterns and ii) multidrug-resistant strains that had similar 
antimicrobial resistance phenotypes but isolated from different sources. 
The isolates were cultured in Müeller-Hinton agar (MH; Biokar Diagnostics) at 37ºC 
and harvested at late exponential phase to perform DNA extraction by using the 
InstaGene Matrix ® (Bio-Rad Laboratories, California, USA) as described by the 
manufacturer. A simple and rapid phylogenetic grouping technique based in a triplex PCR 
was applied, as already described (Clermont et al., 2000).  
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2.5. ERIC-PCR fingerprinting 
A 25-µl ERIC-PCR reaction was carried out using the primers ERIC-1R (5’-ATG 
TAA GCT CCT GGG GAT TCA C) and ERIC 2 (5’-AAG TAA GTG ACT GGG GTG AGC 
G) as previously described (Versalovic et al., 1991; Meacham et al., 2003). The PCR 
amplifications were performed in a DNA thermal cycler MyCycler® (Bio-Rad Laboratories), 
with an initial incubation at 94ºC for 3 min, followed by 30 cycles consisting of 94ºC for 1 
min, 50ºC for 1 min and 72ºC for 3 min. A final extension at 72ºC for 5 min was 
programmed to complete the amplification (Leung et al., 2004). 
The ERIC-PCR patterns of each isolate was visualized after electrophoresis for 45 
min at 150 V using a 1.5% agarose gel containing 1x TBE buffer (National Diagnostics, 
Atlanta, GA, USA) and 0.5 µg/ml ethidium bromide. Gels were photographed using a 
Molecular Imager Gel Doc XR® (Bio-Rad Laboratories). 
 
2.6. PFGE fingerprinting 
All eligible isolates from DA A and DA C were used for both ERIC-PCR and PFGE 
analyses; however, given the high number of isolates selected from DA B and the 
respective ERIC-PCR results, some isolates exhibiting lower ERIC fingerprinting similarity 
(< 85%) and coming from different sources or high similarity but originated from the same 
source were excluded from PFGE analysis. PFGE fingerprints, obtained using XbaI-
digested total DNA, were interpreted by using previous criteria (Johnson et al., 2008; 
Stenske et al., 2009). According to Tenover et al. (1995), isolates can be considered 
clonally related if their fingerprinting profiles do not differ in more than two or three bands.  
Pulsed-field gel electrophoresis was performed as previously described (Barret et 
al., 1994; Ejrnaes et al., 2006), with minor modifications. In brief, a single pure colony of 
each isolate was inoculated in BPW and incubated overnight, at 37ºC. Then, OD600 was 
adjusted to 1.0  and bacterial suspensions were pelleted and washed with a suspension 
buffer (10mM Tris Buffer,  pH7.5; 20 mM NaCl; 50 mM EDTA, pH8.0), and mixed with an 
equal volume of melted LMP agarose at 2% (SeaPlaque Agarose low melting 
temperature). The mixture was dispensed into plug molds. After solidification, agarose 
plugs were transferred to the lysis buffer (10 mM Tris Buffer, pH7.5; 50 mM NaCl; Na 
deoxychotalo 0.2%, Na laurylsarcosine 1% ,1 mg/ml lisozyme) and incubated at 37ºC for 
2 h.  Lysis buffer was removed, and plugs were washed with sterile distilled water for 5 
min, followed by overnight incubation at 50ºC in proteinase K buffer (100mM EDTA pH8, 
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Na deoxycholato 0.2%, Na laurylsarcosine 1%, 1 mg/ml proteinase K). After lysis, plugs 
were washed 45 min in a PMSF buffer (20 mM Tris Buffer pH7.5, 50 mM EDTA, 0.7 mM 
PMSF) and four times in the same buffer but without PMSF. After a 30-min adaptation in 
100 µl of restriction buffer (Buffer Tango 1X; Thermo Fisher Scientific, Waltham, MA, 
USA), plugs were transferred to the fresh mixture containing the restriction enzyme XbaI 
(10 U/µl; Thermo Fisher Scientific) at 40 U/100µl of plug, and incubated overnight at 37ºC. 
Then plugs were briefly soaked in standard Tris-borate-EDTA (TBE) 0.5x buffer, loaded 
into appropriate wells of the gel and sealed with melted 2% LMP agarose. Restriction 
fragments were separated by electrophoresis  through  1% pulsed field agarose (Bio-Rad) 
in 2.5 l of standard TBE 0.5x buffer refrigerated at 14ºC, in a CHEF DR_III apparatus (Bio-
Rad). Gels were run with a voltage of 6 V/cm and a linearly ramped pulse time of 4 to 36 s 
for a day. After electrophoresis, gels were stained with ethidium bromide (1 μg/ml) for 30 
min, destained with distilled water for 15 min and photographed. 
 
2.7. Data analysis 
The assortment of all phenotypically characterized isolates, from each DA, was 
examined for the number of antimicrobial resistance determinants as well as for repetitive 
resistance patterns.  For each DA, a collection with all multidrug-resistant strains with 
different antimicrobial patterns plus all multidrug-resistant strains with similar patterns but 
originated from different sources was created.  The compilation of these isolates was used 
to build up the genetic component of the present study. 
Similarities in ERIC-PCR and PFGE patterns were compared by means of the Dice 
coefficient using the Fingerprinting DST Molecular Analist Software (Bio-Rad 
Laboratories). Dendrograms were constructed by the unweighted pair group method using 
averages (UPGMA), and an optimization of 1% and position tolerance of 2.0% was 
applied. Strains were defined as representing the same strain (being indistinguishable or 
clonal) if they possessed ≥ 94% similarity in the PFGE profile (Johnson et al., 2008; 
Stenske et al., 2009) or defined as having a clonal relationship if they possessed ≥ 85% 
similarity (Ejrnaes et al., 2006). 
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3. Results 
 
3.1. Domestic aggregate description 
Two DA (A and B) allowed complete sampling (pets, owners and home 
environment) whereas DA C just allowed the core dog sampling. 
DA A was composed of a core dog, a 14-year old spayed female Cocker Spaniel 
(Dog A1) that was chronically ill and had been treated repeatedly with multiple 
antimicrobial agents (Table 1). DA A included two more dogs, a 5-year old female Cocker 
Spaniel (Dog A2) and a 2-year old male Boxer (Dog A3), both healthy that had only visited 
the veterinary services for regular prophylaxis; they had never been ill and never took any 
antimicrobial drug. Their owners, a middle-age couple (Gentleman A and Lady A), were 
both healthy without recent antimicrobial treatments. The family lived in a peripheral urban 
villa with a garden, where dogs used to play (dog walking in the street rarely happened). 
All dogs were active elements of the family with free access to all the rooms and items 
within the house. The three pets lived with the owners since birth and were fed only with 
canned dry food. Dogs A2 and A3 used to have coprophagic habits when puppies.  
The core dog from DA B (Dog B) was a 9-year old entire crossbreed female 
suffering from chronic, poorly controlled, allergic skin disease which required multiple 
courses of antimicrobial therapy (Table 1). Four years before, the dog owner (Gentleman 
B) had been hospitalized for two months, after a car accident and, in the hospital, 
contracted a urinary tract infection. No relevant information was detected in the medical 
history of the lady (Lady B), the 2-year old grandchild (Baby B) or their indoor 12-year old 
cohabitant female cat (Cat B). The family lived in an urban central small apartment. They 
were retired from public administration jobs. The dog was the dominant and the most 
active pet with free access to all rooms and items within the house and no restriction of 
interaction with the baby. It was walked throughout the city center twice a day, with a 
leash and had no coprophagic habits. Both pets lived with the owners since birth and were 
fed with canned dry food.  
Domestic aggregate C allowed only the participation of the core dog. It was a 7-
year old spayed female Saint Bernard suffering from a bladder tumor that demanded 
successive antimicrobial therapies as shown in Table 1. This DA was constituted by a 
middle-age couple and a 2-year old child; all three were quite healthy.  
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Table 1. Recent antimicrobial treatment histories of each Domestic Aggregate core pet 
 
Animal Antimicrobial drug Protocol Duration 
End of treatment 
before sampling 
 D
o
g
 A
1
 Enrofloxacin 2.5mg/kg, PO, BID 6 weeks 3 weeks ago 
Amoxicillin-Clavulanic 
Acid 
20mg/kg, PO, BID 2 weeks 3 months ago 
 
D
o
g
 B
 
Ciprofloxacin 5mg/kg, PO, BID 4 weeks 2 weeks ago 
Enrofloxacin 2.5mg/kg, PO, BID 2 weeks 6 weeks ago 
Cefovecin 8mg/kg, SC, q14d 6 weeks 3 months ago 
Amoxicillin-Clavulanic 
Acid 
20mg/kg, PO, BID 2 weeks 4.5 months ago 
Cephalexin 22mg/kg, PO, BID 2 weeks 6 months ago 
 D
o
g
 C
 Enrofloxacin 2.5mg/kg, PO, BID 3 weeks 2 weeks ago 
Amoxicillin-Clavulanic 
Acid 
22mg/kg, PO, BID 2 weeks 4.5 months ago 
 
Legend: PO: per os; SC: subcutaneous; BID: each 12 h; SID: each 24 h; q14d: each 14 days. 
 
 
3.2. Escherichia coli phenotypic and phylogenetic characterization 
A total of 121 E. coli isolates were collected from DA A, the majority obtained from 
Gentleman A feces (n = 13), Dog A1 mouth (n = 11), Dog A2 feces (n = 11), Dog A1 hair 
(n = 10), Dog A3 feces (n = 10) and Lady A feces (n = 10). Antimicrobial susceptibility 
tests displayed 31 different phenotypic patterns, some of them being coincident in isolates 
from dogs, their owners and some environmental samples. The majority of this isolates 
were resistant to ampicillin, nalidixic acid, trimethoprim-sulfamethoxazole, tetracycline, 
ciprofloxacin, chloramphenicol, cephalothin, tobramycin and cephoxitin. A remarkable 
proportion (89.2%) of multidrug-resistant strains was observed. No resistance was found 
towards aztreonam and nitrofurantoin. 
From DA B, 101 isolates were recovered; the majority were isolated from Lady B 
feces (n = 17), Dog B feces (n = 15), Gentleman B feces (n = 15) and cat B feces (n = 13). 
Resistances to tetracycline, ampicillin, streptomycin and chloramphenicol were the most 
common amongst the tested isolates while all were sensitive to amikacin, nitrofurantoin, 
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cefoxitin and imipenem. Antimicrobial susceptibility tests displayed 20 different phenotypic 
patterns with an important representation of multidrug-resistant ones (75.0%) and there 
was an overlap among patterns of isolates from dog feces, mouth and environment 
samples.  
In DA C, nine multidrug-resistant E. coli isolated from feces (n = 7), fur (n = 1) and 
oral secretions (n = 1) of Dog C displayed the same antimicrobial phenotype.  
The compilation of the eligible isolates from DA A (n = 28), DA B (n = 17) and DA 
C (n = 3) for further genetic analyses, their respective antimicrobial resistance patterns 
and phylogenetic groups, are shown in Table 2.  
 
3.3. Escherichia coli clonality 
The genetic relatedness among E. coli isolates, from each DA, was examined by 
the use of ERIC-PCR and PFGE analysis. Pulsed-field gel electrophoresis is considered a 
“gold standard” technique for clonality studies (Goering, 2010), nevertheless, our ERIC-
PCR results were a strong support for the overall outcome in view of the fact that both 
systems pointed toward the same directions (ERIC-PCR results are shown in Fig. S1, Fig. 
S2 and Fig. S3). 
Considering a similarity cutoff of ≥ 94%, one single cluster (X1) was identified in 
DA A, as shown in Fig. 1. The fact that the strains appertaining to cluster X1 have similar 
antimicrobial resistance patterns and belong to phylogenetic group A strengthens the 
probable clonality of those strains. Considering that a similarity of 85% between PFGE 
patterns is enough to consider the isolates genetically related, all DA A studied strains 
(except Lady A feces, which was intentionally included, as control), could have a clonal 
relationship.  
Regarding isolates from DA B, applying the criterion of ≥ 94% similarity to PFGE 
profiles (Fig. 2), three clusters of dissemination could be identified: Y1 (two isolates 
belonging to phylogenetic group B1 from Gentleman B feces); Y2 (Refrigerator door B 1, 
Dog B mouth 2, Kitchen floor B 1, Dog B mouth 1, Dog B feces 1 and Dog B food bowl 1) 
and Y3 (Gentleman B feces 1 and Dog B feces 2). Clone Y2 can be considered clonally 
related with Y3 taking into account the coefficient of similarity obtained (88.4%) and the 
phylogenetic group (all belong to phylogroup A). The remainder strains that had a 
similarity < 85%, either belong to different phylogroups or have more distinct antimicrobial 
resistance patterns, suggesting a probable diverse source.  
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Figure 3 displays the PFGE patterns of isolates from Dog C. A 100% similarity 
between the strains is perceived, suggesting a clonal (Z1) spread between feces, mouth 
and hair, supported by the same antimicrobial resistance pattern as well as the same 
phylogenetic group (phylogroup A).  
 
 
4. Discussion 
Firstly, it should be underlined that the problem of antimicrobial resistance is 
starting to catch the public attention. People are becoming aware about the consequences 
that the recurrent intake of antimicrobial drugs can have in the human and animal health; 
having families’ agreement to participate in this study is a reflection of those concerns.  
Secondly, the observations attained throughout the study of these three cases 
supported the hypotheses initially raised. Data obtained from DA A could be comparable 
to a multidrug-resistant E. coli outbreak, if transposed to an in-home scale. Results 
demonstrate that the same clonal strains, possibly emerged and disseminated from the 
feces of dog A1 (the element more often subjected to the selective pressure of 
antimicrobial treatments) to its own mouth, hair and skin and frequently touched objects 
for everybody in the house (dogs leashes, toys, food bowls and beds, the banister, the 
refrigerator door and the kitchen floor). Furthermore, the same clonal strain was found in 
the other two healthy dogs of the aggregate; a very likely explanation is a direct or indirect 
clonal intra-species transmission. Likewise, the same multidrug-resistant E. coli clone 
appeared in Gentleman A hands and feces, sustaining an inter-species dissemination. 
The findings obtained from DA B supported the outcomes from DA A. Again multidrug-
resistant E. coli clones were found in different body sites of the dog (feces and mouth) as 
well as through some household surfaces (kitchen floor, refrigerator door and dog food 
bowl) and were closely related (˃ 85%) to another cluster of two isolates found in the dog 
and owner feces. Findings from Dog C confirmed the possibility of fecal E. coli clones to 
colonize other body sites of the same individual. Clonal spread was supported with 100% 
similarity, using both techniques (ERIC-PCR and PFGE), in feces, mouth and hair.  
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Table 2. Antimicrobial resistance patterns and phylogenetic groups of isolates studied 
through PFGE, in each domestic aggregate 
 
Legend: DA – domestic aggregate; PG – phylogenetic group 
  
DA Isolate Source Antimicrobial Resistance Pattern PG 
D
A
  
A
 
Dog A2 Leash AMP, FOX, CIP, GEN, TET, CAZ, AMC, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Dog A2 Food Bowl AMP, FOX, CIP, GEN, TET, CAZ, AMC, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Dog A2 Toy AMP, FOX, CIP, GEN, TET, CAZ, AMC, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Dog A2 Feces AMP, FOX, CIP, GEN, TET, CAZ, AMC, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Dog A2 Mouth AMP, FOX, CIP, GEN, TET, CAZ, AMC, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Dog A2 Hair AMP, FOX, IPM, CIP, GEN, TET, CAZ, AMC, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Dog A1 Feces 2 AMP, FOX, CIP, GEN, TET, CAZ, AMC, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Banister A 2 AMP, FOX, CIP, GEN, TET, CTX, CAZ, AMC, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Gentleman A Hands AMP, FOX, CIP, GEN, TET, CAZ, AMC, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Kitchen Floor A AMP, FOX, CIP, GEN, TET, CTX, CAZ, AMC, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Gentleman A Feces 1 AMP, FOX, CIP, GEN, TET, CAZ, AMC, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Dog A1 Feces 1 AMP, FOX, CIP, GEN, TET, CAZ, AMC, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Dogs bed A AMP, FOX, CIP, GEN, TET, CTX, CAZ, AMC, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Dog A1 Mouth AMP, FOX, CIP, GEN, TET, CAZ, AMC, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Dog A1 Hair 1 AMP, FOX, CIP, GEN, TET, CAZ, AMC, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Dog A1 Skin  AMP, FOX, CIP, GEN, TET, CAZ, AMC, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Dog A1 Food Bowl 2 AMP, FOX, CIP, GEN, TET, CAZ, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Dog A3 Feces AMP, FOX, CIP, GEN, TET, CAZ, AMC, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Dog A3 Leash 1 AMP, FOX, CIP, GEN, TET, CAZ, AMC, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Dog A3 Leash 2 AMP, FOX, CIP, GEN, TET, CAZ, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Dog A3 Food Bowl AMP, FOX, CIP, GEN, TET, CAZ, AMC, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Banister A 1 AMP, FOX, CIP, GEN, TET, CAZ, AMC, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Refrigerator door 
handle A 
AMP, FOX, CIP, GEN, TET, CTX, CAZ, AMC, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Dog A3 Mouth AMP, FOX, IPM, CIP, GEN, TET, CAZ, AMC, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Dog A1 Hair 2 AMP, FOX, CIP, GEN, CAZ, AMC, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Gentleman A Feces 2 AMP, FOX, CIP, GEN, CAZ, AMC, CEF, AMK, STR, NAL, CHL, TOB, SXT, KAN A 
Dog A1 Food Bowl 1 AMP, FOX, CIP, GEN, TET, CAZ, AMC, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Lady A Feces AMP, STR B2 
D
A
 B
 
Lady B Feces 3 CIP, TET, NAL, CHL, SXT, KAN B1 
Cat B Feces 2 TET, STR, NAL, KAN B1 
Gentleman B Feces 3 AMP, TET, CTX, ATM, CAZ, CEF, STR, CHL, STX, TOB B1 
Gentleman B Feces 4 AMP, GEN, TET, CTX, ATM, CAZ, CEF, STR, CHL, TOB, SXT, KAN B1 
Dog B Urine AMP, CIP, TET, ATM, CAZ, CEF, STR, NAL, CHL B1 
Refrigerator door B 1 AMP, CIP, TET, ATM, CEF, STR, NAL, CHL A 
Dog B Mouth 2 AMP, CIP, TET, ATM, CAZ, CEF, STR, NAL, CHL A 
Kitchen Floor B 1 AMP, CIP, TET, ATM, CAZ, CEF, STR, NAL, CHL A 
Dog B Mouth 1 AMP, CIP, GEN, TET, ATM, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Dog B Feces 1 AMP, CIP, GEN, TET, ATM, CAZ, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Dog B Food Bowl 1 AMP, CIP, GEN, TET, ATM, AMC, CEF, AMK, STR, NAL, CHL, TOB, SXT, KAN A 
Gentleman B Feces 1 AMP, TET, CTX, ATM, CAZ, CEF, STR, CHL, SXT, KAN A 
Dog B Feces 2 AMP, CIP, GEN, TET, CAZ, CEF, STR, NAL, CHL, TOB, SXT, KAN A 
Lady B Feces 1 AMP, TET, STR, SXT B1 
Lady B Feces 2 TET, STR, NAL, SXT A 
Baby B Feces 1 AMP, STR, NAL, SXT D 
Refrigerator door B 2 AMP, CIP, TET, ATM, CAZ, AMC, CEF, STR, NAL, CHL D 
D
A
 C
 Dog C Feces AMP, AMC, CEF, CAZ, CTX, NAL, CIP, GEN, STR, CHL, KAN, ATM D 
Dog C Mouth AMP, AMC, CEF, CAZ, CTX, NAL, CIP, GEN, STR, CHL, KAN, ATM D 
Dog C Hair AMP, AMC, CEF, CAZ, CTX, NAL, CIP, GEN, STR, CHL, KAN, ATM D 
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Fig. 1. Dendrogram showing genetic relatedness of selected isolates from DA A, determined by analysis of PFGE 
fingerprinting patterns using Dice similarity coefficient and UPGMA cluster method.  
 
 
 
 
Fig. 2. Dendrogram showing genetic relatedness of selected isolates from DA B, determined by analysis of PFGE 
fingerprinting patterns using Dice similarity coefficient and UPGMA cluster method. 
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Fig. 3. Dendrogram showing genetic relatedness of selected isolates from DA C, determined by analysis of PFGE 
fingerprinting patterns using Dice similarity coefficient and UPGMA cluster method. 
 
In this study, formulating conclusions about the direction of transmission was not 
attempted, although, it was demonstrated that dogs (in different body sites), owners and 
household surfaces can share E. coli isolates with similar antimicrobial resistance profiles 
and ERIC-PCR and PFGE patterns, suggesting that within-household transmission may 
occur, in either direction, mediated directly by feces, oral secretions, urine, skin, fur, 
owners’ hands or, indirectly, by contaminated household surfaces and objects. Rolling and 
rubbing on fecal material, grooming and perigenital licking are frequent behaviors of pets 
that together with their intrinsic hygienic limitations could predispose to the previous 
findings. None of the three core dogs had coprophagic habits that would justify mouth 
colonization with fecal bacteria. 
The clonal dissemination between animals and human cohabitants in DA A and 
DA B may be explained by the intimate relationship that exists between owners and their 
pets, leading them to frequently neglect basic hygiene rules that are seldom forgotten in 
interactions with other humans or animals that are not part of their aggregate.  
Besides the strains isolated from individuals, we also investigated strains isolated 
from the household environment. Our results demonstrate that several in-home surfaces 
may serve as a source of multidrug-resistant E. coli that is able to survive and persist 
outside the natural hosts long enough to potentially contaminate new hosts, including 
incoming visitors. Others have already found that the virulent human pathogen E. coli 
serotype 0157, whose primary reservoir is cattle, remain viable in soil fecal excretion for 
more than 4 months (Jones, 1999) or in wood samples from farmyard material (Williams 
et al., 2005). Garfield et al. (2008) highlighted that the duration of E. coli survival in canine 
feces is very dependent on the water content and evaporative conditions (under low 
evaporative conditions, E. coli can survive longer). Although the simultaneous colonization 
with multidrug-resistant E. coli has already been identified in humans and animals 
(Johnson et al., 2001; Johnson et al., 2008; Platell et al., 2011), our study provides further 
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information in support of the potential contribution of the household environment as a 
passive source of multidrug-resistant E. coli. In fact, such strains could be acquired by 
touching the contaminated surfaces or objects and be repeatedly transmitted between 
humans and animals within the household, building up the in-home and through-home 
transmission mode.  
In addition, it is well known that resistance harbors a fitness cost and it has been 
proposed that a reduction in antibiotic use would benefit the susceptible bacteria over the 
resistant ones; however, compensatory evolution and genetic co-selection also play a 
role, complicating the all scenario (Andersson and Hughes, 2010). Indeed, co-selection of 
resistance to more than one antibiotic, due to the genetic linkage between resistance 
genes, may explain the rise of resistance to an antibiotic that is not currently in use 
(Andersson and Hughes, 20101). 
Further studies are needed to support and corroborate these findings as well as to 
better explore and characterize the interconnections and factors that drive the within-
household antimicrobial resistance diffusion. Antimicrobial resistance is triggering a public 
health challenge, thus, understanding who or which are the participants in the 
transmission chain of resistance will eventually help to deploy new intervention strategies. 
Such strategies should take into account the important interconnections between human 
and animal health in accordance with the Manhattan principles on “One World, One 
Health” (da Costa et al., 2013).  
Antimicrobial resistance is an emerging global problem, not just in the clinical 
settings (Tan et al., 2013) but also in the community. As such, assessing the risk factors 
for the dissemination of drug-resistant bacteria, or their corresponding genetic material, 
between pets and their owners within household is essential for the implementation of 
safe handling procedures of companion animals and prudent use of antimicrobial 
substances in human and veterinary practice. 
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Supplementary material 
 
 
Fig S1. Dendrogram showing genetic relatedness of selected isolates from DA A, determined by analysis of ERIC-PCR 
fingerprint patterns using Dice similarity coefficient and UPGMA cluster method. 
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Fig S2. Dendrogram showing genetic relatedness of selected isolates from DA B, determined by analysis of ERIC-PCR 
fingerprint patterns using Dice similarity coefficient and UPGMA cluster method. 
 
 
 
 
 
 
 
 
 
Fig S3. Dendrogram showing genetic relatedness of selected isolates from DA C, determined by analysis of ERIC-PCR 
fingerprint patterns using Dice similarity coefficient and UPGMA cluster method.  
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2.2. HOUSEHOLD ANTIMICROBIAL RESISTANCE SHARE AND SPREAD 
 
 
2.2.3. Paper V 
 
 
 
 
SPREAD OF MULTIDRUG-RESISTANT ENTEROCOCCUS FAECALIS WITHIN THE 
HOUSEHOLD SETTING 
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3.1. GENERAL DISCUSSION 
 
Besides the strategic purpose of veterinary medicine: “illness prevention”, small 
animal veterinary practitioners are frequently faced with the requirement for prescribing 
antimicrobial agents. Antimicrobial selection is a complex process involving several 
requests: the objective necessity for the treatment; possibility to obtain and to delay 
treatment until culture and sensitivity testing are performed; drug availability; drug cost, 
posology; toxicity; animal and owner compliance; adjuvant or alternative therapeutic 
options; and public health treatment implications. The complexity of managing some 
clinical cases submitted to several previous antimicrobial treatments, added to the 
veterinary duty of protecting the health of those persons that directly or indirectly contact 
with the treated animals, were the main reasons for this research project. 
 
 
3.1.1. Antimicrobial resistance prevalence and risk factors - Papers I and II 
 
Results from Papers I and II (Chapter 2) reflected the antimicrobial resistance 
prevalences in fecal E. coli and Enterococcus spp. isolated from domestic dogs and cats 
attending the Porto University Veterinary Hospital. 
Regular surveillance of AMR in pathogens and normal flora has been 
recommended by the World Health Organization (WHO 2012b), although pet animals 
have not been usually included in such programs (Gosh et al., 2011). Recently, various 
research groups have studied and characterized the antimicrobial resistance 
arrangements of canine and feline E. coli, both commensal (Rantala et al., 2004; Moreno 
et al., 2008; Costa et al., 2008a; Murphy et al., 2009; Nam et al., 2010; Leonard et al., 
2012; Albrechtova et al., 2014; Okubo et al., 2014) and pathogenic (Shaheen et al., 2010; 
Boothe et al., 2012; Nam et al., 2013; Wagner et al., 2014) (Table 1). 
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Table 1. Overview of several studies on canine and feline E. coli antimicrobial 
resistances.  
Number of sampled 
animals 
Health status 
Number of 
isolates 
Sample period Year Country Reference 
Dogs Cats 
33 - 33 UTI isolates 33 2002-2011 2014 UK Wagner et al. 
28 - 28 dogs 28 
April-June 
2003 
2014 Japan Okubo et al. 
17 - 17 stray dogs 16 - 2014 Angola 
Albrechtova et 
al. 
10 - 10 UTI before tx 10 2008 2013 Korea Nam et al. 
301 75 
Pathogenic 
isolates 
376 
May- 
September 
2005 
2012 USA Boothe et al. 
136 - Healthy dogs 395 
October 2005-
May 2006 
2012 Canada Leonard et al. 
877 - 
565 Stray + 312 
hospitalized 
628 - 2010 Korea Nam et al. 
? ? 
Pathogenic 
isolates 
376 
May-
September 
2005 
2010 USA Shaheen et al. 
188 39 Healthy pets 1135 
May- 
December 
2002 
2009 Canada Murphy et al. 
78 66 Healthy pets 144 2003 2008a Portugal Costa et al. 
30 - 
Hospital (52 tx + 
18 non tx) 
70 
March-June 
2006 
2008 Chile Moreno et al. 
78 - 
Hospital (22 tx 
Pyoderma + 56 
non tx) 
98 - 2004 Finland Rantala et al. 
Legend: UTI – urinary tract infection; USA – United States of America; UK – United Kingdom; tx – treatment. 
 
 
Some studies aimed to illustrate the AMR profiles of fecal canine and feline 
commensal E. coli (Table 2). The comparison between their results is hampered by 
design variability, small number of studied animals, and lack of non-medicated control 
groups, the latter being often a consequence of low compliance on the animal owners 
part. 
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Table 2: Synopsis of antimicrobial resistance prevalence rates from canine and feline 
fecal E. coli. 
Legend: AMP – ampicillin; AMC – amoxicillin-clavulanic acid; ATM – aztreonam; CEF – cephalothin; FOX – 
cephoxitin; CAZ – ceftazidime; CTX – cefotaxime; IPM – imipenem; GEN – gentamicin; STR – streptomycin; 
TOB – tobramycin; KAN – kanamycin; NAL – nalidixic acid; CIP – ciprofloxacin; TET – tetracycline; CHL – 
chloramphenicol; SXT – trimethoprim-sulfamethoxazol; NIT – nitrofurantoin; 1 – Different antimicrobials from 
the same family; 2 – Stray animals; 3 – Hospitalized animals; 4 – Dogs; 5 – Cats; 6 – Non-treated animals; 7 – 
Treated animals.  
 
If studies that used antimicrobial supplemented medium for E. coli isolation 
(Moreno et al., 2008; Albrechtova et al., 2014; Okubo et al., 2014) were excluded from the 
analysis, it appears that the majority of the remaining ones reported lower AMR 
prevalences when compared with our results. Only one study (Nam et al., 2010) of 565 
stray and 312 hospitalized dogs reported prevalences similar to ours. The authors 
hypothesized that such high AMR frequencies may have been a consequence of the 
inclusion of hospitalized animals as well as the high volumes of antimicrobials used by 
Korean veterinary practitioners. 
Similarly, various studies aimed to characterize the antimicrobial resistance 
frequencies of canine and feline enterococci, both commensal (Rodrigues et al., 2002; 
Leener et al., 2005; Poeta et al., 2006; Damborg et al., 2008; Ossiprandi et al., 2008; 
Damborg et al., 2009; Jackon et al., 2009; Jackson et al., 2010; Türkylmaz et al., 2010; 
Ghosh et al., 2011; Lopez et al., 2011; Hamilton et al., 2013; Kataoka et al., 2013) and 
Beta lactam Aminoglicoside Quinolone Other 
Reference 
AMP AMC ATM CEF FOX CAZ CTX IPM GEN STR TOB KAN NAL CIP TET CHL SXT NIT 
51.3 12.1 17.7 46.7 5.8 13.6 14.6 0 5.8 43.4 3.0 13.9 35.9 29.5 45.2 18.2 36.4 0 
Leite-
Martins et 
al. 2014 
12.7 3.8 - - 3.3 3.31 3.31 - 0.3 4.3 - 0.3 4.8 2.5 9.6 2.5 4.8 - 
Leonard et 
al. 2012 
32.9 5.2 - 8.5 4.7 - 2.4 0 - 35.8 16.1 - 21.6 13.5 53.6 17.1 19.7 - 
Nam et al. 
20102 
47.1 6.3 - 18.4 4.4 - 3.9 0 - 41.7 21.8 - 37.4 21.4 52.4 24.3 36.4 - 
Nam et al. 
20103 
13.0 - - 13.0 - - - - - 17.0 - - - - 11.0 - - - 
Murphy et 
al. 20094 
4.0 - - 1.0 - - - - - 2.0 - - - - 2.0 - - - 
Murphy et 
al. 20095 
12.0 3.5 1.4 - 0 0 1.4 0 2.1 15.0 15.0 - 3.5 0.7 20.0 2.8 - - 
Costa et al. 
2008 
12.0 - - - - - - - - 12.0 - - - - 10.0 - 8.0 - 
Rantala et 
al. 20046 
18.0 - - - - - - - - 22.0 - - - - 0 - 15.0 - 
Rantala et 
al. 20047 
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pathogenic (Kwon et al., 2011; Tremblay et al., 2013) (Table 3). The results of some 
studies are not comparable to ours because enterococci isolation was performed on 
antimicrobial supplemented media (Damborg et al., 2009; Jackson et al., 2010) or 
because the enterococci pool was mainly constituted by pathogenic isolates (Kwon et al., 
2011; Tremblay et al., 2013). Data from the remaining studies are displayed in Table 4.  
 
Table 3. Overview of studies on canine and feline enterococci antimicrobial resistances 
Number of 
sampled 
animals Health status 
Number 
of 
isolates 
Sample period Year Country Reference 
Dogs Cats 
622 92 Healthy + Ill 1111 
February 2007-
December 2009 
2013 Michigan Hamilton et al. 
5 
 
Clinical ARE 5 ? 2013 Canada Tremblay et al. 
60 31 Healthy + Ill 91 
January-
November 2006 
2010 Turkey Türkylmaz et al. 
7 - 
Under antimicrobial     
Tx in ICU 
207 2008-2009 2011 Kansas Ghosh et al. 
? - 28 UTI + 10 fecal 38 
January 2010-
May 2011 
2011 Korea Kwon et al. 
126 - Healthy + Ill 126 Jun-July 2009 2011 Spain Lopez et al. 
155 121 Healthy + Ill 420 2007 2010 USA Jackson et al. 
155 121 Healthy + Ill 420 2007 2009 USA Jackson et al. 
208 - Health + Ill 208 2006 and 2007 2009 
UK + 
Denmark 
Damborg et al. 
127 - Healthy + Ill 73 Jun-August 2006 2008 Denmark Damborg et al. 
99 - 
56 tx <6 months + 
43 non tx 
165 ? 2006 Italy Ossiprandi et al. 
39 32 Healthy 142 2003 2006 Portugal Poeta et al. 
88 72 Healthy + Ill 201 2002-2003 2005 Belgium Leener et al. 
85 19 Healthy + Ill 104 ? 2002 Portugal Rodrigues et al. 
Legend: ARE – ampicillin-resistant enterococci; ICU – intensive care unit; UTI – urinary tract infection; Tx – 
treatment. 
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Table 4: Synopsis of antimicrobial resistance prevalence rates from canine and feline 
fecal enterococci. 
Glicopeptide Macrolide Other 
Reference 
QD TEC VAN ERI AZM AMP TET RIF GEN CHL CIP NIT 
54.0 2.2 1.0 53.0 58.4 12.1 67.0 60.3 6.3 6.3 29.5 9.2 
Leite-Martins 
et al., 2014 
- - - 33.0 - 4.3 - - 44.7 12.8 23.4 - 
Kataoka et al. 
2013 3 
- - - 45.3 - 37.5 - - 48.4 35.9 75.0 - 
Kataoka et al. 
2013 4 
- - - 43.9 - 6.8 - - 42.4 28.8 12.1 - 
Kataoka et al. 
2013 5 
52.4 - 0.4 - - - 39.0 37.5 - - - - 
Hamilton et al. 
2013 
- 0 0 63.0 - 4.0 70.3 - 14.0 11.0 - - 
Türkyilmaz et 
al. 2010 
NA* - 0 57.0 - 5.0 60.0 - - - 32.0 0 
Ghosh et al. 
20111 
- - 0 54.0 - 98.0 85.0 - 50.0 - 98.0 28.0 
Ghosh et al. 
20112 
- - - 10.7 - 10.2 51.4 - 5.7 4.7 2.4 4.5 
Jackson et al., 
2009 
- - 0 8.0 - 0.0 31.0 65.0 2.0 2.0 0 - 
Damborg et al. 
20081 
0 - 0 30.0 - 20.0 30.0 60.0 0 0 20.0 - 
Damborg et al. 
20082 
- - 0 89.2 - 6.2 84.6 90.8 - - 16.9 - 
Ossiprandi et 
al. 20061 
- - 0 84.6 - 25.0 84.6 69.2 - - 57.7 - 
Ossiprandi et 
al. 20062 
- 0 0 47.0 - 1.0 50.0 - 6.0 6.0 8.0 - 
Poeta et al. 
2006 
2.0 - 0 26.0 - - 41.0 - - 11.0 - - 
Leener et al. 
20056 
12.0 - 0 31.0 - - 66.0 - - 8.0 - - 
Leener et al. 
20057 
4.0 - 0 15.0 - - 38.0 - - 4.0 - - 
Leener et al. 
20058 
0 - 0 53.0 - - 81.0 - - 31.0 - - 
Leener et al. 
20059 
15.0 - 0 40.0 - - 75.0 - - 5.0 - - 
Leener et al. 
200510 
 
- 0 100.0 - 21.2 95.2 - - - 71.3 - 
Rodrigues et 
al. 2002 
Legend: AMP – ampicillin; QD - Quinupristin/dalfopristin; TEC – teicoplanin; VAN – vancomycin; ERI - 
erythromycin; AZM - azithromycin; TET – tetracycline; RIF - rifampicin; GEN – gentamicin; CHL - 
chloramphenicol; CIP – ciprofloxacin; NIT – nitrofurantoin; 1 - E. faecalis; 2 - E. faecium; 3 -  almost without 
antimicrobial exposure; 4 - with antimicrobial exposure; 5 - without antimicrobial exposure (puppies and 
kittens); 6 - Privately owned dogs; 7 - Kennel dogs; 8 - Privately owned cats; 9 - Cattery cats; 10 - Hospitalized 
cats; NA*: not applicable to E. faecalis isolates due to their intrinsic resistance.  
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In the work of Ghosh et al. (2011), a considerable higher AMR prevalence was 
found for ampicillin (98.0%), gentamicin (50.0%), ciprofloxacin (98.0%) and nitrofurantoin 
(28.0%) (Table 4). The authors postulated that it was a consequence of the recent 
antimicrobial selective pressures over commensals from ICU patients under antimicrobial 
treatment, potentiated by the enterococci ability to horizontally transfer their resistance 
traits. Similar results were obtained by Kataoka et al. (2013) that characterized the AMR 
of three enterococci groups with different antimicrobials exposure histories (almost without 
antimicrobial exposure; with antimicrobial exposure and puppies and kittens without 
antimicrobial exposure) and concluded that prior antimicrobial exposures had a significant 
impact on the resistance rates for ampicillin and ciprofloxacin (37.5% and 75.0%, 
respectively). Not only the prior antimicrobial exposure has a substantial influence in the 
acquisition of AMR (Rodrigues et al., 2002; Leener et al., 2005; Damborg et al., 2008) but 
the elapsed time from the last exposure is of paramount importance, as demonstrated by 
Ossiprandi et al. (2006). 
In our studies, both microorganisms presented higher resistance frequencies than 
previously reported (Tables 2 and 4), with E. coli isolates being particularly illustrative of 
the phenomenon. Although it could be stated that the Porto city area follows the urban 
trend of higher pet longevity, better veterinary care and widespread use of antibiotics in 
companion animal treatments; there are no evidences that such characteristics are in any 
way different from other areas. However, it has been showed that the Porto region suffers 
from a high level of environmental contamination with multidrug resistant enterococci and 
E. coli (Novais et al., 2005; Martins da Costa et al., 2006; Simões et al., 2010; Flores et 
al., 2013; Varela et al., 2014). It seems plausible to assume that these resistance 
acquisitions are multifactorial and its mitigation is not possible with single or simple 
measures; still, with such worryingly high levels of resistance, it seems imperative that 
mitigating measures need to be urgently implemented. These may include: 
i) Privilege the topical treatment of skin and ear diseases; 
ii) Systematically culture and test for resistances of all suspected infectious diseases 
before using antimicrobial therapies. Even in emergency cases where 
antimicrobial treatments cannot be postponed, such routine allows for invaluable 
information in the guidance of future preventive measures;  
iii) Favor, when prescribing antimicrobial drugs, those with higher bacterial fitness 
cost and, simultaneously, with resistances less prone to be maintained through co-
selection with other antimicrobials still in clinical use. The magnitude of these 
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critical parameters is the main biological feature that influences the rate of 
development of resistance, the stability of the resistance and the rate at which the 
resistance might decrease if any prescribing reduction policy is adopted (van Elsas 
et al., 2011; Perry and Wright, 2013).  
iv) Instruct pet owners to invest on prophylaxis (e.g. vaccines, ectoparasiticides, 
preventive allergic skin and ear management, dental hygiene, early diagnosis); 
v) Educate pet owners on the measures to reduce exposure to environmental 
sources of microorganisms (e.g. refrain from drinking untreated water from natural 
sources, do not feed the animals with row food, reduce the contact with other 
animals’ feces, regular skin and coat hygiene). 
 
In our studies the prevalence of resistant fecal enterococci and E. coli was 
associated with previous exposure to antimicrobials, corroborating previous reports 
(McEwen and Fedorka-Cray, 2002; Berge et al., 2006; Enne, 2010; da Costa et al., 2013). 
In the multivariable analysis two risk factors emerged as significantly associated with the 
presence of multiple antimicrobial resistance phenotypes in both bacterial species: 
“previous treatment with quinolones” and “coprophagic habits”.  
A quinolone selective pressure, enhancing the emergence of the respective 
resistant bacteria, whose resistance determinants are recognized for confering to 
microorganisms a low fitness-cost (Marcusson et al., 2009), is also known to induce 
resistance to other antibiotics through the genetic linkage between resistance genes 
(Andersson and Hughes, 2010). These facts support the concept that the use of 
quinolones should be restricted only to the least and indispensable situations. 
Furthermore, pets submitted to quinolone treatments should be handled properly and their 
hygiene reinforced, both during hospitalization (recommended) and at home, during and 
after treatment. All secretions, excrements and touched fomites should be considered 
contaminated with AMR bacteria and dealt accordingly.  
Coprophagy promotes the inoculation of own or foreign, potentially antimicrobial 
resistant, enteric flora. Furthermore, some feces may contain high concentrations of 
antibiotics, particularly those with poor oral bioavailability, so their consumption may lead 
to drug transfer between animals (allocoprophagy) or drug recycling (autocoprophagy), 
enhancing the emergence and dissemination of AMR (Toutain et al., 2010). Coprophagy 
was traditionally considered a minor inconvenience for both pet owners and veterinary 
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practitioners, mostly for being as a repugnant habit rather than a health risk. However, our 
results demonstrate that it may have serious public health consequences by favoring the 
emergence of AMR. Consequently, such habit must be reversed or prevented and the 
potential consequences of its persistence explained to owners.  
 
 
3.1.2. Household antimicrobial resistance share and spread – Papers III, IV and V 
 
In opposition to many other medical products, antimicrobial prescription to an 
individual may affect the health of others. This non-obvious dimension for antimicrobial 
use and our anthropocentric view of human pathogens led us to ignore for decades, the 
existence of an ecological cycle that allows resistant bacteria, selected by the 
administration of antibiotics in other domains, to colonize or transfer resistance genes to 
pathogenic and commensal human bacteria (Rodrigues et al., 2002; Guardabassi et al., 
2004; Leener et al., 2005; Damborg et al., 2008; Ossiprandi et al., 2008; Ghosh et al., 
2011; da Costa et al., 2013; EMA, 2013; Kataoka et al., 2013). 
In the second part of this thesis, the role of pets in the dissemination of multidrug-
resistant E. coli and Enterococcus spp. throughout its body surfaces, household 
environment and cohabitants was explored.  
Related clones of both microorganisms (Papers III and IV for E. coli and Paper V 
for Enterococcus spp.) were identified: 
i) In different body parts of each studied core pet (skin, oral secretions and fur); 
ii) In their human (hands and feces) and animal (skin, oral secretions and fur) 
cohabitants; 
iii) In various household surfaces and objects (door knobs, locking devices, banisters, 
refrigerator door handles, kitchen floors, pet beds, leashes, toys, food and water 
recipients). 
These results support the concept of within household AMR transmission by intra 
and inter-species transfer of multidrug-resistant bacteria, and highlight the crucial role of 
the household environment as suitable for the spread of multidrug-resistant bacteria 
amongst its inhabitants. Such conclusion emphasizes the importance of preventive 
measures both at the hygienic and social/interactive levels in domestic aggregates that 
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include pets, especially if there are family members or pets that are or have been 
submitted to antimicrobial treatments. 
 
Knowledge provided from these preliminary investigations contributes to raise the 
global awareness on the AMR problem, both in human and veterinary clinical settings and 
in the general community. In this perspective, the results herein obtained should:  
i) Assist in the implementation of safer handling procedures outside the house, 
namely the importance of removing the pets’ feces from public areas, hence 
reducing the chance for coprophagic habits and the spread of AMR 
microorganisms and antibiotic substances in the environment; 
ii) Assist in the implementation of safer handling procedures inside the house, 
namely the improvement of hygienic habits towards pets, objects and facilities, 
particularly when animals or owners are submitted to antimicrobial treatments. 
Such procedures must be implemented and enforced by veterinary practitioners as 
part of the recommendations on the antibiotics usage;  
iii) Scientifically support veterinary practitioners to assume a more cautious and 
responsible attitude when prescribing antimicrobials and to contribute for the 
creation of guidelines for safe antimicrobial prescription, administration and 
handling.  
iv) Justify the implementation of in-hospital biosafety rules and practices, as well as a 
clear definition of drugs that require hospitalization of the patient in order to be 
safely administrated.  
 During the past two decades, AMR studies have been conducted mainly in food-
producing animals. As a consequence, these species are now considered as an important 
part of the global cycle of enrichment and dissemination of AMR species (CDC, 2013). 
Our results, albeit preliminary, point to the need of regularly and systematically monitor 
AMR in companion pets and in the domestic biome. 
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3.2. FINAL REMARKS AND FUTURE PERSPECTIVES 
The results of the present study must be regarded as preliminary and a starting 
point for the collection of information about the prevalence, incidence, and risk factors for 
AMR in companion animals, as well as its public health impact. Such knowledge is 
essential for the implementation of effective rules and practices by all professionals 
involved in the protection of public health, such as veterinarians, human health 
professionals, pharmacists, animal breeders, handlers, and trainers. 
Within this perspective, future studies on this important issue are warranted, namely 
in order to: 
i) Improve monitoring studies with larger sampled animals; the specific study of 
particular groups such as cats, young animals, health professionals owned 
animals, animals under anti-tumor chemotherapy; more extensive anamnestic data 
such as the particularities of the antibiotic therapeutic regimens, hospitalizations 
and previous illnesses; 
ii) Expand survey studies to the monitoring of the AMR decline in order to better 
characterize the fitness cost as well as the co-selection persistence and magnitude 
for the different antimicrobial classes; 
iii) Perform more and extensive household researches to better understand and 
explore critical points at the household biome; 
iv) Produce, analyze and divulgate data in order to perform some well justified 
guidelines on safer and improved antimicrobial prescription protocols as well as on 
ideal handling and petting in-treatment animals. 
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 Abstract 
Staphylococcus pseudintermedius is the most prevalent coagulase-positive 
Staphylococcus inhabitant of the skin and mucosa of dogs and cats, causing skin and 
soft tissue infections in these animals. In this study, coagulase-positive Staphylococcus 
species were isolated from companion animals, veterinary professionals and objects of 
a clinical veterinary environment, by using two particular culture media, Baird-Parker 
RPF agar and CHROMagar Staph aureus. Different morphology features of colonies on 
the media allowed the identification of the species, which was confirmed by performing 
a multiplex PCR. Among 23 animals, 15 (65.2%) harbored coagulase-positive 
Staphylococcus, being 12 Staphylococcus pseudintermedius carriers. Four out of 12 
were methicillin-resistant S. pseudintermedius (MRSP). All veterinary professionals had 
CoPS species on their hands and two out of nine objects sampled harbored MRSP. The 
antimicrobial resistance pattern was achieved for all isolates, revealing the presence of 
many multidrug-resistant CoPS, particularly S. pseudintermedius. The combined 
analysis of the antimicrobial resistance patterns shown by the isolates led to the 
hypothesis that there is a possible cross contamination and dissemination of S. aureus 
and S. pseudintermedius species between the three types of carriers sampled in this 
study that could facilitate the spread of the methicillin resistance phenotype. 
  
 1. Introduction 
Coagulase-positive Staphylococcus (CoPS) species are commensal bacteria 
present in skin and nasal flora, however they can cause opportunistic infections in 
animals and humans (Devriese et al., 2005; Sasaki et al., 2010). Among CoPS, 
Staphylococcus pseudintermedius has particular importance in the veterinary setting, 
mainly in small animals, being associated with dermatological problems such as 
pyoderma, post-operatory wound infection and otitis (Griffeth et al., 2006; Weese and 
Duijkeren 2010; Sasaki et al., 2010). Although, the zoonotic potential of S. 
pseudintermedius is not well defined yet, it has been isolated from human infections and 
humans in contact with animals (van Duijkeren et al., 2008; Paul et al., 2011; van 
Duijkeren et al., 2011). In addition, since the phenotypic differentiation of CoPS species 
is difficult, it is probable that S. pseudintermedius has been misidentified in routine 
laboratory diagnostics with other CoPS, especially Staphylococcus intermedius and 
Staphylococcus aureus, and thus its prevalence may have been underestimated (Weese 
and Duijkeren 2010). 
Several methods to isolate and identify S. pseudintermedius have been 
documented. A combination of biochemical tests (D-mannitol test, arginine dihydrolase 
test and β-gentibiose test) are particularly used to phenotypically differentiate other 
Staphylococcus species from S. pseudintermedius (EMA, 2013). Molecular methods 
such as Pulsed-Field Gel Electrophoresis (PFGE), multiplex-PCR and PCR-restriction 
fragment length polymorphism are the most effective for S. pseudintermedius 
identification (van Duijkeren et al., 2008; Sasaki et al., 2010; Bannoehr et al., 2009). 
Similarly to S. aureus, S. pseudintermedius can acquire the mecA gene, which is 
located on staphylococcal cassette chromosome mec (SCCmec) elements and confers 
resistance to β-lactam antibiotics by encoding an altered penicillin binding protein 
(Perreten et al., 2010). The number of cases reporting methicillin-resistant S. 
pseudintermedius (MRSP) has been increasing and, usually, these MRSP are multidrug-
resistant (van Duijkeren et al., 2008; Bannoehr et al., 2009; Kadlec et al., 2010; Perreten 
et al., 2010; Weese and Duijkeren 2010; Gómez-Sanz et al., 2011; Paul et al., 2011; van 
Duijkeren et al., 2011; EMA, 2013;). 
The phenotypic identification of MRSP species can be made by antimicrobial 
susceptibility testing using a MIC breakpoint for oxacillin of ≥ 0.5 mg/l in broth dilution 
methods or by measuring an inhibition halo with a diameter ≤ 17 mm when using 1µg of 
oxacillin/disc in the agar diffusion methods, following the interpretative criteria of CLSI 
 (formerly NCCLS) of 2004 (NCCLS, 2004; Bemis et al., 2009; Schissler et al., 2009). 
Both tests can be highly consistent to detect MRSP species, however the detection of 
mecA gene by PCR is still the most reliable and also confirmatory method to identify 
methicillin-resistance Staphylococcus species (Black et al., 2009; Perreten et al., 2010; 
Ruscher et al., 2010).  
The main objective of this study was to find a new isolation method that could 
differentiate S. pseudintermedius from other CoPS using culture media. Two agar media 
were used, the Baird-Parker RPF agar, which has been mostly used in Food 
Microbiology for the direct detection and enumeration of coagulase-positive 
Staphylococci and CHROMagar Staph aureus, which is a selective medium for the 
isolation, enumeration and identification of S. aureus from clinical and food sources. 
Subsequently, the prevalence of two CoPS species, S. pseudintermedius and S. aureus, 
isolated from domestic animals, veterinary professionals and environment of a veterinary 
hospital was achieved. The antimicrobial resistance profile of CoPS isolates was also 
determined. Finally, there was an attempt to establish a possible correlation between all 
collected samples. 
 
 
2. Materials and Methods 
 
2.1. Sampling 
Companion animals 
Between February and May 2013, a total of 23 animals (21 dogs and two cats) 
were enrolled at the Veterinary Hospital of XXX after the positive consent of the owners, 
in order to collect samples from skin and oral and nasal mucosae. Two samples were 
collected from each body site, soon after the animal observation by a veterinarian, using 
a pre-moistened sterile swab and inoculated in 5 ml of Brain Heart Infusion1 (BHI) 
supplemented with 0.1 % Tween 802 (T80) – BHI+T80.  During the sample collection 
procedure, an inquiry was made to the owners, in order to obtain some information about 
potential risk factors for the presence of S. aureus or S. pseudintermedius, such as 
animal age, sex, residential area and animal health status. 
                                                 
1 Oxoid, Basingstoke, United Kingdom 
2 Merck, Darmstadt, Germany 
 Veterinary professionals 
A total of nine veterinary professionals, including veterinarians, technicians and 
veterinary nurses, affiliated with the Veterinary Hospital of XXX were recruited and 
consented samples collection, at the same day, for the isolation of S. aureus and S. 
pseudintermedius, from hands and nasal mucosa. The hand sample was collected with 
moistened sterile gauze and the nasal sample with two sterile swabs. Gauze and swabs 
were then placed in 50 ml and 5 ml of BHI+T80, respectively. 
 
Clinical environment 
On a single day, samples were collected from nine different objects and surfaces 
(e.g. floors, top parts of medical examination stands, computer keyboard, cages) of the 
veterinary hospital environment. There was no information about the disinfection status 
of the objects/surfaces. Sample collection was done with sterile gauze that was placed 
in 50 ml of BHI+T80. Afterwards, 1 ml was taken to perform a 1:10 dilution in 9 ml of 
BHI+T80. All samples were kept in the broth medium no longer than 1 hr until processing 
in the laboratory. 
 
2.2. Bacterial isolates and antimicrobial susceptibility testing 
The following procedure was similarly performed for all samples (animals, 
veterinary professionals and clinical environment samples). 
At the laboratory, each sample was incubated at 37 °C. After 6 hr of incubation, 
an aliquot of 30 µl was inoculated onto Baird-Parker RPF.3 Completed 18 hr of 
incubation, an aliquot of 30 µl was streaked onto Baird-Parker RPF and 60 µl were 
spread on the same culture media supplemented with oxacillin4 (2 µg/ml). All plates were 
incubated at 37 °C for further evaluation of coagulase-positive activity at 24, 28, 32 and 
48 hr. 
During the observation period, every Baird-Parker RPF plate presenting typical 
coagulase positive colonies (white halo surrounding a well delimited round shape colony, 
whose color vary from grey to black) was subcultured by streaking onto CHROMagarTM 
                                                 
3 Biokar Diagnostics, Beauvais, France 
4 Sigma–Aldrich, St. Louis, MO 
 Staph aureus.5 Two to five colonies isolated from each sampling site were selected for 
subculture. CHROMagar Staph aureus plates were incubated at 37 °C for 24 hr. After 
that time, a maximum of four colonies exhibiting typical S. aureus morphology (mauve-
colored colonies) or S. pseudintermedius (purple and blue colonies) were selected for 
antimicrobial susceptibility testing and storage. Antimicrobial susceptibility testing was 
performed by the agar disc diffusion method on Mueller-Hinton agar, following the 
Clinical and Laboratory Standards Institute guidelines and interpretative criteria (formerly 
NCCLS) of 2004 (NCCLS, 2004), according to a previous study (Schissler et al., 2009), 
for a panel of 23 antimicrobial agents:6 fucsidic acid (FD, 10 µg), amoxicilin (AMC, 10 
µg), ampicillin (AMP, 10 µg), kanamycin (K, 30 µg), cefoxitin (FOX, 30 µg), ciprofloxacin 
(CIP, 5 µg), clindamycin (DA, 2 µg), chloramphenicol (C, 30 µg), erythromycin (E, 15 µg), 
streptomycin (S, 10 µg), gentamicin (CN, 10 µg), imipenem (IPM, 10 µg), lomefloxacin 
(LOM, 10 µg), neomicin (N, 10 µg), nitrofurantoin (F, 300 µg), oxacillin (OX, 1 µg), 
penicillin (P, 10 µg), quinupristin-dalfopristin (QD, 15 µg), rifampicin (RD, 5 µg), 
teicoplanin (TEC, 30 µg), tetracycline (TE, 30µg), trimethoprim/sulfamethoxazole (SXT, 
25 µg) and vancomycin (VA, 30 µg). Staphylococcus  aureus ATCC 25293 was used as 
a quality control strain. 
 
2.3. Species identification by Polymerase Chain Reaction (PCR) 
The DNA was extracted from isolated colonies that presented coagulase-positive 
activity in Baird-Parker RPF and the mauve, dark mauve, purple and blue colors in 
CHROMagar Staph aureus. A total of 41 DNA extractions were performed using 
lysostaphind (100 μg/ml) and proteinase K7 (100 μg/ml). Then, a multiplex PCR for the 
species-specific detection of nuc gene was performed by using the primers as previously 
described for the identification of three species of coagulase-positive staphylococci: S. 
pseudintermedius, S. aureus and S. intermedius (Sasaki et al., 2010). The reaction 
mixture for the PCR, with a total volume of 50 µl, consisted of 33 µl of distilled water, 5 
µl reaction buffer (x10)-complete II KCl,g 1 µl of dNTP Mix 10 mM,8 2,5 µl of each primer, 
1µl of DFS-Taq DNA Polymerase 500 Ug and 5 µl of DNA. The reaction mixture was 
performed in a MyCycler Thermal Cycler9 at 95°C for 1 min, followed by 30 cycles at 
95°C for 1 min, 53°C for 1 min, and 72°C for 1 min, and a final extension at 72°C for 7 
                                                 
5 CHROMagar, Paris, France 
6 Oxoid, Basingstoke, United Kingdom 
7 Bioron GmbH, Germany 
8 Fermentas, Vilnius, Lithuania 
9 Bio-Rad Laboratories, Hercules, CA 
 min. Samples (5 µl) of PCR products were analyzed by electrophoresis in a 1.5% (w/v) 
agarose gel at 100 V for 60  min. Gels were stained with ethidium bromide and observed 
in a Ultra Violet Gel Doc XR.i 
 
 
3. Results 
Overall, 138, 18 and 9 samples were collected from companion animals (dogs 
and cats), veterinary professionals and objects/surfaces of the clinical environment, 
respectively. Staphylococcus aureus and S. pseudintermedius were phenotypically 
detected in the media Baird-Parker RPF and CHROMagar Staph aureus and 
genotypically confirmed by multiplex PCR. Staphylococcus pseudintermedius presented 
a white color in Baird-Parker RPF, with creamy consistence. Its coagulase halo was not 
as exuberant as the one presented by S. aureus colonies, which showed black to grey 
color with pasty consistence. In CHROMagar Staph aureus the main observation was 
the different color presented by S. pseudintermedius and S. aureus colonies. The first 
ones presented a color between purple and blue with aqueous consistency while S. 
aureus colonies presented mauve to dark mauve color with mucous consistency (see 
supplementary Figure I). The use of CHROMagar Staph aureus was particularly useful 
in one oral sample to allow the differentiation of colonies that appeared to be one single 
Staphylococcus species in Baird-Parker RPF. For every sample analyzed, each purple 
and blue colony in CHROMagar was identified by PCR (data not shown) as being S. 
pseudintermedius and the mauve and dark mauve colonies were identified as S. aureus 
species. The multiplex PCR confirmed not only the species identification as well as the 
“purity” of the colonies with different colors. For each colony tested, the presence of one 
Staphylococcus species excluded the presence of the other.  
During the coagulase activity observation on Baird-Parker RPF, it was found that 
S. pseudintermedius presented a coagulase-positive activity only after 28 hr of 
incubation at 37 o C, instead of the 24 hr needed for S. aureus isolates to show the 
positive activity.  
 
 
 
 3.1. Prevalence of CoPS isolates in companion animals 
Among the 23 animals, 15 (65.2%) had CoPS species and the remaining eight 
were non-CoPS carriers; 14 (93.3 %) out of the 15 were dogs, only one was a cat (6.7%) 
The distribution of the two CoPS isolated from the two kinds of animals and among 
different body sites of the animals is shown in Table 1. A detailed analysis of these 15 
CoPS-animals allowed us to observe that eight (53.3%) were S. pseudintermedius 
exclusive carriers, three (20.0%) were S. aureus exclusive carriers and four (26.7%) of 
them carried both S. aureus and S. pseudintermedius. The oral mucosa was the site 
where S. aureus was most isolated. Two out of the seven S. aureus carriers were MRSA. 
Regarding S. pseudintermedius, it was similarly present in the three body sites sampled, 
being the skin the site that provided the major number of S. pseudintermedius isolates 
(Table 1). Moreover, it must be highlighted that from the 12 S. pseudintermedius carriers, 
four harbored MRSP. The antimicrobial resistance exhibited by the two Staphylococcus 
species isolated from the animals is presented on Table 2, showing multidrug-resistance 
particularly by S. pseudintermedius isolates. Diverse antimicrobial resistance patterns 
were shown by S. pseudintermedius and S. aureus isolated from different body sites of 
the animals (Table 3).  
 
Table 1. Number of total isolates of S. pseudintermedius and S. aureus recovered per 
animal and per body site of the animal. 
 
 
Number of S. 
pseudintermedius isolates 
n(%) 
Number of S. aureus 
isolates  
n (%) 
Amimal     
Dog (n=14) 11 (73.3) 7 (46.7) 
Cat (n=1) 1 (6.7) 0 (0.0) 
Body site   
Oral mucosa 6 (50.0) 5 (71.4) 
Nasal mucosa 5 (41.7) 3 (42.9) 
Skin 7 (58.3) 0 (0.0) 
 
 
 Tabela 2. Antimicrobial resistance of all S. pseudintermedius and S. aureus isolated 
from animals. 
 
Antimicrobial drug 
S. pseudintermedius S. aureus 
(n = 12) (n = 7) 
n (%) n (%) 
Fucsidic acid (FD)  1 (8) 0 
Amoxicilin (AMC) 3 (25) 1 (14.3) 
Ampicillin (AMP)  12 (100) 5 (71.4) 
Kanamycin (KAN) 6 (50) 1 (14.3) 
Cefoxitin (FOX) 0 1 (14.3) 
Ciprofloxacin (CIP)  4 (33.3) 1 (14.3) 
Clindamycin (DA) 6 (50) 1 (14.3) 
Chloramphenicol (CHL)  4 (33.3) 2 (28.6) 
Erythromycin (ERI)  6 (50) 1 (14.3) 
Streptomycin (STR) 6 (50) 1 (14.3) 
Gentamicin (GEN) 3 (25) 0 
Imipenem (IPM)  0 0 
Lomefloxacin (LOM) 4 (33.3) 1 (14.3) 
Neomicin (N) 6 (50) 1 (14.3) 
Nitrofurantoin (NIT) 0 0 
Oxacillin (OX) 4 (33.3) 2 (28.6) 
Penicillin (P) 11 (91.7) 5 (71.4) 
Quinupristin-dalfopristin (QD) 0 0 
Rifampicin (RIF)  1 (8) 0 
Teicoplanin (TEC)  0 0 
Tetracycline (TE) 3 (25) 1 (14.3) 
Sulfamethoxazole/trimethoprim (SXT)  4 (33.3) 0 
Vancomycin (VAN) 0 0 
 
 
 
 
 
  
 Table 3. Antimicrobial resistance pattern of CoSP species isolated from different body 
sites of the animals. 
Site of 
isolation Isolated species Antimicrobial* resistance profile 
Animal 
identification 
     
Oral mucosa S. aureus AMP P 17,22 
  
AMP S C K N E P DA  12 
 
S. 
pseudintermedius AMP P 
14,22 
  AMP P OX CIP LOM  15 
  AMP SXT OX CIP LOM  15 
  AMP S C K N E P DA  6, 11  
  AMP SXT P OX CIP LOM  15 
  AMP SXT S AMC OX CIP K N E LOM P DA  13 
  
AMP SXT S AMC OX CIP C K N CN E LOM 
P DA  
13 
    
Nasal mucosa S. aureus AMP P 
4 
  
AMP P TE OX C  17 
    
 
S. 
pseudintermedius AMP P 
21 
  AMP S C K N E P DA  6,11 
  AMP SXT S AMC OX CIP K N E LOM P DA  13 
  
AMP SXT P AMC OX CIP C K DA CN LOM S 
N  
17 
    
Skin S. aureus   
    
 
S. 
pseudintermedius AMP P 
20 
  AMP SXT OX CIP LOM  15 
  AMP S C K N E P DA  11,12 
  AMP SXT RD P OX CIP LOM  15 
  AMP SXT RD P OX FD CIP LOM  15 
  
AMP SXT P AMC OX CIP C K DA CN E LOM 
S N  
17 
    
AMP SXT S TE AMC OXA CIP K N CN E 
LOM P DA  
1,13 
*For abbreviations: see Table 2 
 
 
3.2. Prevalence of CoPS in veterinary professionals 
The analysis of the samples collected from the veterinary professionals showed 
that all of them had CoPS species in their hands. However, only two presented CoPS in 
the nasal mucosa and were identified as being S. aureus. Eight (88.8%)  S. aureus and 
five (55.6%) S. pseudintermedius were isolated from nine hand samples. All the S. 
 aureus were methicillin-sensitive (MSSA) and only one of the S. pseudintermedius was 
MRSP. The resistance pattern of the isolates is shown in Table 4.  
 
Table 4. Antimicrobial resistance pattern of CoSP species isolated from 2 body sites of 
the veterinary professionals. 
Site of isolation Isolated species Antimicrobial*  Number identifying the 
    Resistance profile Professional  
    
Hand S. aureus AMP P 1, 2, 3, 4, 5, 6, 7, 9, 9 
    
 S. pseudintermedius AMP P 1, 5, 6, 7, 8 
  AMP P OX 7 
    
Nasal mucosa S. aureus AMP P 2, 4 
    
  S. pseudintermedius     
*For abbreviations: see Table 2 
 
 
3.3. Prevalence of CoPS in objects and surfaces of the veterinary hospital 
Only three (33.3%) out of the nine samples collected from the veterinary objects 
harbored CoPS. Two were S. pseudintermedius and both methicilin-resistant. 
Staphylococcus aureus was isolated only in one object and was a MSSA. In particular, 
one MRSP isolate showed resistance to a high number of antimicrobials (Table 5).  
 
Table 5. Antimicrobial resistance pattern of CoSP species isolated from a surface and 
an object of the veterinary hospital. 
Objects harboring Isolated species Antimicrobial* resistance profile 
CoPS     
Cage floor S. pseudintermedius 
AMP SXT P AMC OX CIP K DA E 
LOM  
 S. pseudintermedius 
AMP SXT P AMC OX CIP K DA CN E 
LOM  
   
Computer keyboard S. aureus AMP P 
*For abbreviations: see Table 2 
 
 4. Discussion 
Taking into account the present results, it may be appropriate to draw attention 
to the potential use of CHROMagar Staph aureus as a very selective medium to isolate 
not only S. aureus but also S. pseudintermedius. This medium can overcome other 
culture media such as Mannitol-Salt agar and Blood Agar, due to its selectivity for CoPS 
species and by hampering the proliferation of contaminant bacteria (Simões et al., 2011; 
van Duijkeren et al., 2011). The origin of color differentiation between S. aureus and S. 
pseudintermedius colonies on CHROMagar Staph aureus remains uncertain, however, 
it is probably related to the chromogenic mixture mentioned by the manufacturer or to 
the pH indicator present in this culture media. Though this medium appears to be reliable 
for S. aureus and S. pseudintermedius identification, molecular methods such as PCR 
or PFGE should always be recommended as confirmatory methods.  
Regarding the prevalence of CoPS in the companion animals, it was observed 
that S. pseudintermedius isolates prevailed over S. aureus, which is not surprising 
(Hanselman et al., 2009; van Duijkeren et al., 2011). Staphylococcus aureus was mostly 
isolated from oral mucosa whereas S. pseudintermedius was equally present in the three 
body sites sampled. In fact, this finding is not in agreement with other reports, which 
stated that nasal and anal regions were the body sites more commonly colonized by S. 
pseudintermedius (Weese and van Duijkeren, 2010; Bannoehr and Guardabassi, 2012). 
It is also important to refer that S. pseudintermedius with different resistance profiles 
were isolated from the same animal and from the same sampled site. 
All S. pseudintermedius were multidrug-resistant, showing resistance toward at 
least two antimicrobial agents, which is in accordance with previous observations 
(Ruscher et al., 2010; Stegmann et al., 2010; Detwiler et al., 2013). Moreover, four out 
of 12 S. pseudintermedius isolated from the animals were MRSP. The high number of 
MRSP found in the companion animals may be related to a regular use of antimicrobial 
agents to treat these animals. Available data indicates that in Portugal the use of 
antimicrobial agents in animals, including the use of drugs that are critically important to 
human medicine, is one of the highest amongst 19 European countries (EMA, 2013) 
unfortunately, there is no detailed information regarding the use of antimicrobials in 
companion animals. The growing number of household pets and their increasing health 
care standards led to an augmented number of geriatric animals, which have an 
extensive medical history, including antimicrobial drug administration, and longer contact 
with owners, increasing both the risk of antimicrobial resistance emergence and inter-
species clonal spread. 
 In our work, the percentage of MRSP doubles the one of MRSA, supporting 
previous results (Ruscher et al., 2009) and represents an additional concern to the 
European efforts that are already trying to combat the spread of MRSA (EFSA, 2013). 
The close contact of small animals with people and also with other animals can promote 
the spread of resistant clones, namely methicillin-resistant clones, and may explain the 
increasing of MRSP species in small animals, even in healthy ones (Frank et al., 2009; 
Ruscher et al., 2010). A recent study that has screened healthy dogs in Portugal for the 
presence of nasal MRSA, concluded that those dogs may be a reservoir of MRSA that 
could be transmitted to humans, by direct contact (skin and mouth) or indirectly, via the 
household environment (Coelho et al., 2011). Thus, the high number of MRSA isolated 
from healthy dogs may also contribute to the disquieting scenario of MRSA in Portugal 
(according to the European Centre for Disease Prevention and Control, the proportion of 
MRSA amongst S. aureus clinical isolates in Portugal in the year 2011 was higher than 
50%) (ECDPC, 2013). 
All the veterinary professionals sampled in this study harbored CoPS species. 
These results substantiate that these professionals are very likely to be colonized by 
CoPS species, like are the pet owners (Hanselman et al., 2009; Frank et al., 2009; Morris 
et al., 2010). However, the potential risk to veterinary professionals health still to be 
investigated. 
Regarding the clinical environment, only a small percentage of objects harbored 
CoPS. However, a larger number of collected samples would certainly provide more 
information about these two Staphylococcus species present in the clinical environment. 
The presence of a MRSP with such a high antibiotic resistance pattern in the clinical 
environment can be worrisome in terms of public health and underlines the need of an 
exhaustive disinfection of clinical surfaces as well as good hand hygiene on the part of 
all veterinary professionals.  
The combined analysis of isolates from small animals, veterinary professionals 
and clinical environment led us to conclude that there was a MSSA phenotype common 
to eight veterinary professionals, one clinical object (computer keyboard) and three 
animals (AMPR PR). A MSSP phenotype was common to one veterinary professional and 
four dogs (AMPR PR) and two MRSP isolates (one from a dog and one from the computer 
keyboard showed the same resistance pattern comprising simultaneous resistance 
against ampicillin, lomefloxacin, oxacillin, clindamycin, ciprofloxacin, amoxicillin, 
erythromycin, gentamicin, neomicin, sulfamethoxazole/trimethoprim, kanamycin, 
streptomycin and  penicillin. These findings may be an indication of possible cross 
 contamination and dissemination of S. aureus and S. pseudintermedius clones among 
the three types of carriers analyzed in this study. Although the colonization mechanism 
remains unknown, a longitudinal study could provide additional information on how these 
contaminations might occur. 
 
 
5. Conclusion 
In this study, a phenotypic identification method, using CHROMagar Staph 
aureus, turned out to be very reliable in the identification of S. aureus and S. 
pseudintermedius isolated from animal, human and abiotic sources and, thus, can be 
very helpful in veterinarian clinical diagnostic practices. CoPS isolated herein showed 
diverse antimicrobial resistance patterns and several methicillin-resistant 
Staphylococcus species were found in the different sources sampled, underlining that 
dissemination of resistance clones is very likely to happen in the veterinary environment. 
Therefore, our results highlight the necessity of taking precautions in order to avoid the 
spread of multidrug-resistant strains, and in particular methicillin-resistant 
Staphylococcus, among animals and humans (owners and veterinary professionals). 
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Figure I. Macroscopic image of CHROMagar Staph aureus medium with purple and blue colonies (S. 
pseudintermedius) and mauve and dark mauve colonies (S. aureus).  
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Abstract 
Este estudo teve como objectivos: i) a determinação da prevalência da 
resistência aos antimicrobianos em E. coli e enterococos fecais isolados de cães (n=78) 
e gatos (n=22) atendidos no Hospital Veterinário da Universidade do Porto (UPVET); e 
ii) a análise da correlação estatística dos factores de risco que, potencialmente, a 
influenciam. 
As amostras foram recolhidas de Setembro de 2009 a Maio de 2012. Após 
explicação dos objectivos do estudo, solicitou-se a cada proprietário participante o 
preenchimento de um questionário. A amostragem foi realizada através de zaragatoa 
rectal. O isolamento de E. coli (n = 398) e Esterococcus spp. (n = 315) realizou-se 
mediante sementeira em TBX agar e Slanetz & Bartley, respectivamente. A 
susceptibilidade aos antimicrobianos foi determinada através da técnica de difusão em 
agar. Para o processamento estatístico utilizou-se um modelo de análise multivariada 
multinível (GLMM), atendendo a que a cada animal correspondiam mais do que um 
isolado. 
 Os resultados destacaram-se pelas elevadas taxas de resistência de E. coli. O 
tratamento prévio com quinolonas e a prática de coprofagia foram os factores de risco 
mais significativamente associados à resistência a ciprofloxacina, cefalotina, cefoxitim, 
ceftazidima, cefotaxime, gentamicina, estreptomicina e trimetroprim-sulfametoxazol. 
A co-selecção de resistências antimicrobianas fomentada pelo uso de 
quinolonas teve, provavelmente, um papel preponderante na elevada frequência e 
diversidade de resistências antimicrobianas. No caso particular da coprofagia, os efeitos 
podem transcender a “ingestão” de estirpes fecais presentes em outros animais, em 
virtude de quantidades subinibitórias de antimicrobianos também poderem estar 
presentes nas fezes. Estes resultados ilustram os efeitos selectivos resultantes da 
administração de antimicrobianos, poderão auxiliar a classe médico-veterinária a 
orientar a sua prescrição em função de eventuais impactos para a saúde pública e, não 
menos importante, estimulam os proprietários a adoptarem medidas de maneio e 
higiene mais seguras. 
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A pressão seletiva originada pelo uso de antimicrobianos na medicina humana e veterinária tem contribuído 
para a emergência de estirpes bacterianas multirresistentes. Porque os animais e os seus proprietários partilham o 
mesmo espaço habitacional, apresentando comportamentos de contacto próximo, existe uma hipótese elevada de 
transferência microbiana inter-espécie. Ante esta possibilidade é importante escrutinar o papel dos animais de 
companhia enquanto reservatórios assim como a sua envolvência na disseminação de estirpes bacterianas 
multirresistentes. Importa também, investigar o papel das superfícies e objetos domésticos, como potenciadores 
deste fenómeno. Assim, com este trabalho pretendeu-se inferir sobre a partilha de clones de Escherichia coli e 
Enterococcus spp. com elevadas resistências, em agregados familiares (humanos e seus animais de companhia) 
avaliando também a sua possível disseminação no ambiente doméstico.  
Previamente, em animais que apresentavam historial de várias terapias antimicrobianas, consultados no 
Hospital Veterinário do ICBAS – UPVET, foram recolhidas zaragatoas de fezes, mucosa oral, pelo, e em alguns 
casos, dos seus proprietários e ambiente doméstico. O processamento das zaragatoas permitiu o isolamento de 
estirpes que foram submetidas a testes de suscetibilidade antimicrobiana e seleção de isolados com perfis de 
resistência similares. A técnica de multiplex PCR foi utilizada para caracterização de filogrupos (Escherichia coli) e 
identificação de espécie (Enterococcus spp.). A avaliação da proximidade clonal entre isolados foi efetuada por 
genótipagem (ERIC PCR e PFGE). 
Nos “agregados familiares” estudados foi observada uma partilha frequente de clones de Escherichia coli e 
Enterococcus faecalis com múltiplas resistências, isolados em fezes, mucosa oral e pelo de cães e gatos e fezes e 
mãos dos respetivos proprietários, evidenciando-se assim uma possível transferência entre coabitantes, que pode 
ocorrer em ambos os sentidos. Ficou também comprovado com percentagens elevadas de similaridade genotípica 
que essa disseminação ocorre para o ambiente doméstico, envolvendo objetos dos animais e de uso comum. Os 
resultados obtidos reforçam a necessidade de um uso prudente dos antimicrobianos, pois elevados padrões de 
resistências terão um impacto na qualidade de vida dos animais e também na saúde humana. Adicionalmente 
importa sensibilizar os proprietários para a necessidade de uma maior vigilância relativamente às formas de 
interação com os animais, bem como para a adoção de medidas higiénicas cautelares após essa mesma interação. 
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The selective pressure caused by the excessive use of antimicrobials, both in human and veterinary 
medicine, has triggered the emergence of multidrug-resistant bacterial strains. Since animals and their owners share 
the same living space, with close contact behaviors, there is a chance of inter-species microbial transfer. Taking into 
account this hypothesis, it is important to scrutinize the role of companion animals as a reservoir of bacterial strains, 
as well as their involvement in the dissemination of multidrug-resistant bacteria. It is also important to investigate 
the role of surfaces and objects shared by both animals and humans, as potential enhancers of this phenomenon. 
Hence, with this work, it was sought to infer about the sharing of Escherichia coli and Enterococcus spp. clones in 
households (humans and their pets) as well as observe their dissemination across the domestic environment. 
 Previously, in companion animals that had been prescribed with various antimicrobial therapies 
and that had appointments in the Veterinary Hospital of ICBAS-UP - UPVET, swabs from their feces, oral mucosa 
and hair were collected, and in some cases from their owners, as well as from the domestic environment. Swabs 
were processed and antimicrobial susceptibility tests were performed which allowed the selection of isolates with 
similar resistance phenotypes. Multiplex-PCR techniques were used to characterize phylogenetic groups 
(Escherichia coli), and to species identification (Enterococcus spp.). Genotyping techniques - ERIC PCR, PFGE - 
were used to study the clonal proximity between isolates.  
In the studied households, it was observed the sharing of Escherichia coli and Enterococcus faecalis clones 
with multiple resistances, among cats and dogs’ feces and oral mucosa, and their respective owners hands and feces, 
being evident that there was a possible direct transmission between cohabitants. Such transference can occur in both 
directions. It has also been demonstrated with large rates of similarity in the genotypic profile that this dissemination 
also occurs in the home environment, with transference to common use and animal objects. Regarding these results, 
it is easily noticeable that it is necessary to use antibiotics cautiously since high resistance levels will have an impact 
on pet’s quality of life, but also on human health. Additionally, it’s important to make the owners aware of the need 
of greater vigilance on how they interact with the animals, as well as for the adoption of precautionary hygienic 
measures after that interaction. 
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Avanços na medicina veterinária e uma maior sensibilidade por parte da
população em relação à saúde e bem-estar dos animais de companhia
estão associados com o aumento da população geriátrica, que
necessita de múltiplas terapias antimicrobianas. Este facto leva à
emergência de multirresistências tanto nas bactérias patogénicas como
na flora comensal endógena. Atualmente, os animais de companhia e
os seus proprietários partilham o mesmo espaço habitacional,
apresentando comportamentos de contacto próximo, devido à corrente
perceção destes animais como membros da família [1][2], pelo que
existe uma hipótese elevada de transferência microbiana entre estes
coabitantes. Ante esta possibilidade é importante escrutinar o papel dos
animais de companhia enquanto reservatórios assim como o seu papel
na disseminação de estirpes bacterianas multirresistentes. Importa
também, investigar o papel das superfícies e objetos domésticos, como
potenciadores deste fenómeno. Existem alguns estudos longitudinais
envolvendo agregados que verificaram a transmissão de clones de
Escherichia coli entre familiares e animais de estimação. Dentro de um
agregado familiar foi verificado que o clone responsável pela ITU da
mãe era partilhada por vários membros, incluindo o cão [3].
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ESTUDO DA PARTILHA DE CLONES 
BACTERIANOS ENTRE ANIMAIS DE 
COMPANHIA, COABITANTES HUMANOS E 
SUPERFÍCIES DOMÉSTICAS
Neste trabalho pretendemos inferir sobre a partilha de clones de E. coli
e Enterococcus spp. com elevadas resistências, entre os proprietários e
os seus animais de companhia, avaliando também a sua possível
disseminação no ambiente doméstico.
Os objetivos do estudo foram explicados aos proprietários e uma
autorização formal foi assinada. Em animais que apresentavam historial
clínico de várias terapias antimicrobianas, consultados no Hospital
Veterinário do ICBAS – UPVET (Porto, Portugal), foram recolhidas
zaragatoas de fezes, mucosa oral e pelo. Quando os proprietários
aceitaram colaborar na fase seguinte do estudo, foram pedidas
zaragatoas das suas mãos e fezes, assim como colheitas noutros
animais coabitantes e de superfícies/objetos de suas casas. Todos os
participantes preencheram um questionário para recolha de um conjunto
de informações pessoais e médicas.
Figura 2 – Dendrograma Agregado A obtido por PFGE - Este agregado é constituído por uma cadela com uma doença crónica de pele para a qual foi tratada com várias terapias antimicrobianas assim
como o seu proprietário, (e.g. amoxicilina - ácido clavulânico, ciprofloxacina). Do “agregado familiar” fazia também parte um neto ainda bebé e uma gata de interior, saudáveis e sem terapias anteriores.
Isolaram-se estirpes de E.coli com fenótipos de resistência similar procedendo-se a estudos de proximidade clonal por genotipagem (PFGE). A vermelho estão realçados alguns conjuntos de isolados com
similaridades superiores a 94%.
Detetou-se transferência de clones bacterianos com múltiplas
resistências entre os coabitantes humanos e animais do mesmo
agregado familiar, com disseminação para superfícies e objetos
domésticos
É necessário:
- Fazer um uso prudente dos antimicrobianos - impacto na qualidade de
vida dos animais e também na saúde humana.
- maior vigilância nas formas de interação com os animais e a adoção de
medidas higiénicas cautelares após essa interação.
Introdução
Objetivos
Métodos
Resultados
Conclusão
Disseminação de um clone de E.coli com múltiplas resistências da boca 
e fezes da cadela para o ambiente doméstico. 
Partilha de um clone de E.coli multirresistente entre a cadela e o seu 
proprietário
Figura 3 – Dendrograma Agregado E obtido por PFGE - Este agregado é constituído por um cão (cão A) que apresenta otites alérgicas e purulentas, motivo pelo qual foi sujeito a várias terapias
antimicrobianas. Do mesmo agregado faziam parte outro cão (cão B) e uma cadela, saudáveis, assim como os seus proprietários. Selecionaram-se estirpes de E.coli com um perfil de resistência similar e
aparentemente disseminado, procedendo-se a estudo genético por PFGE. Isolaram-se também quatro conjuntos de Enterococcus faecalis, organizados com base em quatro fenótipos de resistências que
se encontravam disseminados, que foram analisados por ERIC PCR (dendrograma não apresentado, representativo das mesmas conclusões) .
Disseminação de um clone de E. coli  entre diferentes membros do 
agregado e ambiente doméstico. 
Um clone de E. coli colonizou várias partes do corpo do animal, além do 
trato intestinal.
Referências: [1] Guardabassi et al. (2004) The Journal of Antimicrobial Chemotherapy, 54(2), 321–32. [2] Voith, V. L. (1985) The Veterinary clinics of North America. Small animal practice, 15(2), 289–95 [3] Johnson, J R, & Clabots, C.
(2006). Clinical infectious diseases, 43(10), e101–8 [4] Clermont et al. (2000). Applied and environmental microbiology, 66(10), 4555–8. [5] Jackson et al. (2004). Journal of clinical microbiology, 42(8), 3558–65. [6] Versalovic et al. (1991). Nucleic
acids research, 19(24), 6823–31. [7] Barrett et al. (1994). Journal of clinicalmicrobiology, 32(12), 3013–7.CLSI 2007 – Clinical and Laboratory Standards Institute ,Performancestandards for antimicrobial susceptibility testing.
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Figura 1 – Seleção de isolados com base na semelhança do seu
fenótipo de resistência e perfil com múltiplas resistências.
Para interpretação da proximidade clonal dos isolados foi utilizado um
cutoff de 94%, em que os isolados que apresentassem maior ou igual
percentagem seriam considerados como sendo o mesmo clone [3].
Cinco agregados foram arrolados para estudo, apenas os resultados de
dois são demonstrados neste poster, devido às dimensões dos
dendrogramas resultantes.
Abreviaturas: AK - Amicacina , AMC - Amoxicilina/ácido clavulânico , AMP - Ampicilina, ATM - Aztreonamo, AZM - Azitromicina, C - Cloranfenicol , CAZ - Ceftazidima , CIP - Ciprofloxacina , 
CN - Gentamicina , CTX - Cefotaxima , E - Eritromicina , F – Nitrofurantoína, FOX - Cefoxitina , IPM - Imipenem , K - Kanamicina , KF - Cefalotina , NA - Ácido nalidíxico , S - Estreptomicina , 
SXT - Sulfametoxazol/trimetoprima, TE - Tetraciclina , TOB - Tobramicina , ITU – Infeção do trato urinário.
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In the last decade, there has been an increasing awareness of the potential 
problems that selection of antimicrobial resistant bacteria among companion animals 
may cause on human health, due to the increasing use of the same antimicrobial 
substances in both species and to the close contact between pets and their human co-
habitants. 
The aims of the present study were to characterize the antimicrobial resistance 
profiles among Escherichia coli and enterococci strains isolated from cohabitant pets 
and humans, evaluating the concurrent colonization of pets, owners and home surfaces 
by bacteria carrying the same antimicrobial resistance genes. 
Three domestic aggregates (A, B and C) were selected from the universe of 
clients of UPVET (Porto University Veterinary Clinic, Portugal). After a study explanation, 
clients signed the agreement and ethical documents and answered to a complete 
questionnaire. Samples were delivered and/or collected as soon as possible (faeces, 
urine, oral swabs, home surfaces swabs and hands swabs) and E. coli and enterococci 
were isolated. Susceptibility to antimicrobial agents was tested using the disk diffusion 
method. The identification of antimicrobial resistance genes was made through 
polymerase chain reaction amplification using previously described probes.  
From the aggregate A, a total of 124 E. coli isolates were recovered displaying 
24 different resistance patterns with a remarkable percentage of multi-resistant ones 
 (46% displayed simultaneous resistance to at least nine different antimicrobials). Strains 
displaying the same resistance patterns were isolated from the dog’s urine and mouth, 
laundry floor, refrigerator door and dog’s food bowl. Other multi-resistant phenotypes 
and resistance genes were found repeatedly in different inhabitants and surfaces of the 
house. From the domestic aggregate B, the same resistance phenotype was found 
among enterococci isolated from the cat faeces and the two home inhabitants (female 
owner and her daughter). Finally, from the domestic aggregate C, enterococci isolated 
from faeces and oral secretions of the dog and the hands of both owners exhibited the 
same resistance pattern encompassing simultaneous resistance against eight 
antimicrobial drugs. In order to analyse phylogenetic and epidemiological relations 
between the E. coli strains from domestic aggregate A, a polymerase chain reaction 
(PCR) of enterobacterial repetitive intergenic consensus sequences (ERIC) was 
performed. Through the dendrogram overview, the same isolates (100% similarity) 
existed in the dog mouth, it’s food bowl, the kitchen floor and the refrigerator door. With 
93% similarity the above strains plus the ones from the dog’s faeces and urine, the cat 
faeces and its owner faeces, can be said to belong to the same clone.  
Direct, close contact between all the cohabitants and the touch of contaminated 
household surfaces and objects could be an explanation for these observations. These 
findings raise questions regarding the potential contribution of shared household 
surfaces in antimicrobial resistance transfer between animal and human cohabitants. 
Finally it was established that a pet can orally transport E. coli strains with the same 
antimicrobial resistance profile of their faecal and urinary strains, which could be 
explained by some frequent behaviour of dogs such as rolling on faeces, grooming and 
perigenital licking. The presence of those resistant strains in the dog’s mouth is likely to 
have played a key role in their spread. Although resistance patterns are not static, the 
genotypic and phenotypic correspondences demonstrated in this applied study suggest 
interspecies transmission. Furthermore, the finding that almost all of the resistance 
genes were also present among strains isolated from the household environment, could 
be indicative of an in-home and through-home transmission.  
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Introduction
Antimicrobial resistance is a major public-health problem worldwide [2,3]. In the last decade, there has been an increasing awareness of the potential problems that the selection of antimicrobial
resistant bacteria among companion animals may cause on human health due to the increasing use of the same antimicrobial substances in both species and to the close contact between pets
and their human co-habitants [2].
The aims of the present study were to characterize the antimicrobial resistance profiles among Escherichia coli and enterococci strains isolated from cohabitant pets and humans, evaluating the
concurrent colonization of pets, owners and home surfaces by bacteria carrying the same antimicrobial resistance genes, assessing the possible contribution of household surfaces to the in-
home and through-home spread of antimicrobial resistance.
Materials and Methods
Three domestic aggregates (A, B and C) were selected from the universe of clients of UPVET (Porto University Veterinary Clinic, Portugal). After a study explanation, clients signed the
agreement and ethical documents and answered to a complete questionnaire about environment, human and veterinary medical records with antibiotic usage by themselves, family members
and their pets. Samples were delivered and/or collected as soon as possible (faeces, urine, oral swabs, home surfaces swabs and hands swabs) and E. coli and enterococci were isolated
according to protocols followed by others [1,3,4]. Susceptibility to antimicrobial agents was tested using the disk diffusion method and clinical and laboratory standards guidelines were followed
(CLSI, 2007). The identification of antimicrobial resistance genes was made through polymerase chain reaction amplification using previously described probes [1,3,4].
Discussion
Direct, close contact between all the cohabitants and the touch of contaminated household surfaces and objects could be an explanation for the above observations. These findings raise
questions regarding the potential contribution of shared household surfaces in antimicrobial resistance transfer between animal and human cohabitants. Finally it was established that a pet can
orally transport E. coli strains with the same antimicrobial resistance profile of their faecal and urinary strains, which could be explained by some frequent behaviour of dogs such as rolling on
faeces, coprophagy, grooming and perigenital licking. The presence of those resistant strains in the dog’s mouth is likely to have played a key role in their spread. Although resistance patterns
are not static, the genotypic and phenotypic correspondences demonstrated in this applied study suggest interspecies transmission. Furthermore, the finding that almost all of the resistance
genes were also present among strains isolated from the household environment, could be indicative of an in-home and through-home transmission.
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Domestic aggregate A
resistance pattern1
AMPR ATMR CEFR CAZR GENR STRR TOBR KANR CIPR NALR TETR CHLR SXTR
AMPR ATMR CEFR CAZR STRR CIPR NALR TETR CHLR
resistance pattern2
resistance pattern 1
Q-DR TETR RIFR ERYR AZMR CIPR
Domestic aggregate B Domestic aggregate C
resistance pattern 1
AMPR Q-DR TETR RIFR ERYR GENR AZMR CHLR
Results
Escherichia coli enterococci enterococci
From aggregate A, one multidrug-resistant strain isolated from the dog’s faeces was also found in it’s oral cavity; the isolate from the dog’s urine was found in it’s mouth, laundry floor,
refrigerator door and dog’s food bowl. Other multi-resistant phenotypes and resistance genes were found repeatedly in different inhabitants and surfaces of the house. From the domestic
aggregate B, the same resistance phenotype was found among enterococci isolated from the cat faeces and from two of the home inhabitants. From the domestic aggregate C, enterococci
isolated from faeces and oral secretions of the dog and the hands of both owners exhibited the same resistance pattern encompassing simultaneous resistance against eight antimicrobial
drugs.
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Abstract 
Staphylococcus aureus and Staphylococcus pseudointermedius are well 
recognized as potential pathogens in both animal and human medicine. In the present 
study, oral, nasal and skin swabs were collected from 21 dogs and 2 cats attended in a 
Veterinary Hospital in Porto, Portugal, from veterinary practitioners and auxiliary workers 
(hands and nose), and from nine different contact surfaces used by veterinary 
practitioners, auxiliary workers and animals.  
Swabs were cultured in Baird Parker – Rabbit Plasma fibrinogen (Biokar) and 
incubated at 37o C for 36 hours. Subsequently all coagulase-positive Staphylococcus 
were subcultured onto Chromagar STAPHaureus (CHROMAGAR) and then screened 
for antimicrobial susceptibility.  Polymerase Chain Reaction was performed with primers 
for S. aureus (au-F3, and au-nucR) and S. pseudointermedius (pse-F2, pse-R5,) in order 
to identify the Staphylococcus species. 
 All colonies exhibiting typical S. aureus morphology (mauve colour) and all 
purple-blue coloured colonies were identified as S. aureus and S. pseudointermedius, 
respectively. This procedure has proven to be reliable for S. pseudointermedius isolation, 
being an alternative to the laborious and time consuming biochemical tests. 
Among the tested animals, 65.2% (n=15) carried coagulase-positive 
Staphylococcus: 30.4% (n=7) S. aureus and 52.2% (n=12) S. pseudointermedius. Two 
dogs (8.7%) carried methicilin resistant Staphylococcus aureus (MRSA) and four 
(17.4%) dogs were colonized with methicilin resistant Staphylococcus 
pseudointermedius (MRSP). Antimicrobial resistances to amoxicillin, thrimethropim-
sulphamethoxazole and lomefloxacin were the most common in MRSP carriers. Four 
animals carried both S. aureus and S. pseudointermedius from the same swabs. In two 
animals, MRSP isolates presenting more than one antimicrobial resistance profile were 
found in the isolation place. Oral and nasal mucosae were the animal locations where 
more S. aureus bacteria were isolated while S. pseudointermedius were isolated mostly 
in oral mucosae and skin. 
Among the environment swabs, S. pseudointermedius was isolated from the floor 
of the Hospital recovery area and the computer keyboards, both isolates being MRSP. 
S. aureus was found only in computers keyboards. 
Regarding the nine veterinary practitioners and auxiliary workers tested, in all 
hand samples and in 22.2% of the nasal swabs, Staphylococcus displaying coagulase 
positive activity were isolated. Hand isolates consisted of S. aureus in 88.9% (n=8) and 
S. pseudointermedius in 55.6% (n=5), one of which was MRSP. Only 22.2% (n=2) 
presented S. aureus in nose samples and none S. pseudointermedius was isolated. 
S. aureus isolated from computer keyboard and veterinary practitioners displayed 
the same resistance pattern. 
This last fact alerts to the necessity of good hygiene practices such as hand 
washing, aseptic practices and good surface disinfection during all processes of animal 
management. 
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Culture media for isolation of Staphylococcus pseudointermedius and Staphylococcus spp 
coagulase positive -prevalence in domestic animals, veterinary practitioners, veterinary 
auxiliary workers and environment of a Veterinary Hospital
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The combined use of BHI supplemented with Tween 80 and further culture on Baird Parker- RPF and CHROMagar Staphaureus confirmation appears to be a very
reliable method for Staphylococcus pseudointermedius isolation.
Antimicrobial resistance pattern for each animal attending the small animal clinic might seem necessity in every pathological cases, in order to perform an animal
effective treatment. Mutual information exchange between Microbiology Laboratories and Small Animal Clinic/ Hospitals can not only provide an effective animal
treatment but also avoid empirical antibiotic treatments and public health threats.
Good hygiene practices such as hand washing, aseptic practices and good surface disinfection are key factors during all animal management processes.
1
2
3
4
Phenotipe Number (%)
MSSA 5 (21.7 %)
MRSA 2 (8.7 %)
MSSP 8 (34.8 %)
MRSP 4 (17.4 %)
Figure 1. Macroscopique picture
of S. pseudointeremedius colonies.
S. pseudointermedius coagulase
positive activity started 4 hours
after the plaque was left at
environmental temperature
(22-24 oC)
Figure 2.  CHROMagar STAPhaureus colony
colours: S. pseuintermedius purple (1) and
blue (2) colors; S. aureus mauve (3) and dark
mauve (4) colours
S. pseudointermedius were isolated the most at oral mucosae and skin
S. aureus were isolated the most at oral mucosae
Methicilin Susceptible
Staphylococcus aureus
Resistance pattern
AMPR PENR
Table 1. Prevalence by phenotipe of the isolated coagulase positive 
Staphylococcus on the 23 tested animals
Methicilin Susceptible
Staphylococcus pseudointermedius
Resistance pattern
AMPR PENR
Methicilin Resistance
Staphylococcus pseudointermedius
Resistance pattern 1
AMPR SXTR STRR PENR AMCR OXR CIPR KANR DAR ERYR LOMR NR
Resistance pattern 2
AMPR SXTR STRR PENR AMCR OXR CIPR KANR DAR CNR ERYR LOMR NR
Resistance pattern 3
AMPR PENR OXR
Clinic computer
keyboard Clinic recovery area and pavement
(n=3) (n=1)
(n=4)
Small animal attended at the clinic
INTRODUCTION
Staphylococcus aureus and Staphylococcus pseudointermedius are two coagulase positive Staphylococcus with high relevance in Veterinary Medicine (Weese et al,2010). S. pseudointermedius is a
comensal bacteria in small animal which can be associated to Immunocompromised cases, atopic allergy cases or surgical procedures (Bannoehr and Guardabassi, 2012).
MATERIAL AND METHODS
Oral, nasal and skin swabs were collected from 21 dogs and 2 cats attended in a Veterinary Hospital in Porto, Portugal, from veterinary practitioners and auxiliary workers (hands and nose), and from
nine different contact surfaces used by veterinary practitioners, auxiliary workers and animals. Swabs were cultured in Baird Parker – Rabbit Plasma fibrinogen (Biokar) and incubated at 37o C for 24
hours. Plaques observation for coagulase activity were done at 24 and then let at environmental temperature between 22-24oC for further coagulase activity observation.Subsequently all coagulase-
positive Staphylococcus were subcultured onto Chromagar STAPHaureus (CHROMAGAR) and then screened for antimicrobial susceptibility test. Polymerase Chain Reaction was performed with
primers for S. aureus (au-F3, and au-nucR) and S. pseudointermedius (pse-F2, pse-R5,) in order to identify the Staphylococcus species. (Sasaki et al. 2010).
RESULTS
Figure 3. Eletrophoresis in 1.5 % gel agarose after PCR 
1-5 primers pse-F2 e pse-R5 – S. Pseudointermedius // 6-10 primers au-F3 e au-nucR
– S. Aureus // 11-15 – without adding primers [1,6,11] Animal ID6 oral sample
DNA(not relevant for this case) // [2,7,12] Animal ID22 oral sample DNA ,mauve
colour in CHROMagar // [3,8,13] Animal ID22 oral sample DNA ,purple colour in
CHROMagar // 4,9,14- Animal ID22 oral sample DNA blue colour in CHROMagar //
[5,10,15]- S. aureus ATCC 25 293 DNA
CONCLUSIONS
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